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Abstract 
Health care for individuals living with myotonic dystrophy (DM1)—an uncommon, life-
limiting neurological condition for which there are few treatments—may be challenged by 
patients’ symptoms including cognitive and behavioral impairments.  Is patient-centered 
care—which incorporates the values, experiences and expertise of patients and their 
caregivers—feasible or achievable?  Uncovering patients’ and their caregivers’ experiences 
of living with DM1, their health care expectations, and their health care providers’ (HCP) 
perspectives about care is essential for examining patient-centered care in this population.  
Therefore, the purpose of this research is to: (1) add patients’ and caregivers’ voices to the 
literature, (2) explore on-going care provision for individuals with DM1, and (3) probe 
whether patients’ and caregivers’ needs are being met.     
Forty-nine participants were purposively sampled from one academic centre in Ontario, 
Canada to participate in three studies.  Phenomenology, photovoice and grounded theory—
qualitative methodologies that prioritize participants’ experiences and recognize that 
researchers and participants co-construct the data—were used to explore patients’, 
caregivers’ and HCPs’ experiences about living— or caring for individuals—with DM1.  
Semi-structured interviews were the primary data collection method; focus groups and 
photographs were also used in the photovoice study.  Data analysis varied by methodology.    
Patient and caregiver participants’ described that DM1 symptoms—particularly fatigue and 
weakness— impacted their daily activities and sense of self; however, participants were 
resilient and problem-solved coping strategies.   Patient and caregiver participants’ 
motivations for clinic attendance evolved along the disease trajectory, but most participants 
perceived that clinic attendance had tangible benefits. HCPs described that their main role 
was to provide hope for patients and their families. Most importantly, this research revealed 
that patient, caregiver and HCP participants described clinic as a ‘safe place’ for patients and 
caregivers to be understood, and to be empowered to take a proactive role in health care.   
DM1 participants derived a therapeutic benefit from attending clinic despite providers’ 
concerns that patient-centered care was challenged by complex biopsychosocial issues.  This 
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research raises questions about whether a physician-led model is the most efficient mode of 
care provision, or whether other models warrant investigation. 
Keywords 
Myotonic Dystrophy; caregiver; dysphagia; Huntington’s disease; patient-centered care; 
qualitative research 
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Chapter 1  
1 Introduction 
“Helping patients to be more active in consultations changes centuries of physician-
dominated dialogues to those that engage patients as active participants” (Epstein & 
Street, 2011, p. 100). ‘Patient-centered care’ is widely accepted as a key component of 
quality health care (Institute of Medicine, 2014), and health care professionals (HCPs) are 
taught and encouraged to put patients at the centre of clinical care.   However, patient-
centered care is poorly defined and variably enacted in practice (Berwick, 2009).  What, 
then, is ‘patient-centered care’, and is it achievable for all patients, particularly those 
challenged by cognitive and behavioral impairments?   To explore this, I used a variety of 
qualitative research methodologies and methods to explore on-going clinical care 
provision for individuals living with myotonic dystrophy (DM1).   DM1—the most 
common adult muscular dystrophy—is a chronic, progressive and life-limiting, multi-
system neurological disorder in which affected individuals may experience apathy and 
borderline IQ (Harper, 2001).   
Research suggests that care for individuals with muscular dystrophy may be insufficient 
(Hill & Phillips, 2006); in particular, care for individuals with DM1 may be complicated 
by patients’ variable symptoms, their complex biopsychosocial needs, few treatment 
options, or patients’ and health care providers’ divergent goals (Heatwole, 2012; Gagnon 
et al, 2010; Meola & Sansone, 2007; Udd & Krahe, 2012).   Despite these challenges, 
only two studies have used qualitative research methods to explore perspectives about on-
going clinical care for patients with muscular dystrophy (Hartley, Goodwin & Goldbart, 
2011; Nätterlund & Ahlström, 1999).  Only 18 individuals with DM1 participated in this 
research, suggesting that DM1 patients’ voices are relatively absent from the literature 
when compared to patient populations with other uncommon neurological conditions 
(LaDonna, 2011).  There is also insufficient research regarding caregivers’ and HCPs’ 
perspectives about care for individuals with DM1.  
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No exploration or evaluation of patient-centred care can be complete without including 
and accounting for the voices and the experiences of the patients, caregivers and health 
care providers who are at the centre of that care. The goal of this research is to add DM1 
patients’, caregivers’ and HCPs’ perspectives to the literature, and to explore the current 
clinical care model at one academic centre in Ontario, Canada.  Three qualitative research 
methodologies—phenomenology (van Manen, 1990), photovoice (Wang & Burris, 1994; 
1997) and grounded theory (Charmaz, 2006)—that recognize, prioritize and emphasize 
individual experience were used.   In this introduction, I will locate myself within the 
constructivist qualitative research paradigm, describe how I came to my interest in 
patient-centered care, introduce DM1 and care provision for these individuals, describe 
‘patient-centered care’, and state my research questions. 
1.1 Background 
Hereditary neurological conditions like DM1 may have a physical, emotional, and social 
impact on individuals and their families, particularly when there are few effective 
treatments and no cure.  I speculate that the lack of curative treatments—coupled with 
DM1 patients’ complex and variable symptom presentation—may complicate on-going, 
patient-centered care provision.  However, patients’, caregivers’, and HCPs’ perspectives 
about patient-centered care provision (and on-going follow-up) in DM1 have not yet been 
explored.  I contend that any exploration is challenged by (1) the relative absence of DM1 
patients’ voices from the literature, and (2) the lack of a uniform definition or 
conceptualization of what ‘patient-centered care’ is, or how it is experienced in practice 
(Berwick 2009).   
1.1.1 Locating the Researcher 
My interest in patient-centered care stems from experiences working with patients with 
neurodegenerative conditions, their caregivers and health care providers in a variety of 
professional contexts.  I began working in the Department of Neurology at the University 
of Rochester in Rochester, New York as a fifteen-year-old summer student hired to do 
filing and data entry for research that explored experimental therapeutics for patients with 
Huntington’s and Parkinson’s disease.  This experience gave me a behind-the-scenes look 
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at—and an appreciation for—the long, and sometimes arduous, process of clinical trials 
research.  I had the opportunity to work with international leaders in Parkinson’s and 
Huntington’s disease research and witnessed first-hand their passion to try to find 
answers—if not tangible treatments—that would improve the daily lives of their patients.  
Their passion sparked my own interest in health research, and I pursued a dual Bachelors 
of Arts degree in English and Communication with a specialization in Health 
Communication.  Throughout my studies, I continued with secretarial and administrative 
tasks in a neurology outpatient clinic where I had the opportunity to interact with patients 
and observe their relationships with their providers.   My growing interest in patient-
centered health care led to an internship with the Huntington’s Disease Society of 
America (HDSA) where my duties included charitable fundraising, organizing patient 
education and advocacy events, and serving on the Board of Directors for the HDSA 
Upstate New York Chapter.  In addition, I acted as a support group facilitator for patients 
and families with Huntington’s disease and young onset Parkinson’s disease, an 
experience that illuminated how these conditions impact patients’ and families’, and 
underscored their resiliency while living with a chronic and progressive health condition.     
My research career began as a clinical research coordinator for studies exploring 
depression and Parkinson’s disease and the natural histories of rare neuromuscular 
disorders.  My work with Dr. Shannon Venance and Wilma J. Koopman, Nurse 
Practitioner on a groundbreaking project exploring the transition of young men with 
Duchenne Muscular Dystrophy from the pediatric to the adult neuromuscular clinic 
introduced me to the impact that qualitative research methodologies and methods may 
have on exploring illness experiences and health care.  This research led me to pursue 
graduate studies using qualitative methodologies.  My doctoral research program has 
provided insight into the day-to-day experiences of individuals living with chronic 
neurological conditions, and emphasizes the importance of qualitative research for adding 
individuals’ voices to the literature. 
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1.1.2 Locating the Researcher Within the Qualitative Research 
Paradigm 
Guba and Lincoln (1994) define a research paradigm as a worldview that guides a 
researcher’s epistemological and ontological approach to inquiry.  In particular, 
epistemology is a theory of knowledge that considers what can be known and the 
relationship between the ‘knower’ and the ‘known’, while ontology refers to the ‘form 
and nature of reality’ (Guba & Lincoln, 1994).    Common research paradigms include 
positivism, postpositivism, post-modernism and constructivism.  Given my personal and 
professional experience working with individuals with chronic neurological illnesses, I 
come to this research with assumptions, biases, and theoretical presuppositions.  In 
particular, I believe that individuals have the best insight into how their disease impacts 
their lives, and are thus able to provide important information to health care professionals 
that may improve health care.  Further, researchers do not come into the research field 
without leaving an imprint of their knowledge and interpretations.  The interplay between 
researchers and research participants is not only unavoidable, but is essential for 
developing authentic and important data.       
Therefore, I align myself within the constructivist paradigm.  The constructivist paradigm 
includes a relativist ontological position and transactional/subjectivist epistemological 
position (Guba & Lincoln, 1994).  Ontologically, a constructivist researcher believes that 
there are multiple realities that change over time.  Epistemologically, constructivists 
believe that data is co-constructed between the researcher and the participant.  Findings 
therefore are subjective, and there is not one objective truth that can be discovered.  As a 
relativist, I acknowledge that meanings are fluid and constructed by the language 
participants use to describe them (Finlay & Ballinger, 2006). 
1.2 Myotonic Dystrophy (DM1) 
Myotonic dystrophy (DM1) is a chronic, progressive, inherited and life-limiting 
neurodegenerative disorder.  DM1 is a multi-system condition presenting with central, 
muscular, endocrine, cardiac, ocular and gastrointestinal system abnormalities; in turn, 
patients may experience cognitive and behavioral manifestations, muscle weakness, 
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diabetes, arrhythmias, early-onset cataracts and incontinence (Harper, 2001).   Severe 
disability generally occurs in the fifth and sixth decades of life (Schara & Schoser, 2006), 
and respiratory failure, cardiac rhythm disturbances, and pneumonia are common causes 
of death for individuals with DM1 (de Die-Smulders et al., 1998; Mathieu et al., 1999).  
DM1 is caused by a CTG repeat expansion in the 3′ region of DMPK on chromosome 
19q13, and is autosomal dominantly inherited; consequently, each child of an affected 
parent has a 50% chance of inheriting the condition.  Moreover, DM1 is characterized by 
anticipation and symptoms are highly variable; that is, the condition tends to present 
earlier and with greater symptom severity in subsequent generations.  For example, 
individuals with shorter CTG repeat expansions may experience mild or minimally 
impactful symptoms while those with longer expansions may have significant physical 
disabilities and cognitive impairments (Harper, 2001).   Consequently, it is common for 
entire families to be affected; that is, a mildly affected parent may provide care for a 
severely affected child, or a non-affected caregiver may help manage the health of 
multiple family members.   
Researchers have developed a DM1 cognitive and personality profile suggesting that 
patients may have difficulty with executive function (Sistiaga et al, 2010) and display 
avoidant personality traits (Delaporte, 1998; Meola et al, 2003).  However, research 
examining cognitive and behavioral impairment in adult-onset DM1 is inconclusive.     
Some studies have found minimal or no difference in intelligence and cognitive function 
between individuals with DM1 and healthy controls (Gaul et al., 2006; Rubinsztein, 
Rubinsztein, McKenna, Goodburn, & Holland, 1997; Van Spaendonck et al., 1995).  
Others, however, have found significant differences (Perini et al., 1989; Perini et al., 
1999), and suggest that affected individuals have structural brain abnormalities including 
white matter lesions (Minnerop et al., 2011; Tanaka, Arai, Harada, Hozumi, & Hirata, 
2012) or frontal lobe impairments (Meola et al., 2003; Modoni et al., 2008; Sansone et 
al., 2007; Tanaka et al., 2012).  Cognition and personality may be related to patients’ 
CTG gene repeat length (Perini et al, Sistiaga et al, 2010) suggesting that patients with 
more severe disease experience greater cognitive and behavioural challenges. However, 
this was not found in a study conducted with a different cohort (Winblad, Lindberg & 
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Hansen, 2005). Individuals with late onset disease and mild symptoms (i.e., smaller CTG 
repeat expansions) may experience progressive cognitive decline (Modoni et al., 2004; 
Modoni et al., 2008; Sansone et al., 2007) or develop focal dementia (Modoni et al., 
2004).   
The DM1 cognitive and personality profile suggests that affected individuals have 
paranoid or avoidant personality traits that render it difficult for them to participate in 
activities or develop relationships (Delaporte, 1998; Sistiaga et al., 2010; Winblad, 
Lindberg, & Hansen, 2005).  Affected individuals may also experience impaired 
executive dysfunction related to cognitive inflexibility (Sistiaga et al., 2010), reasoning, 
planning, attention and verbal and visual memory (Antonini et al., 2006; Modoni et al., 
2008; Sistiaga et al., 2010; Zalonis et al., 2010). Depression and anxiety are variably 
experienced, but may be related to central nervous system involvement (Antonini et al., 
2006), or to social withdrawal or maladjustment to living with a chronic and progressive 
illness (Meola et al., 2003; Minnerop et al., 2011).  Causality, however, is difficult to 
determine.  Cognitive dysfunction and personality traits may be an organic part of DM1 
(Perini et al., 1999), or the result of limited social or educational  opportunities (Bird, 
Follett, & Griep, 1983; Modoni et al., 2008; Sistiaga et al., 2010).   
Regardless, the impact of symptoms on DM1 patients’ health related quality of life 
(HRQOL) have been described (Antonini et al, 2006; Peric et al, 2010, Laberge et al, 
2013).  Twenty patients with DM1 had significantly lower scores on the short-form 36 
(SF-36)—a HRQOL questionnaire that assesses 8 health domains including physical and 
emotional health (Ware & Sherbourne, 1992)—than the general population (Antonini et 
al, 2006).   In particular, findings suggest that age and disease severity are inversely 
related to SF-36 scores (Antonini et al, 2006; Peric et al, 2010), and that cognition, 
fatigue and mood may decrease HRQOL (Laberge et al 2013).  Research suggests that 
individuals with DM1 living in Quebec, Canada had low educational attainment, high 
rates of unemployment, low income and were highly reliant on social assistance (Laberge 
et al, 2007).   Moreover, DM1-affected individuals may experience disrupted social 
participation resulting from their difficulty or inability to engage in employment and 
recreational activities (Gagnon, Mathieu & Noreau, 2007); the social participation of 200 
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DM1-affected individuals was impacted by factors including problems navigating the 
physical environment, poor access to government, health or community services, and 
limited support from family or friends (Gagnon et al, 2008).  Additionally, results from a 
study exploring the lifestyle risk factors for 200 DM1 individuals found that being 
overweight or obese, using addictive substances and being physically inactive impacted 
their health.  Finally, the clinical manifestations of DM1 including fatigue, weakness, and 
low educational attainment and socioeconomic status may challenge patients’ ability to 
engage in health promotion behaviors (Gagnon et al, 2013).  Symptoms causing 
decreased HRQOL—for example, constipation, cataracts, and depression— may be 
amenable to treatment (Peric et al., 2013), but the complex and variable symptom 
presentations may challenge care for individuals with DM1 (Heatwole et al 2012; Meola 
& Sansone, 2007). It is therefore imperative to explore DM1-affected individuals’ 
understanding of their health, and the perspectives of caregivers and HCPs providing care 
for this population.  
DM1 families may experience significant psychosocial problems that may not be 
adequately addressed by HCPs (Cup et al, 2011).   Instead, clinicians may preferentially 
monitor patients’ breathing, cardiac, and swallowing symptoms because they are the most 
likely to cause serious complications or sudden and/or early death.  However, these may 
be challenging to identify and manage due to the multitude of physical, cognitive, and 
behavioral impairments that patients may experience (Gagnon et al, 2010; LaDonna, 
Koopman, & Venance, 2011).  
There are no treatments to halt the progressive muscle weakness associated with DM1, 
and health care providers provide surveillance for both symptomatic and asymptomatic 
complications (Gagnon et al, 2010; Turner & Hilton-Jones, 2008). DM1 is relatively 
uncommon, affecting approximately 1 in 8,000 individuals (Harper, 2001), therefore few 
family or generalist physicians follow these patients.  However, DM1 is more prevalent 
in certain areas of Canada, and the prevalence of DM1 in the Saguenay-Lac-Saint-Jean 
region of Quebec is 30-60 times higher than the worldwide prevalence (Mathieu, De 
Braekeleer & Prevost, 1990).  Consequently, extensive biopsychosocial and clinical 
management research has been conducted in this region.  For example, researchers in 
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Quebec have proposed that DM1 patients’ complex needs—including the potential for 
individuals to have limited educational, economic and social opportunities—often 
requires specialist clinicians to follow a systematic surveillance and treatment plan 
(Chouinard et al., 2009; Gagnon et al., 2007; Gagnon et al., 2010). Researchers have 
proposed DM1 management and health supervision models that address routine 
symptomatic surveillance in addition to potential life-threatening complications.  At the 
neuromuscular clinic where this research was conducted, cardiac conduction 
abnormalities would typically be monitored with an annual electrocardiogram (ECG), 
and a referral to a cardiologist would be initiated if there were any symptoms or changes 
on the ECG.   Similarly, pulmonary function tests and inquiry about symptoms related to 
breathing help to anticipate the need for a referral to a respirologist to follow individuals 
with chronic respiratory failure.  Those with excessive daytime sleepiness may be 
referred for a sleep study to consider the role of obstructive sleep apnea and are often 
prescribed a central nervous system stimulant (e.g. modafinil or methylphenidate).  
Individuals with chronic respiratory failure or sleep apnea may benefit from noninvasive 
ventilation (Turner & Hilton-Jones, 2008).  Often, individuals either complaining of, or 
suspected of having dysphagia are sent for a swallowing evaluation and instructed on 
strategies for safe swallowing.  Cataracts are treated surgically.  Health care providers 
may assess patients’ mobility, social and recreational opportunities, employment and 
financial status, and overall quality of life (Chouinard et al, 2009).  Further, individuals 
with DM1 may require referrals for genetic counseling, community services and 
individual or family support resources (Gagnon et al, 2007; Gagnon et al, 2010).   
However, the published literature suggests that clinical care for these individuals may be 
complicated by their cognitive and behavioral challenges.  There are reports in the 
literature documenting that DM1 individuals may miss clinic appointments, poorly 
adhere to rehabilitation treatment recommendations, and seem indifferent about their 
health (Chouinard et al., 2009; Meola & Sansone, 2007); however, this has not been the 
experience of others where DM1 individuals are found to be diligent about keeping their 
appointments (personal communication, Dr. Shannon Venance).  To date, there has been 
no research that explores DM1-affected individuals’ motivations for maintaining on-
going clinical follow-up. 
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1.3 Coming to the Question 
‘Patient-centered care’ is loosely defined as “providing care that is respectful of and 
responsive to individual patient preferences, needs, and values, and ensuring that patient 
values guide all clinical decisions” (Institute of Medicine, IOM, 2014).  Patient-centered 
care approaches are taught in medical school as a marker of good patient-physician 
communication that may lead to better patient self-management and improved health 
outcomes (de Haes, 2006).  However, de Haes (2006) contends that these improved 
outcomes may be difficult to attain in practice and that “a more nuanced standpoint has to 
be taken” (p. 291).  It may also be difficult to evaluate patient-centered care outcomes 
because ‘patient-centered care’ is poorly conceptualized and variably defined (Berwick, 
2009); in turn, the lack of a cohesive definition and set of goals makes it difficult to 
evaluate patient-centered care approaches, particularly when these approaches are 
enacted for patients with complex needs. Regardless, researchers suggest that patient-
centered care means:  
Helping patients to be more active in consultations (which) changes centuries of 
physician-dominated dialogues to those that engage patients as active participants. 
Training physicians to be more mindful, informative, and empathic transforms 
their role from one characterized by authority to one that has the goals of 
partnership, solidarity, empathy, and collaboration. (Epstein & Street, 2011)  
How do physicians, nurses and allied health professionals approach care for 
individuals with DM1, and is it possible to take a ‘patient-centered’ care approach 
with a chronic disease population that presents with cognitive and behavioral 
impairments?  Since the literature suggests that patients may lack awareness about 
the significance of their symptoms, I speculate that the complex physical, cognitive 
and behavioral clinical manifestations of DM1 may influence on-going patient-
centered care provision.   Others have hypothesized that cognitive impairment may 
cause patients to be in denial about their diagnosis; consequently, patients may 
refuse to seek information about their condition, ask for help (Nätterlund, Sjöden & 
Ahlström, 2001) or miss clinic appointments because they are disinterested in their 
health (Meola & Sansone, 2007).   There is a paucity of research exploring DM1 
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patients’, caregivers’ or health care providers’ (HCPs) experiences seeking or 
providing on-going patient-centered care.  This is a considerable gap because (1) 
patients’ and caregivers’ voices are relatively absent in the literature and therefore 
we do not know if their needs are being addressed, and (2) it is difficult—if not 
impossible—to provide, examine or evaluate ‘patient-centered’ care if patients’ 
experiences are absent. 
1.4 Qualitative Explorations of DM1 
A review of the literature found few studies that used a qualitative or mixed methods 
approach to explore adult DM1 (Boström, Alhström & Sunvisson, 2006; Cup et al, 2011; 
Faulkner & Kingston, 1998; Geirdal, Lund-Peterson & Heiberg, 2014; Heatwole et al 
2012; Nätterlund, Sjöden & Ahlström, 2001; Timman, Tibben & Wintzen, 2010); of 
these, very few occur in a North American context.   Moreover, most studies explore 
individuals living with a range of muscular dystrophies, while only a few are DM1-
specific (Cup et al, 2011; Geirdal, Lund-Peterson & Heiberg, 2014; Heatwole et al, 2012; 
Timman, Tibben & Wintzen, 2010).  Regardless, all provide a rich description of 
symptom impact on patients’ and/or caregivers’ daily lives; in particular, caregivers 
describe feeling anxious—and burdened—by their family member’s complex needs 
(Boström, Alhström & Sunvisson, 2006; Cup et al, 2011), and DM1 participants perceive 
that their altered physical appearance and progressive functional decline impact their 
sense of identity (Nätterlund, Sjöden & Ahlström, 2001).  Furthermore, clinicians and 
researchers interviewed 20 DM1 patients to elucidate the ‘patient reported impact of 
symptoms in DM1’ (PRISM); this exploration was the first phase of a longitudinal 
project intended to develop patient-centered outcome measures for clinical trials 
(Heatwole et al, 2012).   Findings suggest that patients and HCPs may prioritize different 
symptoms; that is, participants reported that fatigue had the greatest impact on their lives, 
yet citations in the literature typically consider myotonia or muscle weakness, not fatigue, 
to be the primary or characteristic symptoms of DM1.   Similarly, Nätterlund, Sjöden and 
Ahlström (2001) used a descriptive, qualitative approach and interviewed 15 individuals 
with muscular dystrophy (n =5 DM1) to explore how their lives were impacted by their 
condition.   Findings were condensed to create a ‘generic’ patient profile that represented 
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patients’ experiences.  The DM1 narrative profile suggests that patients’ worlds 
essentially ‘shrink’ as their disease progresses; that is, patients are no longer able to be 
employed or to participate in athletic or recreational activities that they once enjoyed.  
Individuals may also have difficulty making new friends, partly because of a lack of 
desire to have to continuously explain symptoms like speech impairment and frequent 
falls (Nätterlund, Sjöden & Ahlström, 2001). Physical symptoms—particularly weakness 
and fatigue—preclude individuals from engaging in education or employment and restrict 
their recreational and leisure activities, which resonates with findings from the PRISM 
study (Heatwole et al, 2012).  It is possible that fatigue is widely reported and highly 
impactful to patients because other symptoms—including muscle weakness, depression 
or excessive daytime sleepiness—may be labeled and experienced as ‘fatigue’ (Heatwole 
et al., 2012).  Moreover, patients may lack awareness about their symptoms; an interview 
study assessing 25 affected females understanding of DM1 found that participants’ had 
variable understanding about their condition, and that their symptomatic knowledge was 
sometimes informed by their personal experience and family history, not ‘book’ or 
medical knowledge.  The participants also had misunderstandings about prognosis and 
genetic information that—in turn—were used to make important health and reproductive 
decisions (Faulkner & Kingston, 1998).  Regardless, weakness and fatigue seem to 
significantly reduce patients’ quality of life.  Consequently, findings suggest that these 
are the symptoms that patients are most concerned about (Heatwole et al, 2012), not 
those—like cardiac, swallowing or respiratory issues--that clinicians prioritize because of 
their potential to be life-limiting.   
Symptoms and functional decline may negatively impact relationships between patients 
and caregivers (Cup et al, 2011), and some caregivers describe feeling burdened and 
anxious about their loved one’s deteriorating health (Boström, Ahlström, Sunvisson, 
2006).  Geirdal, Lund-Peterson and Heiberg (2014) used a mixed methods approach—
including quality of life questionnaires and semi-structured interviews—to investigate the 
quality of life of 13 individuals with DM1 and 8 caregivers.  The analysis of the 
qualitative findings suggests that individuals with DM1 experienced reduced quality of 
life as a consequence of having to change their expectations; that is, participants 
acknowledged making difficult reproductive choices, and having reduced levels of 
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employment and social participation.  Individuals with DM1 perceived that others judged 
them as “lazy” (p. 5) because they were unemployed and limited in their ability to 
participate in daily activities.  In turn, caregivers reported that their quality of life was 
impacted by isolation and increased responsibilities at home and at work.  Life was 
described as a “roller-coaster”:  “Life goes up in the sense that they feel they have the 
energy, and down when they feel they cannot meet expectations and desires, tasks and 
challenges…” (p. 5).  These findings resonate with results from a hermeneutic study in 
which five couples living with DM1 were interviewed to explore the effect of DM1 on 
their relationship (Cup et al., 2011).  The couples described that the challenges of living 
with—and managing—DM1 was akin to the “give and take” of marriage, but that 
patients’ functional decline required couples’ to renegotiate their roles and reconsider 
their social and leisure activities.  The experience of caregiving may depend on whether it 
is done out of love or out of a sense of obligation (Boström, Ahlström & Sunvisson, 
2006).    
However, despite the significant challenges that patients and their caregivers face—and 
evidence that patients and clinicians prioritize different symptoms--there are no studies 
that explore DM1 patients perspectives regarding on-going, clinical care.  However, a 
phenomenological approach was used to explore the experiences of patients with various 
muscular dystrophies (n= 16 DM1) at a multi-disciplinary rehabilitation program in 
Sweden (Nätterlund & Ahlström, 1999).  Patients reported that they felt listened to and 
understood by expert HCPs who provided them with information about their condition, 
support and strategies to cope with their illness-related challenges.  They also appreciated 
having the opportunity to interact with others living with similar conditions.   These 
findings resonate with a qualitative study that explored the experiences of adults with 
neuromuscular disease (n =1 DM1) who attended a neuromuscular rehabilitation centre in 
the United Kingdom (Hartley, Goodwin & Goldbart, 2011). 
1.4.1 Gaps 
While the perspectives of patients living with other uncommon neuromuscular conditions 
like amyotrophic lateral sclerosis and Duchenne muscular dystrophy are well-represented 
in the literature, there are relatively few studies that use qualitative research to explore 
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the experiences of individuals living with DM1 (LaDonna, 2011).   It is possible that 
researchers and clinicians do not use qualitative methodologies and methods with DM1 
patients because of their perception that individuals with DM1 are likely to have 
significant cognitive or behavioral impairments.  For example, researchers who explored 
the illness experience of patients living with muscular dystrophy excluded some 
individuals with DM1 because of difficulty understanding their speech (due to 
oropharyngeal muscle weakness) and cognitive impairment (Nätterlund, Sjöden & 
Ahlström, 2001). Furthermore, the authors noted  “these conditions prevented them from 
reflecting deeper upon their situation” (Nätterlund, Sjöden & Ahlström, 2001, p. 790).  
As a result of limited qualitative research exploring DM1-affected individuals 
perspectives about their health care, we do not know if the voices of those with DM1 are 
being heard by clinicians and researchers, or if their clinical and psychosocial needs are 
being met.  Moreover, no studies provide an exploration of health care providers’ 
experiences providing on-going care for individuals along the DM1 disease trajectory.  
Therefore, we know little about clinicians’ approaches, or whether HCPs perceive that 
they are meeting patients’ needs.  The multi-system nature of DM1 makes it an important 
condition to explore because findings may have implications for a host of complex, 
chronic conditions that present with multiple co-morbidities. 
1.4.2 Purpose 
The purpose of this research was to explore patients’ and caregivers’ experiences of 
living with DM1, including their health care expectations and motivations for 
maintaining on-going clinical care in an outpatient neurology clinic. This research also 
sought to explore HCPs perspectives about care provision for persons living with DM1.  I 
chose a qualitative research approach to: (1) add patients’ and caregivers’ voices to the 
neuromuscular disease literature, (2) explore on-going care provision for individuals with 
DM1, and (3) probe whether patients’ and caregivers’ clinical and psychosocial needs are 
being met.  Finally, I was interested in exploring what patient-centered care provision 
‘looks like’— if it is feasible, and if it occurs—in DM1 clinical care.  Therefore, 
individuals with DM1 and their caregivers were recruited from a neuromuscular clinic at 
one academic centre in Ontario, Canada.   To facilitate a deeper exploration of patient-
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centered care provision in chronic neurological conditions, I invited patients with 
Huntington’s disease (HD), their caregivers and health care providers to participate in a 
study exploring motivations for clinic attendance.  HD is an uncommon neurological 
movement disorder characterized by involuntary movements, progressive physical and 
cognitive decline, and significant psychiatric manifestations including depression, 
anxiety, obsessions, and psychosis (Roos, 2010; Sturrock & Leavitt, 2010).  DM1 and 
HD have a number of similarities: (1) both conditions are autosomal dominantly inherited 
and characterized by anticipation, (2) they have highly variably clinical manifestations 
that include motor, cognitive and behavioral features, (3) present with complex 
biopsychosocial issues, and (4) there are no treatments to cure, slow, or reverse 
neurodegeneration.  The purpose of adding an exploration of care provision in HD was 
not to compare the two populations; instead, the goal was to add breadth and depth to 
how care at one academic centre is provided for patients with chronic neurological 
disease who present with cognitive and behavioral impairments.     
1.5 Research Summary 
This research includes three studies that produced five manuscripts (Figure 1; Table 1).  
The perspectives of 49 participants are included in this research; details about the 
research setting and study sample are described in the relevant chapters.  Twenty-one 
patients including 13 individuals with adult-onset DM1 and 9 individuals with HD, 16 
caregivers (n= 8 DM1) and 11 HCPs participated.  The HCPs included 5 neurologists, 
two specialist physicians including a psychiatrist and a respirologist, a nurse, two social 
workers and a physiotherapist.  Of note, one individual with DM1 participated in two 
studies. 
 
 
 
 
Figure 1-1 : Dissertation Research 
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1.6 Chapter III:  Hard to Swallow: A Phenomenological 
Exploration of Caring for Individuals with Myotonic 
Dystrophy and Dysphagia. 
The literature suggests that cardiac, respiratory and swallowing dysfunction are the most 
life-threatening symptoms in DM1—and the symptoms that clinicians may preferentially 
monitor—because they have the propensity to cause serious complications including 
sudden death (Garrett, DuBose, Jackson, & Norman, 1969).  Dysphagia should be one 
symptom that clinicians, patients and caregivers can proactively address through 
education, evaluation and dietary management.  The literature suggests that caregivers for 
patients with other chronic illnesses that present with dysphagia are responsible for 
managing their loved one’s diet and responding to choking emergencies (Johansson & 
Johansson, 2009), therefore, the purpose of this study was to explore the experience of 
caring for an individual with DM1 and known dysphagia.  Phenomenology—a qualitative 
research methodology that explores lived experience (van Manen, 1990)—was used, and 
individuals with DM1 and dysphagia (by physician report) were approached by their 
health care provider and asked to identify a caregiver and provide him or her with a letter 
of information about the study.    Six caregivers consented to participate in interviews 
about their caregiving experiences.  The interview transcripts were transcribed verbatim 
and analyzed by considering participants’ experiences in the context of their “lived 
body”, “lived time”, “lived space” and “lived relations”. 
1.7 Chapter IV:  Picturing the Experience of Living with 
Myotonic Dystrophy: A Qualitative Exploration Using 
Photovoice. 
Following the exploration of the caregivers’ perspectives, I was interested in exploring 
patients’ experiences of living with DM1.  Since the literature suggests that patients may 
have cognitive, behavioral and speech impairments, an innovative approach for 
conducting research with this population was warranted.  Therefore, photovoice—a novel 
qualitative visual research methodology that was developed to engage participants with 
low literacy as research collaborators (Wang & Burris, 1994; 1997)—was used to explore 
participants’ illness experiences and the barriers and facilitators to living successfully 
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with DM1.  Nine participants were given digital cameras and asked to “take pictures of 
what it is like to live with DM1”; in turn, participants’ photographs stimulated individual 
interviews and focus group discussions.  The purpose of this study was (1) to use an 
innovative qualitative research methodology to explore the experiences of living with 
DM1, (2) to identify barriers and facilitators to living successfully with DM1, and (3) to 
assess if photovoice is a useful methodology to use to conduct research in this population. 
1.8 Chapter V:  Truths and Misinformation: A Qualitative 
Exploration of Myotonic Dystrophy Type 1. 
While analyzing the data from Picturing the Experience, it became evident that 
participants had variable knowledge about their condition, and “Truths and 
Misinformation” – a theme that was identified during data analysis for the Picturing the 
Experience study—warranted a deeper exploration.  Therefore, I worked with two 
clinicians to conduct a content analysis of this theme to examine how participants talk 
about—and make sense of—their condition.  Transcripts were re-read and re-coded to 
determine patients’ understanding of DM1—including their awareness or misinformation 
about symptoms, treatment and prognosis; in turn frequently occurring codes were 
collapsed into themes and categories, and supporting quotations were extracted from the 
data set.   
1.9 Chapter VI:  “[The Neurologist] is Throwing you a Raft”:  
Exploring Motivations for On-going Clinic Attendance 
for Individuals Living with Chronic, Progressive and 
Life-limiting Neurological Conditions. 
The literature suggests that individuals with DM1 and HD may lack awareness about 
their symptoms (Boström & Ahlström, 2005; Hoth et al, 2007) and our findings resonate 
with previous literature suggesting that individuals with DM1 have variable knowledge 
about their condition (Laberge et al, 2010; Faulkner & Kingston, 1998). Given the lack of 
disease-halting or curative treatment options for DM1 or HD—coupled with the potential 
that patients are disinterested in their health and unaware of problematic symptoms—it is 
unknown why individuals with these conditions maintain regular, on-going follow-up at 
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an outpatient neurology clinic.  Therefore, this research sought to elucidate patients’ and 
caregivers’ motivations for clinic attendance and their health care expectations, and HCPs 
perspectives about care provision for these conditions.  
Constructivist grounded theory (CGT)—a qualitative research methodology that studies 
basic social processes to generate an explanatory theory—informed the iterative data 
collection and analysis process (Charmaz, 2006; 2014).  14 patients (n=5 DM1), 10 
caregivers (n=2 DM1), and 11 HCPs (n=5 neurologists; 2 specialist physicians; a nurse; 
two social workers and a physiotherapist) participated in semi-structured interviews that 
were transcribed verbatim and coded using words or phrases that represented the 
participants’ experiences.  DM1 and HD data were not analyzed separately, and the 
themes and categories represent the perspectives of patients, caregivers, and HCPs from 
both groups.   
1.10 Chapter VII:  “We Like to Think We’re Making a 
Difference”: Health Care Providers’ Perspectives About 
Caring for Individuals with Myotonic Dystrophy and 
Huntington’s Disease.   
The HCPs’ perspectives about motivations for clinic attendance for individuals with 
DM1 and HD warranted a deeper exploration and were presented in a separate 
manuscript; this analytical project used the same data collection and analysis procedures 
as the previous study. 
1.11 Acknowledging the Boundaries  
In summary, my doctoral research has three main goals: (1) to use qualitative research 
methodologies and methods to explore the experiences of patients, caregivers and health 
care providers who live with—or provide care for—individuals living with myotonic 
dystrophy, (2) to add patients’ and caregivers’ voices to the largely biomedical 
neuromuscular literature, and (3) to explore what DM1 care ‘looks like’ at one academic 
medical centre in Ontario, Canada.  The purpose of this research, however, is not to 
evaluate patient-centered care in DM1 because: (1) there is not a uniform definition or 
conceptualization of patient-centered care, therefore rendering it impossible to evaluate, 
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(2) the literature does not yet report whether ‘patient-centered care’ is implemented, 
feasible or achievable in DM1 care, and (3) DM1 patients’ and caregivers’ perspectives 
are under-represented in the literature suggesting that the ‘patient’ is not currently present 
in conversations about DM1 ‘patient-centered care’.  Rather, the intention of this research 
program is to contribute to a scholarly conversation about patient-centered care provision 
in DM1. 
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Chapter 2 
2 Methodologies and Methods  
This chapter describes the background and theoretical underpinnings of phenomenology, 
photovoice and grounded theory, and describes the methods associated with these 
methodologies. Methodologies and methods are distinct; methodologies are guiding 
frameworks that are based on conceptual, theoretical, or philosophical foundations, while 
methods are the tools used to conduct research within the framework of the chosen 
methodology (Finlay, 2006).   For instance, an in-depth or semi-structured interview is a 
frequently used research method for many qualitative methodologies like 
phenomenology, photovoice or grounded theory (van Manen, 1990; Wang & Burris, 
1994; 1997; Charmaz, 2006; 2014).  The researcher’s choice of methodology and method 
generally reflects his or her research question and location along the spectrum of 
qualitative research paradigms.  Therefore, a researcher located within the positivist 
research paradigm might choose to combine statistical analysis with a traditional 
grounded theory approach (Glaser & Strauss, 1967), while critical theorists—who are 
located on the opposite end of the spectrum—would be more likely to use methodologies 
and methods based on participatory action research or feminist theory (Finlay, 2006).  I 
align myself within the constructivist paradigm because I do not believe that there is an 
‘objective truth’ that can be discovered; rather, I believe that truth is subjective and that 
meaning is influenced—and therefore co-constructed by—researchers’ and participants’ 
experiences.  Consequently, I chose three qualitative research methodologies—
phenomenology (van Manen, 1990), photovoice (Wang & Burris, 1994; 1997) and 
constructivist grounded theory (Charmaz, 2006; 2014)— that recognize how individual 
experience and the research setting may influence data collection, analysis and findings.  
Following a description of the methodologies, considerations for ensuring the 
trustworthiness of qualitative research data will be discussed. 
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2.1 Participants and Research Setting 
The specific data collection and analysis procedures for each study will be described in 
Chapters III-VII.  However, all research participants were recruited from one academic 
medical centre in Ontario, Canada.  At this centre, one neuromuscular physician—with 
clinical support from a nurse practitioner and/or medical students, residents or fellows—
provides care for most DM1 patients within the specialist’s general adult muscle disease 
clinic.  Patients are typically followed every six months to two years (depending on 
need), and the clinic staff has access to other specialist physicians and allied health 
professionals including a social worker, dietician, occupational therapist and a 
physiotherapist on a referral basis.  However, the allied health professionals typically 
only see DM1 patients on a one-time referral basis for a specific issue.  Huntington’s 
disease patients (who were explored in Chapters VI and VII) may be seen by any of the 
four movement disorder specialists at the centre, but most are followed in a dedicated 
Huntington’s disease clinic that is held once a month.  At the HD clinic, a neurologist, 
psychiatrist and social worker typically conduct clinic visits concurrently.  At both 
clinics, caregivers and other family members may also access clinic staff.    
2.2 Chapter III:  Hard to Swallow: A Phenomenological 
Exploration of the Experience of Caring for Individuals 
with Myotonic Dystrophy (DM1) and Dysphagia 
The purpose of this study was to explore the lived experience of caregivers for 
individuals with DM1 and swallowing dysfunction.  Participants were posed with an 
open-ended question about the experience of caring for someone with DM1 and 
dysphagia.  To follow-up, participants were asked to describe their caregiving duties, 
ideas about strategies for safe swallowing, their opinions about their loved one’s 
perceptions of DM1 and swallowing dysfunction, and the impact of DM1 on their lives.  
A phenomenological research approach was chosen to explore the lived experiences of 
caregivers for individuals with DM1. 
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2.2.1 Methodology: Phenomenology 
Phenomenology is both a philosophy and a research methodology that encompasses a 
variety of European and North American traditions (Dowling, 2007; Earle, 2010).  The 
philosophy of phenomenology was developed in early 20
th
 century Germany to discuss 
the idea of truth (Dowling, 2007), and the ‘father of phenomenology’, Edmund Husserl, 
devoted much of his work to understanding “what is real and valid, what constitutes 
evidence, and what is the relationship between the knower and the known” (Todres, 
2005, p. 104).  In particular, Husserl (1970) was interested in the lifeworld (Lebenswelt) 
and essences, and he sought to understand human experience by examining things as they 
appear. Husserl was interested in intentionality, reduction and the constitution of meaning 
- concepts that continue to influence the various and evolving phenomenological 
traditions (Earle, 2010).  Intentionality invokes the ability of humans to be aware of, and 
to be able to reason and communicate about objects in their lifeworld (Earle, 2010).  For 
Husserl, this understanding should be pre-reflexive.  To do this, Husserl proposed that 
individuals engage in phenomenological reduction to ‘bracket’ or set aside their 
knowledge and their preconceptions about an experience; that is, individuals should 
attempt to understand a phenomenon without a cultural context (Dowling, 2007), 
preconceived theoretical ideas (van Manen, 1997), or interpretations (Dowling, 2007).  
Through intentionality and reduction, individuals are able to identify the essences and 
meaning of an experience (Earle, 2010).    
Husserl was primarily interested in the description of experiences (Earle, 2010).  
However, the writings of Martin Heidegger, a student—and later critic—of Husserl 
shifted phenomenological inquiry from descriptive to interpretive (Dowling, 2007).  
Heidegger’s main interest surrounded the meaning of Being, or the individual’s presence 
in the world, and he differed from Husserl in his belief that to understand an experience is 
more important than describing it (Dowling, 2007).  Heidegger’s Being and Time (1927) 
focuses on the meaning of being in the world (Dasein) (Earle, 2010).  For Heidegger, 
exploring existential concepts like temporality (i.e., the past, present and future) is 
essential for understanding being, and he criticized Husserl’s ideas of intentionality and 
reduction (Dowling, 2007; Earle, 2010).  In particular, Heidegger believed that it is 
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impossible to set aside one’s assumptions and pre-conceptions about an experience.  
Instead, Heidegger proposed the idea of the hermeneutic circle in which individuals 
examine the ‘parts and whole’ of a phenomenon by continuously examining and 
comparing their pre-suppositions and understandings of an experience with the unfolding 
essence of being (Earle, 2010).  
French philosopher Maurice Merleau-Ponty’s work evolved from the writings of Husserl 
and Heidegger, but he emphasized the “primacy of perception” (Dowling, 2007, p. 134).  
Merleau-Ponty was interested in viewing experiences pre-reflexively, not using pre-
defined categories, and he was particularly interested in exploring the existentials of lived 
space, lived time, lived human relation, and lived body (Dowling, 2007).  The next 
generation—or New Phenomenologists—follow the tenets of either interpretive (e.g. 
Heidegger or Merleau-Ponty) or descriptive phenomenology (Husserl).  However, Max 
van Manen (1990) incorporates both interpretive and descriptive phenomenology in his 
version of the methodology.  Further, van Manen views phenomenological inquiry and 
analysis through the lens of the four existentials of being in the world, and also considers 
the role of the researcher in data collection and analysis (van Manen, 1990).   
In her monograph titled Illness: The Cry of the Flesh (2008), philosopher Havi Carel 
argues that the naturalistic approach to illness is insufficient for understanding the life 
changing impact that chronic illness has on an individual.  Thus, Carel makes a strong 
argument for using phenomenology to study the experiences of individuals living with 
chronic illness.  In particular, Carel believes that “phenomenology does not deny the 
importance of the physiological description or of the clinical interventions offered by 
current mainstream medicine.  It does, though, propose to augment this approach to 
illness by emphasizing the importance of the first person experience” (2008, p. 8). 
2.2.2 Method: Van Manen 
One of the difficulties facing novice researchers undertaking a phenomenological 
exploration is that there is no uniform method to collect or analyze data (Caelli, 2000).  
Van Manen (1997), however, articulates an approach to human science research that 
engages researchers in six research components: (1) to explore a phenomenon of interest; 
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(2) explore this experience as lived rather than as it is conceptualized; (3) reflection on 
essential themes; (4) describing a phenomenon through the art of writing; (5) remaining 
orientated to the phenomenon, and (6) being mindful of the ‘parts and wholes’ of the 
research context. 
Van Manen describes several possibilities for data collection and analysis; however he 
cautions against using these suggestions as a ‘prescription’ for phenomenological work.   
Instead, he encourages researchers to approach the question creatively.  
Phenomenological research views the lifeworld as the “source and object” of inquiry; 
therefore, the “nature of data” (van Manen, 1997, p. 53) can take many forms including 
the researcher’s personal experience, research participants’ descriptions, observation, 
biography, literature and art.  In particular, interviews with research participants may 
serve two purposes: (1) to explore a participant’s experiences to gain a deeper 
understanding of a phenomenon, or (2) to embark on a conversation with a participant to 
explore the meaning of an experience (van Manen, 1997).  Van Manen (1997) suggests 
asking participants a concrete question about a phenomenon, then encouraging them to 
describe anecdotes, incidents, and stories regarding this experience.  It is not necessary to 
ask a litany of questions; rather, participants should be given the freedom to articulate 
their experience.  The researcher may then use probes to gain a deeper understanding of 
the participant’s narrative. 
Once data has been collected, the researcher reflects on the findings to try to understand 
their meaning.  Van Manen (1997) distinguishes between the researcher’s pre-reflective 
and reflective understanding of an experience; that is, one may be able to describe that 
life is regulated by time, but have difficulty discussing what time actually means or ‘is’.  
Therefore, “the insight into the essence of a phenomenon involves a process of 
reflectively appropriating, of clarifying and of making explicit the structure of meaning 
of the lived experience” (Van Manen, 1997, p. 77).  This may be done in a variety of 
ways including thematic analysis.  Thematic analysis may be explored using a holistic, 
selective, then detailed approach (van Manen, 1997).  During the holistic or sententious 
approach, the researcher reads the text as a whole, then writes a sentence or phrase that 
captures the essence of the narrative.  Next, the researcher may highlight statements or 
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phrases that exemplify the experience as lived.  Finally, the researcher reads each 
sentence or sentence cluster in detail to determine what they ‘reveal’ about the 
phenomenon being explored.  Once a list of themes has been drafted, the researcher may 
return to the participants to ask them to reflect on the findings to ensure that the themes 
resonate with their experience.  Therefore, participants become active collaborators in 
interpretation and analysis. 
Van Manen suggests using the lifeworld existentials of corporeality, spatiality, 
temporality and relationality as guides for hermeneutic phenomenological reflection.  
These four existentials may guide the way humans experience the world (van Manen, 
1997).  Corporeality refers to the idea that humans are always “bodily in the world” (p. 
103).  Van Manen describes how human bodies may unconsciously ‘reveal’ or ‘conceal’ 
aspects of the human experience; that is, he suggests that one may behave awkwardly 
when looked at by another critically, or conversely, develop grace when gazed at 
admiringly.  Spatiality refers to “felt space” or “the world or landscape in which human 
beings move and find themselves at home” (p. 102).  How one experiences a physical 
space gives meaning to a phenomenon, and influences how an individual feels in certain 
situations.  For example, one may feel small in a large, open space, or feel lost or 
vulnerable in an unfamiliar space (van Manen, 1997).  Van Manen argues that, in a sense, 
humans become the space they inhabit.  Temporality, or lived time, is subjective time 
rather than ‘clock’ time.  The idea that ‘time flies when you’re having fun’ speaks to 
temporality, and the past, present and future make up an individual’s “temporal 
landscape” (van Manen, 1997, p. 104).  Finally, relationality refers to the lived relation 
individuals have with each other in a shared space.  Relationality may confirm—or not—
notions one has of others.   
Writing is an intrinsic part of the phenomenological research process that should occur 
simultaneously with data collection and analysis, not simply as a means to report findings 
(van Manen, 1997).  In order to balance the ‘parts and wholes’ of the research context, 
researchers should have an understanding of how the study will be conducted and how 
the text may be structured, but that researchers are free to flesh out these details and make 
decisions as the study unfolds (Earle, 2010; Van Manen, 1997). 
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2.3 Chapter IV: Picturing the Experience of Living with 
Myotonic Dystrophy (DM1): A Qualitative Exploration 
Using Photovoice / Chapter V: Truths and 
Misinformation: A Qualitative Exploration of Myotonic 
Dystrophy 
The purpose of the study described in Chapter IV was to use photovoice—an innovative 
qualitative research approach— to explore the experience of living with DM1.  Nine 
participants were given a digital camera and asked to take pictures of ‘what it is like to 
live with DM1’.  The goals of this study were to elucidate individual experience about 
DM1, to identify barriers and facilitators to living successfully with DM1, and to assess 
whether photovoice is a useful methodology for conducting research with this population.    
One theme identified during data analysis was titled DM1: Truths & Misinformation, and 
pertained to affected individuals understanding or misperceptions about DM1.   The 
purpose of the paper described in Chapter V was to provide a deeper exploration of this 
theme and to examine patients’ variable understanding of their condition, and the 
potential implications of ‘truths & misinformation’ for patient-centered care provision.  
Content analysis (Miles & Huberman, 1994) was used in conjunction with participant-
directed analysis to analyze the data for both studies. 
2.3.1 Methodology: Photovoice 
There seems to be a debate amongst researchers as to whether photovoice is a 
methodology, a method, or both. A scan of titles produced during a literature search 
illustrates this confusion.   That is, titles—even by the author who conceptualized 
photovoice—variably refer to photovoice as a method or a methodology (Wang & Burris, 
1997; Baker & Wang, 2006).  I argue that Wang and Burris (1994; 1997) originally 
intended photovoice to be a method for Participatory Action Research (PAR), but that 
photovoice has since evolved into its own distinct methodology, yet continues to be used 
as a data collection method for other methodological approaches (Plunkett, Liepert & 
Ray, 2013).  A scoping review of the photovoice literature found that 55% of the 191 
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studies use photovoice as the sole methodology and method for data collection and 
analysis, while 45% use photovoice as method for other qualitative or quantitative 
methodological approaches (Lal, Jarus & Suto, 2012).    
Regardless, photovoice is rooted in—and shares many of the philosophical and 
theoretical conceptualizations as—PAR.  Both methodologies are located within the 
critical research paradigm and are a “systematic investigation, with the collaboration of 
those affected by the issue being studied, for the purposes of education and taking action 
or effecting social change” (cited in Minkler, 2000).  Social psychologist Kurt Lewin 
(1946; 1952) coined the phrase “action research” to describe a cyclical research process 
that includes planning, action, observation and evaluation.  Both PAR and photovoice 
were influenced by Paulo Friere’s work on critical consciousness (Freire,1970; Fals-
Borda, 1987; Wang & Burris, 1994; 1997); in particular, Freire was an educator and 
proponent of problem-focused education and believed that a student can be an educator 
while the teacher can become a student.  In turn, a problem or opportunity for change is 
identified by a group of community members who then work together with a researcher 
to determine where and how to make improvements (McTaggart, 1991; Minkler, 2000).  
“Put simply, action research is the way groups of people can organize the conditions 
under which they can learn from their experiences and make this experience accessible to 
others” (McTaggart, 1991, p. 170).  PAR and photovoice distinctly differ from research 
done to or on research participants (McTaggart, 1991).  Instead, PAR and photovoice 
strive to include participants in all stages of the research process, from the 
conceptualization of the question, to data collection and analysis, and finally to 
dissemination of the findings and decision-making about actions to change or improve 
community outcomes (McTaggart, 1991).  In PAR and photovoice studies, participants 
are viewed as experts about their experiences and community concerns, and are engaged 
as active collaborators on important research decisions (Wang & Burris, 1994; 1997).   
Attention to power differentials is an important component of both methodologies, 
particularly because there may be a real or perceived power imbalance between academic 
researchers and participants (Wang & Burris, 1994; 1997).      
However, photovoice –which was developed by Wang and Burris (1994; 1997) as a 
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needs assessment tool to explore the reproductive health issues of rural Chinese 
women—has combined aspects of a number of methodologies and theories to form its 
own distinct methodology with innovative data collection and analysis procedures.  
Originally titled photo novella, Wang and Burris (1994) created their method based on 
concepts from educator Paulo Freire (1970), feminist theory, and documentary 
photography.  In particular, they emphasize the use of female intellect and experience to 
inspire problem-posing education and individual development for personal and social 
change.  Ultimately, Wang and Burris (1994) believe that the visual image is a powerful 
conduit for discussion and change because photographs provide evidence and validation 
of community concerns.   
There are three major goals of photovoice: (1) to have community members record their 
perceptions of the strengths and weaknesses of their surroundings, (2) to use photography 
to encourage dialogue among community members, and (3) to disseminate this 
information to policy makers (Wang & Burris, 1997).  Arguably, the most important 
aspect of photovoice as a needs assessment tool is that participants become advocates for 
change (Wang & Burris, 1997), and to empower participants by putting “cameras directly 
in the hands of people who otherwise would not have access, and allows them to be 
recorders, and potential catalysts, in their own communities” (Wang & Burris, 1994).  
Photovoice adds humanity to data (Wang, Burris, & Ping, 1996) thus, participants, not 
researchers, determine what is important to document and discuss with peers, academic 
researchers, and policy makers.   
Photovoice has been used with adult and children in a variety of contexts including 
explorations of homelessness (Aitken & Wingate, 1993; Fortin, 2014), motherhood 
(Booth, 2003) and child and adolescent programs (Berinstein & Magalhaes, 2009).  
Additionally, it has been widely used in health research to explore a variety of chronic 
illnesses including HIV/AIDS (Kubicek et al, 2012; Moletsane et al, 2007), cancer 
(Lopez et al, 2005), chronic pain (Baker & Wang, 2006) and mental illness (Andonian, 
2010); moreover, it is becoming an important research methodology to explore patients 
with complex needs including speech, cognitive and behavioral impairments.  In 
particular, it has been successfully used to explore chronic neurological disease 
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populations including spinal cord injury (Newman, 2009; 2010), traumatic brain injury 
(Lorenz & Kolb, 2009), dementia (Genoe & Dupuis, 2013), stroke (Levin et al, 2007), 
Alzheimer’s disease (Wiersma, 2008; 2011), and with Huntington’s disease caregivers 
(Aubeeluck & Buchanan, 2006). 
2.3.2 The Photovoice Method: Data Collection and Analysis 
While there are no set guidelines for a photovoice study, descriptions from Wang and 
Burris (1994) suggest that a photovoice study might include an orientation session, focus 
groups and/or individual interviews, and a forum to disseminate findings.  Camera 
orientation sessions should be tailored to the culture of the community, and ethics, power 
regarding data ownership and dissemination, camera operation, and guiding principles 
about the project are typically discussed (Wang & Burris, 1997).  In particular, the 
authors suggest that facilitators guide participants about the appropriate and ethical way 
to approach others to be in pictures, the ethics of taking pictures without the knowledge 
of others, the criteria to be used when analyzing photographs, and the personal and 
societal implications of taking pictures and sharing them publicly.   
While Wang and Burris (1997) suggest that the discussion of camera use should be 
minimal to prevent “stifling creativity” (p. 378), it is important to ensure that participants 
are comfortable operating the camera.  A significant portion of the camera orientation 
session should be devoted to discussing ethics, power, and data ownership.  Participants 
should be reminded that confidentiality is of utmost importance, and that anything shared 
during interviews or focus groups will be de-identified prior to dissemination.  Further, 
participant names or faces (unless specific permission is granted) will never be published.  
Importantly, the camera orientation session might include a discussion about academia 
and the desire for researchers to publish findings or present at conferences.  However, the 
participants should be free to determine if and how they wish to disseminate findings.  
An individual interview is an opportunity for participants to discuss as many of their 
photographs as they wish, and to offer insight that they may be unwilling to share in a 
group setting.  It is important that participants guide the discussion by choosing and 
discussing the implications of their photographs.  Participants are also encouraged to 
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keep a journal or log book of what they photographed and why.  It is also important to 
note what a participant was either unable to, or chose not to, photograph.  Log books may 
serve as guideposts for the interview discussion and become an important part of data 
analysis.   It may be advantageous at this stage to ask participants about the benefits and 
challenges associated with participating in the project.  Another strategy to facilitate the 
participants’ participation in data collection and analysis might be to ask participants to 
title each of their photographs. 
There is no singular method for analyzing photovoice data, and authors (Oliffe & 
Bottorff, 2007; Oliffe, Bottorff, Kelly, & Halpin, 2008) have chosen a variety of 
analytical approaches.  However, Wang and Burris  (1997), and Wang and Redwood-
Jones (2001) describe their data analysis methods. Wang and Burris (1997) offer 
guidelines for data analysis, and they reinforce that participants are an integral part of this 
process.  In particular, the authors discuss a three-stage approach to analysis in which 
participants select, contextualize, and codify the data.  By selecting which photographs to 
discuss, the participants guide the first step of data analysis.  Participants then 
contextualize their photographs by describing why they chose to capture certain objects, 
people or settings, and therefore give meaning to their images.   This part of the analysis 
typically occurs during the individual interview or focus group session when participants 
have the opportunity to discuss how their photographs relate to community issues and 
personal experiences.  Finally, participants codify the photographs through discussion of 
emerging themes, theories, and issues embedded in their photographs and collective 
experience.   Participants therefore engage with researchers to analyze the data; in turn, 
researchers use their own experiences and expertise to co-construct findings. 
In addition, several studies have used content analysis (Hergenrather, Rhodes, & Clark, 
2006; Thompson, et al., 2008) or tenets from grounded theory (Lopez, Eng, Randall-
David, & Robinson, 2005) to analyze data.  Lopez et al. (2005) chose to blend grounded 
theory and photovoice to “provide the means for participants to move beyond merely 
reporting results to policy and decision makers to suggesting strategies and participating 
in developing interventions tailored to specific conditions of their social context” (p. 
101). 
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2.3.3 Ethical Considerations 
Wang and Redwood-Jones (2001) write extensively about the ethical considerations of 
the photovoice method.  In particular, the authors discuss privacy laws and note that 
intrusion into public spaces, disclosure of embarrassing issues, being placed in a false 
light, and using a person’s likeness without compensation are serious concerns that must 
be addressed throughout the process.  In terms of a photovoice project, participants must 
understand that photographers create meaning by capturing and interpreting a subject or 
location (Wang & Redwood-Jones, 2001).  Also, the authors discuss the importance of 
ensuring participants that they own their photographs by giving them the negatives of all 
of their pictures.  Also, when possible, subjects of photographs should be provided 
compensation if their images are disseminated publicly.  In particular, camera orientation 
facilitators should ask participants to reflect on the responsibilities of using a camera, 
how to respectfully approach someone about having his or her picture taken, and how to 
minimize risks to self and others (Wang, 2004 #38).   
 Informed consent is an integral part of the photovoice project. Participants should be 
given a consent approved by a university ethics board describing the purpose of the 
study, their rights and responsibilities, and their willingness to allow their images to enter 
the public domain.  While participants may not be required to obtain consent when taking 
a group photograph in a public setting where individuals are non-identifiable (Wang & 
Redwood-Jones, 2001), participants should provide their photography subjects with a 
separate consent outlining the study and the rights of those having their pictures taken.  In 
particular, all identifiable subjects should understand how and why their image will be 
used, and that no image shall be published or disseminated publicly without their written 
consent.  As with all research studies, consent is a process that should be revisited 
throughout the project. 
2.3.4 Considerations and Benefits 
Since photovoice is an innovative and relatively new methodology, the conceptual and 
theoretical underpinnings need to be critically examined (Guillemin & Drew, 2010), 
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particularly since there is considerable debate whether photovoice is a PAR method or its 
own distinct methodology.   Also, using cameras to document experiences may be a 
novel concept that may be challenging for some participants, and in-depth discussions 
about the purpose of the research and instructions about how to use the camera are crucial 
and should be re-visited throughout the research process (Guillemin & Drew, 2010).    
Further, Foster-Fishman, Nowell, and Deacon (2005) discuss the importance of 
understanding the impact that a photovoice project may have on both the participants and 
their community.  Thus, these authors argue that it is essential to ask participants to not 
only discuss their photographs, but to ask them about their experience using the method, 
and how the project impacted them.  Potential impacts of participation may include 
enhanced self-competence, greater awareness of their environment, and the potential for 
photovoice projects to result in increased resources for social and political action (Foster-
Fishman, Nowell, Deacon, Nievar, & McCann, 2005).  However, one must be cognizant 
of the negatives that may be encountered by being both the participant in, and the subject 
of, publicly disseminated photovoice data.  In particular, participation may have negative 
political consequences (Wang & Burris, 1994), or participants may fear public disclosure 
of personal health issues.  Therefore, questions of who owns the photos and data are 
important to consider and communicate with participants: “This is particularly pertinent 
during analysis, when considering questions of who had control over the camera and the 
image-making moment, and whose understanding or experience is being represented in 
the image; the commentary of participants is crucial in understanding this element of 
construction of the visual story” (Guillemin & Drew, 2010).  It is difficult—if not 
impossible—to know the extent to which the researcher may influence what and how 
participants choose to capture their experiences.  Guillemin and Drew (2010) are 
interested in the concept of the ‘audience’ for a photovoice project—and the role of the 
researcher in particular-- and suggest that ‘audience’ is a concept that needs to be 
explored.   
2.4 Chapter VI: Understanding Motivations for Clinic 
Attendance and Expectations for Care for Individuals 
with Myotonic Dystrophy (DM1) and Huntington’s 
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Disease (HD) / Chapter VII:  “We Like to Think We’re 
Making a Difference” 
The studies that will be presented in Chapters VI and VII sought to elucidate patients’, 
caregivers’ and health care providers’ perceptions about the motivations for patients with 
DM1 and HD to maintain regular follow-up at an outpatient neurology clinic despite the 
lack of curative treatments.  Participants were asked to describe a ‘typical’ clinic visit, 
and to reflect on their expectations of—or approaches to—health care.  Constructivist 
grounded theory (Charmaz 2006) guided the iterative data collection and analysis 
process.   A deeper exploration of HCPs perspectives about providing care for individuals 
with DM1 and HD is explored in Chapter VII.   
2.4.1 Methodology: Constructivist Grounded Theory 
Grounded theory is an appropriate methodology to use to study the process of motivation 
and decision making for individuals with a chronic neurological illness who choose to 
receive regular care in an outpatient clinic despite the lack of a cure or treatment to slow 
the progression of their disease.  Not only is grounded theory a relevant methodology to 
use when little is known about a topic (Stanley, 2006), but Charmaz (1990) argues that 
research using grounded theory may offer physicians an exploration of patients’ views 
that cannot be gained during a clinic visit.  In particular, study findings may encourage 
better communication between doctors and patients, and focus attention on concerns that 
patients identify (Charmaz, 1990).  Constructivist grounded theory (Charmaz, 2006), the 
proposed methodology for this project, is a version of grounded theory that considers the 
interplay of the researcher and the research participant in co-constructing the data.  
However, prior to proposing a constructivist grounded theory approach, it is important to 
understand the evolution of the grounded theory methodology. 
2.4.1.1 Methodology 
Grounded theory was first introduced in the 1960s by sociologists Barney Glaser and 
Anselm Strauss as a methodology to generate theory that is grounded in data.  The 
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ultimate purpose of grounded theory is to use induction, deduction, and verification to 
develop a theory about a social phenomenon (Schwandt, 2007).  In particular, 
practitioners of grounded theory use their preliminary data analysis to guide data 
collection, and iterative data collection and analysis inform emerging theory (Charmaz, 
2003).  
Glaser and Strauss’ book The Discovery of Grounded Theory (1967) was written at a time 
when qualitative research was losing prestige and quantitative methods were gaining 
momentum.  Following World War II, quantitative research that gathered evidence to test 
theories gained momentum, thus consigning qualitative methods to data gathering or 
exploratory tools for survey development.  In other words, qualitative research was useful 
for generating hypotheses, but then quantitative research would “take over” to test 
theories (Glaser & Strauss, 1967, 16).  Glaser and Strauss (1967) responded by arguing 
that both quantitative and qualitative data are useful and important for verifying or 
generating theory, and they proposed a methodology in which “qualitative analysis had 
its own logic and could generate theory” (Charmaz, 2006, p. 5).  Charmaz (2008) argues 
that Glaser and Strauss’ work legitimized qualitative research.  According to Glaser and 
Strauss (1967), a grounded theory study should include the following: an iterative process 
of data collection and analysis, codes and categories that are grounded in the data, a 
constant comparative method, theory development at each stage of research, memo 
writing, theoretical sampling, and a literature review that is conducted after the analysis.  
However, the guidelines and methods for study conduct may be flexible and emerge 
throughout the process (Charmaz, 2008).  
According to Charmaz (2006), Glaser and Strauss each brought experiences from their 
respective training at Columbia University and the Chicago school culture while 
developing grounded theory.  In particular, Glaser wanted researchers to develop middle-
range theories, and he “imbued grounded theory with dispassionate empiricism, rigorous 
codified methods, emphasis on emergent discoveries, and its somewhat ambiguous 
specialized language that echoes quantitative methods” (p. 7).  Strauss emphasized the 
importance of process, problem-solving, the study of action, and subjective meanings.  
Further, the grounded theory of Glaser and Strauss is influenced by symbolic 
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interactionism.  Symbolic interactionism, both a theory about human behavior and an 
approach for studying it (Annells, 1996), defines an individual as being socially 
constructed, and argues that individuals use social interaction processes to navigate their 
world (Stanley, 2006).  This definition is based on the work of social psychologist 
George Herbert Mead (1962) who proposed that individuals define themselves through 
social interactions and perspectives.  In other words, “humans come to understand social 
definitions through a socializing process” (Annells, 1996, p. 381).  Blumer (1969) 
extended Mead’s work by coining the term ‘symbolic interactionism’ and proposing three 
basic tenets about the concept: (1) the meanings that individuals ascribe to others, 
objects, or situations will determine their actions towards them, (2) meanings stem from 
social interactions, and (3) individuals undertake an interpretive process to determine or 
modify meaning in a situation.  Annells (1996) notes that these concepts are open to 
criticism and interpretation by scholars, calling social interactionism a “microsociological 
theory” (p. 381) because it focuses on the individual, not the larger social environment.  
However, despite criticisms, practitioners of grounded theory assume that reality is a 
social construct and that theory can be derived from the social processes individuals 
experience to make sense of a phenomenon.           
Glaser and Strauss eventually disagreed about the direction grounded theory should take, 
and Strauss collaborated with Juliet Corbin to evolve the methodology (Strauss & Corbin, 
1990).  Traditionally, grounded theory reflects a positivist and objectivist worldview that 
assumes an external reality, although Strauss and Corbin moved grounded theory into a 
more postpositivist light by advocating for unbiased data collection, and a fair 
representation of the participants’ voices (Charmaz, 2003; Strauss & Corbin, 1990).  
Strauss and Corbin offered specific procedures for conducting a grounded theory study in 
Basics of Qualitative Research (1990), but Charmaz (2008) argues that this caused 
researchers to design their studies too concretely. Despite the evolving nature of 
grounded theory, Charmaz (2003) argues that all forms espouse strategies including 
simultaneous data collection and analysis, emergence of themes, discovery of basic social 
processes, category construction that explain these processes, theoretical sampling, and 
the integration of categories into a theoretical framework.  Traditional grounded theory is 
paradigmatically aligned with postpositivism and based in critical realist and objectivist 
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philosophies.  However, a version of grounded theory that emphasizes subjectivity and a 
relative perspective is moving the methodology into the constructivist paradigm (Annells, 
1996; Charmaz, 2006). 
2.4.1.2 Constructivist Grounded Theory 
In response to her position as a social constructionist researcher, Charmaz adapted the 
methodology she named constructivist grounded theory (2006; 2008).  In contrast to 
Glaser and Strauss who did not consider that the researcher might influence the analysis 
(Charmaz, 2008), researchers using constructivist grounded theory assume that there are 
multiple realities, and that the researcher and the research participants co-construct and 
analyze the data (Charmaz, 2003; 2006). Constructivist grounded theory argues that data 
does not reflect an objective reality; that is, the data offers a view of the participants’ 
world that is influenced by time, by cultural and structural contexts, and by the 
researcher, the participants, and the research process (Charmaz, 2003; 2006; 2008).  
Therefore, constructivist grounded theory methods are tools for discovery, not conveyors 
of truth.  Further, researchers also have preconceptions, experiences, and biases that may 
color the research experiences and must be handled reflexively.  Charmaz (2006) 
suggests that the research question should shape the research methods, and she offers 
suggestions for conducting a grounded theory study including strategies for sampling, 
semi-structured interviews, data analysis, memoing, and for assessing the quality of a 
study. 
2.4.2 Data Collection: Sampling 
Initially, purposeful sampling is done to identify participants who may provide rich data 
about the research question (Charmaz, 2006).  However, theoretical sampling is a core 
component of grounded theory that is useful once data is analyzed through constant 
comparative methods and themes and categories begin to emerge.  Theoretical sampling 
is a strategy used to flesh out emerging categories and theory (Charmaz, 2006).  In 
particular, a researcher may ask participants new questions, or follow-up with, or recruit 
new participants.  Memo writing is a useful tool for determining the direction of 
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theoretical sampling. Theoretical sampling is particularly useful for identifying the 
characteristics of a category, identifying relationships between categories, to make the 
analysis more abstract, to ground the theory in the data, and to make analytic connections 
between categories (Charmaz, 2006). 
Finally, theoretical sampling may lead to saturation of theoretical categories.  Categories 
are considered saturated when no new insights are forthcoming, although Charmaz 
(2006) cautions that saturation is not the same as seeing similar phrases or events.  
Moreover, early saturation may result if the researcher does not critically analyze 
categories.  To evaluate whether saturation has been reached it is important to have a 
good understanding of the comparisons of category properties and of the relationships 
between categories.  It is then important to assess if and how these comparisons provide 
theoretical insight, specifically if new relationships or themes need further development. 
Saturation is achieved when no new patterns or abstract analyses between categories 
emerge (Charmaz, 2006). 
2.4.3 Data Collection: Semi-Structured Interviews 
Charmaz (2003) offers a guideline for conducting constructivist grounded theory 
interviews that focuses on locating a participant’s story within a basic social process.  
According to Charmaz, interviews begin by defining a central problem (e.g., “Tell me 
about what happened when you were first diagnosed with condition of interest?”) and 
evolve as the researcher and participant co-construct the data.  Constructivists emphasize 
the importance of context, whether of the interview, the participant’s experience, or the 
context of the research question within larger society (Charmaz, 2003).  Since 
constructivist grounded theorists are attempting to uncover the social processes that shape 
events, interview questions should reflect symbolic interactionism, and “be sufficiently 
general to cover a wide range of experiences as well as narrow enough to elicit and 
explore the participant’s specific experience” (Charmaz, 2003, p. 315).  Charmaz 
suggests using a conversational interview style using open-ended questions.  The 
interview script will likely evolve as participants are interviewed and new questions arise 
(Charmaz, 2003), thus multiple interviews with each participant may be necessary to 
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fully explore emerging themes and to ensure that data saturation is reached.  This is 
especially important considering that multiple realities exist, and that perceptions and 
experiences may change over time.  Charmaz (2003) also argues that multiple interviews 
serve as “independent checks” (p. 318) and allow the researcher to probe for more details 
that may enhance emerging theory. 
2.4.4 Data Analysis 
The process of data collection and data analysis is iterative and emergent, and grounded 
theory coding occurs in three phases including an initial phase in which the researcher 
codes a word, line, or segment of data, a focused phase that uses the most frequently 
occurring initial codes to sort and organize the data, and theoretical coding to analyze 
increasingly abstract ideas about the data (Charmaz, 2006).  Charmaz (2006) argues that 
the researcher is not “neutral” (p. 46) when coding because he or she codes using 
language that is based on a particular worldview.  Charmaz (2006) suggests using action 
codes during initial coding (namely gerunds), arguing that this prevents the researcher 
from developing theories too early.  In addition, in vivo codes, codes using the symbolic 
language used by participants, may be useful for merging common phrases into the 
theory (Charmaz, 2006).  Initial codes should be open-ended and “grounded” in the data.  
Importantly, the initial codes provide the researcher with the tools to understand where 
more information needs to be collected, to flesh out data, and to determine the “fit and 
relevance” of the data (Charmaz, 2006, p. 54).  Initial coding may be conducted word-by-
word, line-by-line, or incident-by-incident.     
After a list of codes has been developed, and a number of transcripts have been reviewed, 
Charmaz (2006) suggests that the next step is focused coding.  Focused coding is done to 
organize the data using the initial codes that occur most often, and it checks the relevance 
and analytic value of the initial codes (Charmaz, 2006). At this stage, some codes will be 
collapsed into themes.  Constant comparative methods are an integral part of focused 
coding (Charmaz, 2006).         
Constant comparative methods (Glaser & Strauss, 1967) are an important part of 
grounded theory analysis, and are used to collapse codes into more abstract categories.  
49 
 
Stanley (2006) describes that constant comparative analysis involves comparing all coded 
data within each category to move from simple description of categories to theory.  
Constant comparative analysis in grounded theory includes comparisons of participants’ 
responses, the data from the same participant at different time points, incidents, data with 
categories, and a comparison of categories with categories (Charmaz, 2003; Ghezeljeh & 
Emami, 2009).  By using constant comparative methods, statements made in the same 
interview are compared, and then they are compared with statements in other interviews 
(Charmaz, 2006).   Constant comparison is an on-going process that occurs throughout 
data collection and analysis.   
The final step in grounded theory coding is theoretical coding.  Theoretical coding 
involves assessing the relationships between data coded during focused coding (Charmaz, 
2006).  At this point, it is helpful to draw diagrams to help sort the data, and to make 
comparisons between categories to begin to develop theory.  Glaser (1978) argued for the 
six C’s to examine categories based on causes, consequences, contexts, contingencies, 
covariance, and conditions.  Charmaz (2006) argues that using these categories can 
strengthen the analysis and the emerging theory.  Theoretical coding both guides 
theoretical sampling and identifies relationships between categories (Stanley, 2006). 
Theoretical sorting, diagramming, and integrating are important components of theory 
development in grounded theory (Charmaz, 2006).  Theoretical sorting of memos 
encourages theory evolution by abstractly combining and comparing categories 
(Charmaz, 2006).  Sorting and diagramming may be useful tools for organizing data and 
integrating categories (Charmaz, 2006). 
2.4.5 Memoing 
Memoing is a critical analytical and reflexive tool for grounded theorists, and Charmaz 
(2003) considers memoing the step that bridges coding with drafting the research report. 
The purpose of memoing is to record hypotheses and thoughts about emerging themes, 
and to reflect on the interaction between the researcher and the participants as themes 
evolve from the data (Mills, Bonner, & Francis, 2006).  Memoing may also increase 
abstract thinking (Charmaz, 2006), and a memo provides a schematic for how thoughts, 
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data collection, codes, and categories evolve (Ghezeljeh & Emami, 2009).  However, 
constructivist researchers should keep abstract thinking firmly grounded in the data that 
was co-created by the participant and the researcher (Mills, Bonner, & Francis, 2006).  
Importantly, memo writing is essential for capturing the researcher’s biases and 
preconceptions, the interplay of researcher and participant, and other elements that 
influence the data (Mills, Bonner, & Francis, 2006). 
2.4.6 Developing Theory 
“Interpretive theory calls for the imaginative understanding of the studied phenomenon.  
This type of theory assumes emergent, multiple realities; indeterminacy; facts and values 
as inextricably linked; truth as provisional; and social life as processual” (Charmaz, 2006, 
p. 127).  Theory is established by making connections between, and asking questions 
about, the data, which leads to abstract thinking (Charmaz, 2006).  Using gerunds to code 
data, and studying processes are helpful tools for theory development.  Charmaz (2006) 
cautions against coding for themes rather than actions which may lead to descriptions 
rather than theory.  Again, memo writing is an integral part of theory development 
because it enables the reader to think carefully about the data and connect categories 
(Charmaz, 2006). 
2.4.7 Assessing Qualitative Research:  Trustworthiness   
This section describes procedures that can enhance the rigor of qualitative research; 
specific strategies used to ensure the trustworthiness for each study will be described in 
Chapters III-VII and discussed in Chapter VIII.    The constructivist paradigm 
acknowledges the importance of the researcher, including her/his opinions, beliefs, and 
perceptions, in co-constructing data (Morrow, 2005).  Researcher bias is both 
acknowledged and embraced.  Thus, reflexivity—the practice of engaging in an “explicit 
and self-aware meta-analysis of the research process” to evaluate if and how findings are 
influenced by “subjective and intersubjective elements” (Finlay, 2002, p. 531)—is an 
essential component of qualitative research that allows the researcher to examine her/his 
own biases, perceptions, theories, and worldview in order to understand how they help 
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shape the data.  There is no consensus amongst qualitative researchers about how to best 
assess the rigor and quality of qualitative inquiry (Rolfe, 2006; Sandelowski & Barroso, 
2002; Morse et al, 2002).   One widely accepted approach is to use criteria including 
credibility, transferability, dependability and confirmability to evaluate the 
trustworthiness of qualitative research (Guba, 1981; Lincoln & Guba, 1985).  This 
approach corresponds to criteria—including internal validity, external validity and 
generalizability, reliability and objectivity –that is commonly used to evaluate positivist 
or quantitative research (Guba, 1981; Shenton, 2004).   
Lincoln & Guba (1985) consider credibility to be the primary and perhaps most 
significant criteria for evaluating the trustworthiness of qualitative inquiry.  Credibility—
the degree to which a “true picture” (Shenton, 2004, p. 63) of the research question and 
participants’ responses is portrayed—can be enhanced by a number of strategies 
including—but not limited to—triangulation, member checking, iterative data collection 
and analysis, frequent debriefing sessions with advisors, and peer review of the study 
findings (Shenton, 2004).  Transferability reflects whether findings resonate with—or can 
be applied—to other settings.  Researches need to provide sufficient detail about the 
research setting and the participants in order for a reader to be able to decide whether 
findings are applicable elsewhere.  Dependability—often difficult to achieve in 
qualitative work (Shenton, 2004) because findings are based on the interpretation and co-
construction of data between researchers and participants —can be established by 
providing adequate details about study design and methods for another researcher to 
follow the data collection and analysis procedures and recreate the study.   Finally, 
methods described previously—including triangulation and sufficient detail about 
research methods and setting—can help readers assess the confirmability of qualitative 
research.  The researchers’ reflexivity and an audit trail of research procedures is 
important for establishing confirmability; that is, researchers must demonstrate that 
findings ‘emerged’ or were identified through rigorous data collection and analysis, and 
are therefore not the result of the researchers own biases and preconceived ideas 
(Shenton, 2004). 
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2.5 Summary 
This chapter includes a description of the research setting and study participants, a 
summary of phenomenology, photovoice and grounded theory, and strategies for 
ensuring the trustworthiness of qualitative research. Proponents of all three 
methodologies state that the proposed methods are flexible, and that researchers do not 
have to adhere to them prescriptively. Instead, methods may be modified to fit the context 
and goals of the study, to encourage creativity, and to meet the needs of the participants 
(Charmaz, 2006; van Manen, 1990; Wang & Burris, 1994; 1997).  A detailed description 
of the data collection and analysis procedures for each study will be described in the 
relevant chapters.      
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Chapter 3 
3 Hard to Swallow: A Phenomenological Exploration of 
the Experience of Caring for Individuals with Myotonic 
Dystrophy (DM1) and Dysphagia 
3.1 Abstract 
Background: Myotonic Dystrophy (DM1), a genetic, multi-system disorder, is the most 
prevalent adult form of muscular dystrophy.  Dysphagia is a common symptom that may 
be difficult to diagnose and treat and can be associated with increased morbidity and 
mortality.  Pre-existing cognitive impairment or apathy, both well described in the DM1 
literature, may contribute to management challenges. Caregivers may become important 
for managing a family member’s swallowing dysfunction. While clinicians place great 
importance on swallowing difficulties, it is unknown how dysphagia impacts patients and 
their caregivers.  Therefore, the purpose of this study was to explore the experiences of 
caregivers living with those with DM1and dysphagia.   
Methods:  An interpretive phenomenological approach was used to study the lived 
experience of six caregivers for individuals with DM1 and dysphagia.  Audio-taped semi-
structured interviews were used for data collection, and data was analyzed using van 
Manen’s steps for phenomenological analysis. 
Results:  Despite the potential for dysphagia to cause morbidity and mortality in DM1 
individuals, caregivers did not describe this as a problematic symptom.  Instead, they 
described more debilitating symptoms like fatigue or weakness and discussed the 
caregiving experience. Themes pertaining to participants’ lived body, lived relationality, 
lived time and lived space were identified.   
Conclusion:  Health care providers need to balance issues of clinical concern with those 
that are important for individuals and their family members.  Assessments of caregiver 
knowledge and burden at each clinic visit may be warranted. 
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3.2 Introduction 
Myotonic dystrophy (DM1) is an inherited, chronic, and progressive neuromuscular 
disorder that may occur rarely at birth (congenital form) or more commonly manifest 
during adulthood.  Given the autosomal dominant inheritance, DM1 generally affects 
roughly 50% of every generation of a family.  Complications of DM1 include muscle 
weakness, fatigue, hypersomnolence, cardiac conduction deficits, cognitive dysfunction, 
apathy, and gastrointestinal manifestations including dysphagia (Harper, 2001; Turner & 
Hilton-Jones, 2010).   
Dysphagia is defined as difficulty swallowing foods or liquids safely that may result in 
malnourishment or an aspiration pneumonia that occurs when foreign substances enter 
the lungs (National Institute on Deafness and Other Communication Disorders [NIDCD], 
2014).  Swallowing difficulties are common in DM1, and may affect between 25% to 
80% of patients (Bellini et al., 2006; Ronnblom & Danielsson, 2004).  Individuals 
experiencing dysphagia may report coughing while eating, heartburn, chest pain, or 
reflux (Bellini et al., 2006).  Dysphagia may cause embarrassment and lead to decreased 
social participation, low self-esteem, and poor quality of life.  Relationships with 
caregivers may also be negatively affected by an individual’s inability to share meals 
(Ekberg, Hamdy, Woisard, Wuttge-Hanning & Ortega, 2002; Plowman-Prine et al., 
2009). Health care professionals consider dysphagia particularly serious in DM1 due to 
the risk of sudden death from choking (Garrett, DuBose, Jackson, & Norman, 1969).  
Moreover, in addition to respiratory failure and cardiac problems, aspiration pneumonia  
is a common cause of death for individuals with DM1 (de Die-Smulders et al., 1998; 
Mathieu et al., 1999; Turner & Hilton-Jones, 2010).    
However, diagnosis of dysphagia in DM1 is complicated because patients rarely 
complain about or describe difficulties with their swallowing.  Remarkably, patients with 
DM1 did not report symptoms of dysphagia despite evidence on videofluroscopy 
suggesting abnormal swallowing function (Leonard, Kendall, Johnson, & McKenzie, 
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2001).  It is possible that muscle weakness and swallowing dysfunction progress so 
slowly that individuals develop compensatory strategies that leave them unaware of their 
dysphagia (Leonard et al., 2001).  Moreover, findings from a survey study of 360 frail 
elderly patients suggest that participants believed that dysphagia was untreatable, and 
therefore there was little to gain by mentioning symptoms to health care providers 
(Okberg et al., 2002).  It is unknown if this phenomenon occurs in DM1     
Apathy and cognitive impairment may further complicate the diagnosis and treatment of 
DM1-related dysphagia (LaDonna, Koopman & Venance, 2011). In particular, there is a 
well-described cognitive and personality profile for DM1 individuals that may be 
characterized by low IQ, an avoidant personality, lack of motivation and difficulty with 
executive function (Delaporte, 1998; Meola et al., 2003; Sistiaga, et al., 2010).  Clinical 
experience suggests that some individuals with DM1 manifest apathy and therefore may 
minimize their symptoms, miss clinic appointments, and may not express interest in their 
health (Meola & Sansone, 2007). While speculative, it is possible that these 
characteristics impact an individual’s ability and/or willingness to recognize and manage 
swallowing dysfunction.       
As a result, informal caregivers may play an important role in assessing and managing 
swallowing dysfunction for their loved ones.  To our knowledge, there are relatively few 
studies researching the experiences of caregivers for adults with muscular dystrophy 
(Boström & Ahlström, 2005a, 2005b; Boström, Ahlström, & Sunvisson, 2006; Boyer, 
Drame, Morrone, & Novella, 2006; Cup et al., 2011; Timman, Tibben, & Wintzen, 
2010).  These studies explored a variety of muscular dystrophies using quantitative 
and/or qualitative methods, and did not specifically address the implications of caring for 
individuals with DM1 and swallowing dysfunction. However, a qualitative  study 
explored nine individuals who cared for loved ones experiencing dysphagia after stroke 
or other traumatic injuries and found that caregivers prompted their family members 
about safe eating practices, spent extra time preparing meals, and experienced a sense of 
fear or worry (Johansson & Johansson, 2009).   
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While clinicians provide surveillance for swallowing problems and are concerned about 
the potential for dysphagia to increase the risk of morbidity or mortality, it is unknown if 
and how swallowing problems impact the daily lives of DM1 patients and their identified 
caregivers. Therefore, it may be important to consider the potential disconnect between 
health care provider’s clinical concerns and patients’ and family members’ perceptions.  
However, much of the DM1 literature considers dysphagia largely from the clinicians’ 
perspectives, therefore little is known about the experience from the perspectives of the 
patients and caregivers. Therefore, the purpose of this research is to explore the 
experiences of providing care for a person with DM1 and known dysphagia. Findings 
may influence clinicians’ approach to dysphagia diagnosis and treatment; that is, findings 
may help identify appropriate questions to ask patients and caregivers during clinical 
encounters, and/or to refine management strategies.  
3.3 Methodology 
The methodological framework used to guide this study involved a philosophical inquiry 
of an interpretive phenomenological nature as articulated by Merleau-Ponty (1962) and 
van Manen (1998). Using the viewpoints of van Manen (1990) and Merleau-Ponty 
(1962), we explored each participant’s experience of embodiment, as being situated and 
relational, or as “being-to-the-world”. This refers to the idea that human knowledge is 
relational, temporal, and present in the world, instead of just being a static object in the 
world, independent of the researcher. According to van Manen (1990), Merleau-Ponty 
offers four existentials: “1. Lived body (Corporeality) 2. Lived space (Spatiality), 3. 
Lived time (Temporality), and 4. Lived human relation (Relationality)” (p.101). These 
four existentials were utilized and reflected upon throughout the research process to 
understand the realities of the participants and their lived experiences and to allow the 
findings to be grounded on the fundamental life world structures which all human beings 
experience, although not all in the same ways. The four existentials of lived body, lived 
space, lived time, and lived human relation are categories for phenomenological 
questioning, reflecting, and writing (van Manen, 1990). 
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3.3.1 Methods 
For the purposes of this study, a caregiver was defined as a spouse, family member or 
friend who provided some degree of supportive care to a person living with DM1.   We 
designed the study and collected and analyzed the data using an interpretive  
phenomenological approach (van Manen, 1990). Interpretive phenomenology seeks to 
explore and understand the nuances of lived experience by uncovering taken-for-granted 
assumptions (van Manen, 1990). Individuals with mild to moderate DM1 and swallowing 
problems (by physician report) who attended an outpatient neuromuscular clinic were 
invited to identify and approach a caregiver about the study; six caregivers (two females; 
four males) agreed to participate.  Data was collected during semi-structured interviews 
lasting up to an hour; the interviews began by asking participants to reflect on the 
meaning of the term ‘caregiver’.  Next, the interviewer (KAL) used a series of prompts to 
probe about awareness and understanding of swallowing dysfunction and other DM1-
related symptoms, strategies for management, and symptom impact on daily life.  All 
interviews were recorded and transcribed verbatim.   
Data was analyzed using van Manen’s (1990) suggested steps for phenomenological 
analysis.  Two researchers (KAL and WJK) began by reading each transcript twice to 
gain a holistic sense of the data, and then independently chose a sentence or phrase that 
captured the essence of each transcript. ‘Caregiving is a full-time job’ and ‘caregiving is 
a partnership’ are examples of sentences that described the essence of two transcripts.  
Next, a selective reading approach was independently used to code the data and extract 
statements that described the caregiving experience.  KAL and WJK independently 
underlined key passages from the text related to dysphagia or caregiving and developed a 
list of codes using words or phrases that reflected the participants’ experiences.  KAL and 
WJK then met to discuss their codes and combined them into overarching preliminary 
themes.  Key quotes supporting the themes were extracted from the data.  The themes and 
quotations were then discussed with all authors, and a final list of findings was developed 
by consensus. Recruitment ceased when no further themes emerged.   This does not 
mean, however, that new information would not have been gained by further data 
collection; rather, the data collected was sufficient to allow a rich understanding of the 
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phenomenon under study.  As suggested by van Manen (1998) the use of temporal, 
spatial, relational, and bodily existentials to guide the analysis yields a richly-textured 
understanding of the embodied nature of caregiving for those with DM1 and dysphagia.  
To further ensure the rigor of our study (Morse, Barrett, Mayan, Olson, & Spiers, 2002), 
we sent a letter to participants that described the preliminary findings, and invited each 
caregiver to participate in a second interview to comment on the emerging themes. Only 
two participants agreed to participate in follow-up interviews.   
The Western University Research Ethics Board approved this study. To protect the 
confidentiality of our research participants, we have assigned each person a pseudonym.  
At the time of his follow-up interview, Sam was a 79-year-old living with his moderately 
affected wife. Sam has three children with DM1 and a grandchild with congenital DM1; 
Sam also provides some degree of care for his moderately affected son.  Laura is in her 
60s and lives with her mildly affected husband.  Laura also has a son with moderate DM1 
for whom she does not consider herself a caregiver, although she often run errands for 
him.  Daisy is a caregiver for her moderately affected husband, and she also works 
outside of the home.  Michael is a retired gentleman in his 60s who lives with his mildly 
affected wife, and John is in his 50s and he cares for his mildly affected wife.  Finally, 
Greg is in his late 40s and provides care for his mildly affected partner and for her son 
with congenital DM1.  Greg’s affected father-in-law died unexpectedly following a 
choking episode.   
3.4 Results 
While dysphagia is one of the most life-threatening symptoms of DM1 (Harper, 2001;de 
Die-Smulders, 1998), five of the caregivers in the present study did not consider it to be 
their family members’ most problematic symptom.  Instead, most identified fatigue and 
weakness as symptoms that impacted their affected family members’ function and quality 
of life.  However, despite the interviewer’s attempts to circle the conversation back to the 
experience of caring for someone with dysphagia, participants chose to focus on their role 
as caregivers rather than on their loved ones’ symptoms.  While caregivers offered insight 
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into their beliefs about DM1 and swallowing dysfunction, and were able to describe 
strategies for managing symptoms, the participants continually returned to discuss their 
caregiving roles and responsibilities.  This divergence from the original research question 
is not wholly unexpected given that the purpose of interpretive phenomenology is to have 
participants reflect on their lived experience and to uncover taken-for-granted 
assumptions (van Manen, 1990).  We identified five themes that reflected the bodily, 
spatial, temporal and relational existentials described by van Manen (1990): 
Relationships Drive Perceptions; The Meaning of Caregiving; The Physical Experience 
of Caregiving; Carving Out a Space for Respite, and Looking Into a Crystal Ball.       
3.4.1 Relationality—Relationships Drive Perceptions  
Relationality refers to the lived relations and spaces that are shared with others (van 
Manen, 1990).   In particular, sharing human relationships with others develops 
impressions of others that are confirmed—or not—through interactions.  For instance, 
participants’ relationships with their affected family members influenced their beliefs 
about the meaning of caregiving and the impact of DM1 symptoms on their lives.  For 
example, it was evident that health care providers were concerned about the swallowing 
function of several DM1 patients since Sam, Daisy and Michael all stated that their 
family member had been referred for a videofluroscopic swallowing assessment, yet 
participants were largely unconcerned about their swallowing dysfunction.   This was 
despite being shown video evidence of their loved ones’ swallowing abnormalities.  Sam 
described that it was “the most fascinating thing to see this food go back, stop, and then 
go down”, yet he did not consider swallowing to be a particularly troubling symptom 
because his day-to-day experience of living with his wife reinforced his belief that she 
had developed appropriate compensatory strategies.  However, a health care provider 
would likely be concerned about the potentially serious strategies he described:   
So, as far as that's concerned, she has a way...we have morning vitamin pills.  
There was about 6 or 7 when washed down and they go down then the Omega 3, 
6, 9, they're a lot bigger so but she has an excellent way of popping them back up.  
So in that sense she doesn't have a problem swallowing.  But like yesterday, we 
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had stew so she just put it through the blender.  Because I think more than just 
swallowing problem it is her muscles are weak—too weak—and so she says that's 
enough...and that's obviously related to the myotonic.  But, so in a way, 
swallowing she handles quite well. 
Moreover, Greg’s father-in-law died following a choking episode, an occurrence that 
made his partner more vigilant about her swallowing function. However, Greg was less 
concerned about swallowing abnormalities; instead, he focused on his partner’s difficulty 
breathing.  
My concern is the breathing more so than her choking.  Everybody can get out of 
a choking situation, but the breathing problem is the big issue.  She keeps losing 
percentages of her lungs’ capacity because of her diaphragm.  That’s my big 
concern. 
This was surprising given his father-in-law’s unexpected and sudden death from choking 
and his partner’s concern about her swallowing dysfunction.  Further, respiratory failure 
is a slowly progressive symptom as opposed to choking which can cause an acute 
complication like aspiration pneumonia or sudden death.  However, Greg seemed 
confident that he could help his partner should she choke, yet seemed to feel helpless 
about the progressive decline of her lung capacity.  The fear of losing his partner to a 
symptom or event that he could not control may have influenced how he evaluated the 
impact of his partner’s symptoms, and in turn, where he chose to focus his energy.    
In general, dysphagia appeared to be a symptom that participants felt the individual with 
myotonic dystrophy had compensated for and managed; therefore swallowing 
dysfunction did not seem to cause great concern or to affect shared experiences like 
mealtimes or social activities.  In particular, caregivers described that their loved ones 
were aware of their limitations, and had identified strategies like avoiding certain foods, 
cutting things into smaller pieces, or having liquids with meals to facilitate safer 
swallowing.  
As she told the fellow we were talking to, she’s very careful how she eats.  And 
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by careful, I mean she cuts small pieces.  She eats very slow.  I could probably eat 
two meals to her one (Michael).   
Instead, caregivers considered weakness and fatigue far more troubling symptoms. 
Fatigue impacted the social participation of caregivers and their affected family members, 
and seemed to negatively affect the marital relationship.  Daisy described that it was not 
uncommon for her husband to fall asleep at inappropriate times, and Greg’s partner stated 
that Greg must feel like he “lives alone” because she falls asleep so frequently.  
Moreover, Sam noted that his wife’s fatigue, coupled with her multitude of 
complications, made it difficult for her to be motivated to be active or social.  He 
regularly had to prompt her to leave the house to “get some fresh air”.  Laura and 
Michael described changing their expectations about, and opportunities for, social outlets.  
Michael described staying in to play cards instead of engaging in activities outside of the 
home, and Laura prepared special meals to ensure that her husband could participate in 
meals with friends: 
We know they (husband and son) have muscular dystrophy and we accommodate 
time or meals so that...basically, if we have company and I'll make sure it it's 
something that maybe not 100% of the meal (husband) can eat but a good 
portion—75% maybe even 80%-- and he wants that too because then it's – he's 
not depriving me of doing things. 
3.4.2 Relationality— The Meaning of Caregiving  
While participants did not speak at length about assisting their affected family member 
with managing swallowing dysfunction, they did speak in-depth about the overall 
caregiving experience.  The data suggested that there were three main reasons for being a 
caregiver: (1) It is the nature or personality of the individual to be a carer; (2) There is no 
one else to do the caregiving, and (3) Caregiving is done out of love.  Five of six 
participants endorsed that ‘caregiver’ was a term that they would use to describe 
themselves.  Sam put caregiving for his wife in context with his volunteer work as a 
palliative caregiver in a hospice: 
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Well, it's interesting.  Because in a way, it's different than with the palliative care.  I 
always felt that we gained an awful lot by giving time to chat and so on.  It was 
very enriching in many cases.  With my own wife, it's not so much enriching as to 
feel that I have made it a little more comfortable and I have been able to assist her 
in something that she found difficult or because we've been married for 48 
years...so we've exchanged a lot...  And, it isn't quite the same. 
On the other hand, Laura felt that she was not a caregiver because her spouse and child 
“manage on their own”. For Laura, a ‘caregiver’ is a defined role and title that must be 
earned by performing specific tasks.  She viewed her work checking on her son and 
preparing meals for her husband not as caregiving duties, but as intrinsic parts of her 
lived relations as a wife and mother 
Um...well, the word caregiver is used and it's used for people who actually need 
that kind of care and I think – I guess mostly personal care, feeding and all of that.  
So, I'm not a caregiver for either one of them.  But I help when I can.   
Similarly, for Sam and Michael, caregiving was seen as part of the marital relationship 
that would be present even without factoring in a chronic disease.   
 Well, I guess I could look at it that way too.  … definitely [she] does what she’s 
capable of doing.  And I guess I do that for her too.  In my opinion, she would be 
a caregiver of me too.  To me it’s a 50/50 deal.  You don’t know what life’s going 
to deal you.  You’ve got to make the best of what you have and go from there. 
(Michael) 
Also, some participants seemed to have a nurturing nature in all facets of life that 
influenced their experience of caregiving.  For Sam, his experience of caregiving 
transcended caring for his family members with a chronic, progressive disease.  Sam’s 
caregiving took many forms throughout his life, both as an educator and as a volunteer in 
a hospice. He perhaps chose these vocations because of an inherent need to serve and 
support; in turn, he used these experiences to shape how he cared for his wife.    
I was a teacher for 31 years and there definitely is caring for the kids that they 
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succeed.  Now with [spouse] it definitely is love, I mean she is my wife.  And it 
has become, or it has become a little bit more.  Just last night she said, how did 
she put it, you are doing things that I used to do… 
In contrast, John’s experience of caregiving was one of burden and burnout.  John 
described being responsible for all of the household chores in addition to working full 
time, and he resented what he perceived as his wife’s learned helplessness: “She needs to 
get back on her CPAP and it’s just finding the phone number for her.  And she expects 
me to do that but that’s not my job.  ‘I’m not doing that for you dear.  That’s drawing the 
line there, you can call.’” When asked if there were any rewards of caregiving, he noted 
that the one positive aspect of caregiving was the knowledge that his wife was receiving 
appropriate care:     
No.  Other than I know she’s getting good care.  So, you know, that’s the biggest 
thing.  She’s being taken care of.  ‘Cause I know what else is out there…But, no, 
other than I know she’s getting good care and being taken care of.  Not being 
abused by anybody or nothing, so...Yeah, that’s about it. (John) 
3.4.3 Corporeality—The Physical Experience of Caregiving  
“Lived body” (corporeality) refers to the phenomenological fact that we are always 
bodily in the world” (van Manen, 1990).  For most participants, their physical body 
affected either how they interpreted their loved one’s symptoms or how they were able to 
provide care.  Despite not being cognizant of the extent of their loved one’s swallowing 
dysfunction, some caregivers had good awareness of their loved one’s bodies.  Caregivers 
knowledgably discussed the main DM1 symptoms and the variability of disease 
progression.  Caregivers were readily able to describe the “lived body” of fatigue, cardiac 
and respiratory problems, dysphagia, and weakness as primary symptoms affecting their 
family members.  For example, Michael was mindful about taking objects from his wife 
because her myotonia made it difficult for her to release her grip: 
Well, probably lots of times I help her get dressed, maybe do up her shoes for her.  
The big thing is getting stuff out of the cupboards because of with her grip.  I’m 
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going to have to do that type of thing.  Or you’ve got to be careful when … if she 
hands me something I’ve got to realize that it takes her a while to let go of it, so if 
I don’t, like sometimes pull her over or pull her arm type of thing. 
Participants described that the experience of caregiving involved both physical and 
emotional work. Most caregivers cared not only for their family member with DM1, but 
for other affected family members and/or aging parents.  Participants described that the 
work of caregiving involved the bodily work of cooking, cleaning, heavy-lifting, running 
errands, and assisting with bathing and dressing.  Participants also discussed that 
attending and asking questions at medical appointments were important aspects of their 
roles that facilitated the work of caregiving.  The task of ‘prompting’, whether to take 
medication, chew slowly, or for their family member to be social, was described.  
Moreover, Sam used his body to provide comfort and healing for his wife: “And I do 
Reiki, I give her Reiki treatment.  We do massage, light massage with maybe a bit of 
aromatic oil.”  However, caregivers’ physical limitations sometimes impacted their 
ability to perform the physical tasks of caregiving.  John described having a pinched 
nerve, and Sam stated that a shoulder injury affected his ability to assist his wife in lifting 
or carrying heavy objects.  
Caregiving also enacted an emotional toll on Greg and John who described that the 
constant duties of caregiving were “annoying” and frustrating.  In particular, John stated 
that he felt “down”, and his emotions affected him both physically and emotionally to the 
point that he was on a number of prescription medications to treat his anxiety and 
depression.  Overall, caregivers described that much of the perceived effort of caregiving 
was found to be emotional, with “worry” as a prominent theme. Participants disclosed a 
variety of concerns, including whether their family member was eating enough, the 
impact of DM1 on their own physical and emotional health, increased caregiving tasks as 
DM1 progresses, and the constant fear of the likelihood of an early or unexpected death. 
You know, that's the most important right there cause you never know one day he 
could be lying dead somewhere and I'd never know it…. Like I say, you never 
know if he could end up one day in bed dead, you know, and I wouldn't know it….  
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That's something I don't want to think about.  You know, nobody wants to think 
about that but if it happens it happens. (Daisy)  
3.4.4 Spatiality—Carving Out a Space for Respite 
Spatiality, or lived space, is “felt space” that describes how individuals experience spatial 
dimensions in their everyday lives (van Manen, 1990).   In general, participants described 
that it was difficult to find physical spaces that accommodated individuals with a 
disability, and navigating in public spaces was impacted by their loved ones’ bulky 
mobility aids like wheelchairs or oxygen tanks.  As a result, social circles and outlets 
diminished. 
Other than going places – that’s the biggest drawback, going and figuring out 
whether we need to take her machine and all the stuff, and when it’s really hot out 
she doesn’t bother going outside, it’s so humid. (John) 
Moreover, the emotional toll that Greg and John described also affected their ability to 
feel comfortable and relaxed in their homes because they always felt that they should be 
performing tasks or supporting their partners.   Therefore, for John and Greg, caregiving 
constrained their ability to achieve a physical distance from their duties and 
responsibilities.     
They’re (caregiving duties) intense right now as far as I’m concerned because I 
can’t go out on my own without worrying about her.  As I said, we travel with cell 
phones, so if I’m out and about, I’m always close.  I can’t go anywhere without 
always worrying about her.  So I don’t go too far away.  I stay close to the house.  
So it’s really restricted my life in that respect.  I don’t want to go out and get a 
part-time job, because if I do that, I’m on the job, she phones you up and she has 
trouble, what am I going to do? (Greg) 
Therefore, there was a sense that burden was part of the experience of caregiving for John 
and Greg.  To cope with the stress of caregiving, they attempted to carve out both an 
emotional and a physical lived space for respite.    
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She just takes it (caregiving) for granted.  Which can be real annoying.  I try to sit 
down and relax and she’s going jibber, jibber at me.  Shhh, I’m trying to relax.  
So I just end up going sitting on the porch or going out in the back yard with the 
dogs.  Here we go, here’s some relaxing (John). 
3.4.5 Temporality—Looking Into a Crystal Ball  
Temporality refers to subjective time rather than ‘clock time’, and an individual’s 
‘temporal landscape’ is colored by the past, present and future (van Manen, 1990).  Prior 
to their loved one’s diagnosis, few participants had knowledge about DM: “Like I've 
watched the Jerry Lewis Telethon and there's a bunch of families there with different 
muscular dystrophy diseases but coming up with myotonic dystrophy—no.  No, I [had] 
never heard of the word before (Daisy).”  Daisy also reflected on the changes in their 
lives since her husband’s diagnosis; they had previously enjoyed parties and being social, 
but now spent more time at home alone.  Further, Sam discussed the past with a sense of 
regret and wondered whether he and his wife would have had children had they known 
about the genetic nature of DM1: “We haven't dwelt on that.  Once in a while it came up 
and you know what ‘That's it...that's the way it is.’” 
However, most participants focused on the present and living in the moment with their 
loved one.  In particular, participants described living with their loved one’s symptoms 
and adjusting to them as they progressed.  Therefore, swallowing was not considered 
problematic because the affected individual was coping and managing in the here and 
now.  Overall, there was a sense that while the complications of DM1 (namely fatigue 
and weakness) affected daily life, DM1 was manageable.  Therefore, while some 
caregivers described a sense of regret or fear of the unknown about DM1, others like 
Laura, described DM1 as “no big deal”  
We work with him rather than it dictates what we do.  It's just--you just do it... 
there’s no hardship at all. (Laura) 
There was, however, greater concern for other symptoms including breathing difficulties 
and progressive weakness.  Many participants had a ‘crystal ball’ mentality in which they 
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envisioned that their partners’ decline in time was inevitable and that they would have to 
take on an increased caregiving role.  Caregiving was already viewed as time lived as a 
consuming “24/7 job” (Greg) that was done in addition to full-time employment:   
Like it's hard for me because I work and coming home, you know making meals 
and stuff, keeping our place clean and whatever, you know it's really hard, really 
really hard. (Daisy) 
However, Michael, Greg and John discussed that their retirement afforded them more 
time as lived to devote to caregiving; this was positive for Michael and Greg, but not for 
John who was overwhelmed at the thought of being a full-time caregiver.   
The experience of caregiving also involved future temporality as making plans and being 
prepared for eventual complications, and participants discussed their varying degrees of 
preparedness for the future.  Only two participants (Sam and Greg) had previous 
experience with CPR or the Heimlich maneuver; however, they took first aid courses for 
employment or other purposes, not in preparedness for their loved one’s impaired 
swallowing function.  When prompted, however, all caregivers expressed an interest in 
learning more about what might be done in an emergency or unforeseen situation, but no 
one had plans to be formally trained.  Despite this, most caregivers believed that they 
would be able to appropriately respond should a choking episode occur in future time.   
Well if she were to choke, I could do the Heimlich on her. I plan on 
getting my CPR certificate.  I’m working on that in (location).  I’m 
waiting for a clinic to open up in case I ever need it.  Then I’m certified.  I 
used to be a trainer for a boy’s hockey team.  I had to get certified for that.  
So general first aid and stuff like that, I’m familiar with.  I’m not totally 
lost when it comes to something like that.  But CPR is what I’ve got to 
follow through on. 
While there was a sense that caregivers understood that their loved one’s condition would 
decline, the participants continually circled back to focus on the present time during the 
interviews.  Overall, the experience of caregiving seemed to be one of love and duty, 
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tempered by the expectation that caregiving responsibilities would intensify in future 
lived time.  The experience of caregiving for an individual with DM1, therefore, was 
influenced by their corporeality or lived body in lived time, lived space and lived 
relations when being with their affected family members. 
3.5 Discussion   
Given the attention, concern and surveillance that health care providers impart on DM1 
affected individuals with dysphagia, we set out to explore caregivers’ perceptions about, 
and their experiences with, their family members’ swallowing dysfunction.  However, the 
goal of interpretive phenomenology is to uncover taken-for-granted assumptions (van 
Manen, 1990), and study findings suggest that the overall caregiving experience, coupled 
with troubling symptoms like weakness and fatigue, have a far greater impact on the 
participants’ lived experiences than dysphagia.   Therefore, the study evolved into an in-
depth examination of participants’ knowledge and attitudes about DM1 and the meaning 
of their caregiving experiences.  This speaks to the uncertain, fluid and emergent nature 
of qualitative inquiry (Lincoln, 1995; Whittemore, Chase & Mandle, 2001).   
The participants in our study described their beliefs about DM1 and dysphagia, the 
impact of DM1 symptoms on their lived body, lived time, lived space and lived relations; 
in turn, the four existentials described by van Manen (1990) also influenced caregivers’ 
descriptions of the meaning and work of caregiving.  The relative lack of concern about 
dysphagia echoed other studies suggesting that individuals with DM1 are often not aware 
or concerned about swallowing or other consequences of their condition (Boström & 
Ahlström, 2005a; Meola & Sansone, 2007) despite significant concern from health care 
providers. This disconnect has been explored in other neurological disease populations, 
but to our knowledge it has not been studied in DM1.  In a study of the multiple sclerosis 
population, for example, physicians tended to focus on mobility issues, while patients 
were more concerned about cognitive decline (Heesen, Kopke, Richter, & Kasper, 2007).  
In Parkinson’s disease, while clinicians may attend preferentially to the motor features of 
the disease, it is often the non-motor features including mood problems, nocturia and 
drooling that most impact patients’ health related quality of life (Martinez-Martin et al, 
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2011).  Similarly, there is evidence that the cognitive and psychiatric features of 
Huntington’s disease (HD) are far more disabling than chorea, yet research is often 
geared toward the motor symptoms (Bonelli & Hofmann, 2004). Finally, clinicians and 
patients may differ in their perception of the severity of HD symptoms, with clinicians 
objectively assessing symptom impact on disability, while patients subjectively assess 
symptom impact on daily life.  This suggests that quality of life measures may be more 
indicative of symptom impact than disability scores (Banaszkiewicz et al, 2012).   
Arguably, patients’ description of symptoms may impact their caregivers’ beliefs about 
how they are living with and managing their condition.  In turn, clinical management may 
be influenced by patients’ and caregivers’ subjective reports of symptom impact on 
functional ability (Shulman, et al., 2006).  However, caregivers were aware of health care 
professionals’ concerns that dysphagia increases individual risk of morbidity and 
mortality related to choking, aspiration and sudden death.  Others have hypothesized that 
this dichotomy may occur because there may be a distinction between knowing the 
symptoms of DM1 and fully understanding their implications (Boström & Ahlström, 
2005a).  We speculate that caregivers’ lack of concern mirrors that of patients because 
the swallowing dysfunction evolves gradually over time allowing for strategies to 
compensate.  A survey of 286 older adults with osteoporosis or osteoarthritis found that 
participants used a variety of strategies to compensate for their declining function 
including asking for help, giving up certain activities, performing behaviors that optimize 
their current function, and using assistive devices (Gignac, Cott & Badley, 2000).  While 
this study did not speak to dysphagia, it does illustrate how individuals with chronic 
disease compensate for progressive functional loss. Our findings suggest that individuals 
with DM1 compensate for their abnormal swallowing by avoiding certain foods, having 
liquids with meals, or regurgitating objects that were not safely swallowed.  For 
caregivers, therefore, there is no additional perception that swallowing is difficult to 
manage or is a hardship because their lived relations with their partners reinforce the 
belief that their loved ones have compensated appropriately.   
However, similar to the experiences of thirty muscular dystrophy (n=10 individuals with 
DM1) caregivers described in a questionnaire study by Boyer, Drame, Morrone and 
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Novella (2006), the participants in our study expressed a sense of emotional and physical 
burden, primarily related to the anxiety of disease progression and sudden death.  Further 
in line with our findings regarding the “work” of caregiving, five partners of DM1 
individuals described that they increasingly became responsible for prompting their 
family members, for doing household chores, and for planning social activities (Cup et 
al., 2011).     
Many of our findings resonate with the experiences of thirty-six caregivers for 
individuals with muscular dystrophy (19 DM1 caregivers were included) ascertained 
through inductive content analysis (Boström, Ahlström and Sunvisson, 2006).  In 
particular, the sense that caregiving is shared with the individual living with muscular 
dystrophy and is done out of love or obligation were similar to our findings.  Also, worry 
about disease progression and an increased care load, and the idea that individuals and 
families living with other conditions or life situations are worse off, resonated with our 
participants’ experiences.  Using a hermeneutic qualitative approach, Cup et al (2011) 
found that the marital relationship can be affected by DM1 but that the five couples 
studied found ways to cope including giving each other space, respecting each other’s 
abilities, and allowing each partner to pursue his or her own interests.  Moreover, we 
found that individuals with DM1 and their caregivers who see caregiving as part of the 
marital relationship and/or those who provide care out of love tend to view caregiving 
more positively.  This is similar to studies that suggest that being in a healthy relationship 
was associated with the psychological well-being and better quality of life for individuals 
with muscular dystrophy and their partners (Boström & Ahlström, 2005b; Timman et al., 
2010).  
This is a small study reporting the experiences of six caregivers of individuals with DM1 
and dysphagia and provides preliminary data that may inform future research questions. 
A longitudinal study with a larger sample that explores the experiences and processes of 
caregiving for individuals with DM1 and dysphagia may be warranted.  Moreover, an 
exploration of patients’ experience of dysphagia, or an observational study exploring 
DM1 individuals’ daily activities, food choices and eating patterns may be helpful to 
guide the development of educational initiatives or interventions.   In particular, future 
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research might consider appropriate questions to ask during clinical encounters or an 
examination of patients’ condition-specific knowledge and their uptake of clinical 
information.  Further, areas of education for health care providers might attempt to bridge 
the chasm between health care providers areas of concern with the complications that are 
most impactful to patients and their family members. Finally, a condition-specific 
assessment tool measuring swallowing function for individuals with DM1 may be useful 
(LaDonna, Koopman & Venance, 2011) to quickly assess for dysphagia during follow-up 
visits.  While often outside a routine clinic visit, an assessment of caregiver burden for 
those caring for family members with DM1 may be necessary (Boyer et al., 2006).  
Health care providers may need to pay particular attention to the effect of DM1 on daily 
life for individuals and their families (Cup et al., 2011). While our results may not be 
immediately generalizable to the broader DM1 population, the findings may resonate 
with caregivers and other friends and family of those living with DM1. 
3.6 Conclusion   
In conclusion, while we set out to explore the experiences of caregivers for individuals 
with DM1 and dysphagia, we found that caregivers did not consider dysphagia a major 
concern.  Instead they focused on other troubling symptoms like weakness or fatigue, and 
the impact of caregiving on their lived body in lived time, space and relations.  This 
raises questions about the dichotomy between the concerns of health care providers and 
patients and their families, and how clinicians can assess the needs important to families 
while addressing clinical concerns.  We suggest that clinicians emphasize the importance 
of monitoring and managing potentially life-limiting symptoms like dysphagia while also 
assessing how DM1 symptoms impact the quality of life for patients and their caregivers. 
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Chapter 4 
4 Picturing the Experience of Living with Myotonic 
Dystrophy (DM1): A Qualitative Exploration Using 
Photovoice 
4.1 Abstract 
Background: Myotonic dystrophy (DM1) presents with multi-systemic complications; 
moreover, there is a well-recognized DM1 personality profile that is characterized by 
executive dysfunction, an avoidant personality and impaired cognition. Understanding 
symptom impact on patients’ lives is crucial for providing appropriate patient-centered 
care; however, much of the DM1 literature reflects the biomedical model and there is a 
paucity of articles exploring patient experience.   
Objective: To use a novel research approach to explore DM1 patients’ experiences. 
Methods: Nine individuals participated in a qualitative study using the photovoice 
methodology.  Photovoice uses the visual image to document participants’ lives, and   
participants took pictures pertaining to living with DM1 that stimulated individual and 
focus group interviews.  We used content analysis to analyze the data; in turn, codes were 
collapsed into themes and categories.  Findings were presented to participants to ensure 
resonance. 
Results: Participants took 0-40 photographs that depicted barriers and facilitators to 
living successfully with DM1.  We identified two categories that include participants’ 
challenges with everyday activities, their worries about the future, grief for lost function 
and social opportunities, and their resilience and coping strategies.  Participants also 
described their experiences using the photovoice method. 
Conclusion:  Photovoice is a useful approach for conducting research in DM1.  
Participants were active research collaborators despite perceptions that DM1-affected 
individuals are apathetic.  Our findings suggest that participants’ are concerned about 
symptom impact on reduced quality of life, not symptoms that clinicians preferentially 
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monitor.  Nurses, therefore, are essential for providing patient-centered, holistic care for 
DM1 patients’ complex biopsychosocial needs.  Research exploring current physician-led 
clinical care models is warranted. 
4.2 Introduction 
Myotonic dystrophy (DM1)—the most common adult form of muscular dystrophy—is a 
chronic, progressive and inherited neuromuscular condition presenting with multi-system 
complications including distal muscle weakness, myotonia, hypersomnolence, early-onset 
cataracts, cardiac conduction abnormalities, and slurred speech and swallowing problems 
(Harper, 2001).  DM1 patients’ complex needs—including their cognitive and behavioral 
impairments— may complicate patient-centered care provision.  In particular, patients’ 
lower educational attainment, problems with executive function, and avoidant personality 
traits may make it difficult for them to take risks, make friends, or participate in new 
activities (Delaporte, 1998; Gagnon, Mathieu, & Noreau, 2007; Meola et al., 2003; 
Sistiaga et al., 2010); consequently, individuals with DM1 may be apathetic and 
disinterested in their health (Meola & Sansone, 2007). 
Despite these challenges, it is essential that DM1 patients’ values and experiences drive 
clinical care.  Clinicians are concerned about the potential for cardiac, respiratory or 
swallowing abnormalities to cause morbidity or sudden death, yet research exploring 
patients’ perspectives suggests that weakness, fatigue and myotonia have a greater impact 
on patients’ quality of life (Boström & Ahlström, 2004; Cup et al, 2011; Gagnon, 
Mathieu & Noreau, 2007; Heatwole et al, 2012; Nätterlund et al., 2001).  In particular, 
these symptoms often challenge DM1-affected individuals’ ability to socialize, complete 
household chores, or engage in employment or educational opportunities.  Moreover, 
progressive physical symptoms—coupled with patients’ difficulties with motivation and 
planning— may impact patients’ personal relationships (Cup et al, 2011).  Consequently,  
patients may experience significant disruption and decreased satisfaction with 
employment and social recreation (Gagnon, Mathieu, & Noreau, 2007); in turn, impaired 
mental and physical function and reduced quality of life may result (Laberge et al., 2013).    
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However, despite evidence that clinicians and patients have different concerns and goals, 
much of the current DM1 literature is written from a biomedical perspective, and 
relatively few qualitative studies explore the perspectives of patients with muscular 
dystrophy (Authors, 2014; Boström & Ahlström, 2005; Boström & Ahlström, 2004; 
Boström, Ahlström, & Sunvisson, 2006; Cup et al., 2011; Faulkner & Kingston, 1998; 
Heatwole et al, 2012; Nätterlund, Sjöden, & Ahlström, 2001).  These studies use a range 
of methods including content analysis and phenomenology to explore questions 
pertaining to living with muscular dystrophy; few of these studies represent the 
perspectives of North American patients, and individuals with DM1 are a small 
proportion of the overall sample.  We believe that individuals living with DM1 have 
valuable insights into their condition and life experiences that can inform their health 
management, and that their voices should be more widely distributed in the literature.  To 
address this, we used an innovative qualitative research method called photovoice (Wang 
& Burris, 1994; 1997) to explore the experience of living with DM1.   
Photovoice is rooted in participatory action research (PAR) and was developed to study 
populations with low literacy residing outside of the traditional power structure (Wang & 
Burris, 1994).  “Participatory Action Research (PAR) differs from most other approaches 
to public health research because it is based on reflection, data collection, and action that 
aims to improve health and reduce health inequities through involving the people who, in 
turn, take actions to improve their own health” (Baum, MacDougall, & Smith, 2006). 
While we do not believe that individuals with DM1 are ‘powerless’, we argue that their 
unique physical and emotional challenges, coupled with the power imbalance inherent in 
some medical encounters (Goodyear-Smith & Buetow, 2001) warrants a strategy that 
utilizes their strengths and experiences.  In particular, photovoice uses photography to 
augment traditional interviews by offering participants a creative way to communicate 
their expertise, experiences, knowledge, and needs.  In an effort to educate or enact 
change, participants may choose to disseminate their photographs and experiences to 
‘stakeholders’ like clinicians or patient advocacy groups (Wang & Burris, 1994, 1997).  
Photovoice has been used with individuals with intellectual impairment (Jurkowski & 
Paul-Ward, 2007), acquired brain injury (Lorenz & Kolb, 2009), stroke (Levin et al., 
2007), dementia (Genoe & Dupuis, 2013) and Alzheimer’s disease (Wiersma, 2011).  
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The purpose of this study was to add DM1 patients’ voices to the literature; therefore, we 
used an innovative qualitative research approach to explore patients’ experiences of 
living with a chronic and progressive neurological disease.  In particular, we asked 
participants to reflect on the impact of DM1 symptoms on their daily lives, and to 
consider the barriers and facilitators to living successfully with DM1.  We also sought to 
engage individuals with DM1 as research collaborators; the literature describes that DM1 
patients may be apathetic or cognitively impaired, so we also asked the question: is 
photovoice an effective method for exploring the perspectives of individuals living with 
DM1? 
4.3 Methods 
Participants with mild to moderate DM1 (by physician report) attending an academic 
neuromuscular clinic were invited to participate.  We purposively selected individuals 
who were able to provide informed consent and comply with study procedures; nine 
participants (four females) consented, and each was given a pseudonym to ensure 
confidentiality (Table 1). 
We used a typical photovoice study consisting of a camera orientation session, an 
individual interview, and a focus group (Wang & Burris, 1997).  Participants attended a 
camera orientation session in which they (1) discussed the ethics of picture taking, (2) 
were given a digital camera and instructed about its use, and (3) were asked to “take 
pictures of what it is like to live with DM1.”  Additionally, participants were asked to 
take pictures of people or things that either hindered or facilitated living successfully with 
DM1.  Instructions were purposely kept vague to avoid the potential for researchers to 
influence picture taking.  Participants were instructed that they had to seek written 
consent from each person they wished to photograph.  Researchers asked questions to 
check the participants’ comprehension and understanding of the task and instructions, and 
participants were given the opportunity to practice taking pictures.   
Following the camera orientation session, participants had 2-3 weeks to take pictures and 
then returned for an individual interview.  Participants were asked to describe each of 
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their photographs; in turn, their narratives directed the content and flow of the interviews.   
To further probe participants’ responses, the researchers prepared general questions about 
their DM1-related medical history, their symptoms, and the impact of DM1 on their daily 
activities.  We also asked participants to share their opinions about study participation 
and the photovoice method.  Participants were then invited to choose 2-3 photographs to 
share during a focus group.   
All 9 participants completed the camera orientation session and an individual interview.  
The first 7 participants were scheduled to participate in a focus group, and two focus 
groups were held with two and three participants each.  Two individuals declined 
participation; one participant felt her fatigue precluded focus group participation, and one 
participant was lost to follow-up.  All data was retained and analyzed.  Following the 
focus groups, two additional participants were recruited, and their photographs and 
individual interview data were used to verify preliminary themes (Table 1).   All 
interviews were recorded and transcribed verbatim. 
In keeping with the tenets of PAR and photovoice (Wang & Burris, 1994, 1997), 
participants collaborated with the iterative data collection and analysis process. The first 
step in data collection and analysis began when participants chose what to photograph.   
Photographs were then selected, contextualized and coded.  Participants selected 
photographs to discuss, and gave them meaning by describing what was captured and 
how and why they chose the subject matter (contextualization).   KAL and SLV then used 
content analysis to analyze the interview transcripts; in particular, a double coding 
qualitative method was used to enhance the reliability of the data coding system 
(Miles,  Huberman, & Saldana, 2014) .  The researchers independently coded 
segments of the individual interview and focus group data using words or phrases that 
described participants’ actions or experiences.  The researchers held regular meetings to 
discuss the coding, and a preliminary list of themes was developed by consensus. Data 
collection and analysis were iterative, and preliminary themes were discussed during 
subsequent interviews to ensure that the findings resonated with participants’ experiences 
(Bradbury-Jones, Irvine, & Sambrook, 2010).  No new themes emerged during the final 
two interviews, and recruitment ceased when we determined that the collected data was 
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sufficient for exploring our research questions.  While additional participants might have 
generated new insights, we determined that our themes and categories provided a robust 
exploration of participants’ experiences of living with DM1. Transcripts were re-
examined then re-coded using the finalized list of themes.  Themes were then 
consolidated into categories.  The authors kept a reflexive journal throughout the study to 
record general impressions of emerging findings and to track theme and category 
development.  Nvivo, a qualitative software program, was used to organize and manage 
the data.   
This study complies with the Helsinki Declaration of 1975 and was approved by the 
Western University Research Ethics Board. 
4.4 Results 
All participants were actively engaged research collaborators who took 0-40 photographs 
that captured symptom impact on their activities and quality of life, their management 
strategies, and their sense of self.  We identified seven themes that were consolidated into 
two categories titled A Shifting Identity and Managing Limitations. Participants described 
that their shifting identities caused them to lose their sense of self and to grieve for their 
lost abilities; however, they were able to find solutions to cope with their evolving needs.  
Participants also discussed their variable degrees of study participation; while some 
participants had difficulty following study procedures, others were able to problem-solve 
strategies to mitigate challenges.  Regardless, all participants provided rich descriptions 
about their experiences living and coping with DM1. 
4.4.1 Participating in Research 
In general, participants were actively engaged in the project and stated that they enjoyed 
participating because it gave them the opportunity to share their experiences and 
socialize.  Some participants were either the first in their family to be diagnosed, or had 
never met anyone with DM1 outside of their immediate families.  Consequently, the 
focus group was an opportunity for them to meet other DM1-affected individuals and 
discuss common experiences: 
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I meet a lot of people with MD (muscular dystrophy), but it’s a big umbrella.  So there’s 
all different kinds.  But I only know one person that has myotonic dystrophy and I’d like 
to meet other people that have myotonic dystrophy.  Like males, females, different ages, 
and stuff like that.  Maybe there’ll be a friendship, you know? ‘Cause we can talk and we 
understand what each other is going through, or something like that (Tim). 
There were, however, challenges associated with using an innovative qualitative research 
approach with this population.  Transportation was problematic; two wheelchair bound 
participants (Jenny and Frank) lived approximately two hours from the study site.  While 
Jenny’s caregiver was able to drive her, we had to arrange special transportation for 
Frank.  As a result, Frank’s individual and focus group session were conducted the same 
day, and he stated that the long study visit made him feel fatigued.  Also, Frank’s speech 
impairment rendered it difficult to understand and transcribe his comments.  Moreover, 
two participants (Laura and Marjorie) did not complete the study; Marjorie withdrew 
citing DM1-related fatigue, and Laura did not attend her scheduled focus group meeting.  
Finally, two participants (Max and Peter) had difficulty using the digital camera:   
I was trying to … on Wednesday I was trying to take pictures of my bath seat and my 
walker.  I put the camera on, I pushed it and it didn’t go off, the flash stopped 
working.  So…Well, I wasn’t sure what to do, so I thought I’d just come down and 
tell you.  Maybe I pushed the button that I shouldn’t have, you know? (Peter). 
However, four individuals (Tim, Laura, Marjorie, and Jenny) facilitated their 
participation by asking a friend or care partner to help them take pictures.  Together, 
Marjorie and her husband created a list of her challenges and most problematic symptoms 
and then brainstormed scenarios to photograph these limitations.  Other care partners 
assisted with picture taking and/or participated in the individual interviews.  All 
participants described their interest in participating in research in general—and this 
project in particular—because it gave them the opportunity to educate researchers and 
clinicians about their lives.  
It gives them an idea of what it’s like and learn that it’s not all negative and that 
… like I say, you don’t know what it’s like unless you live it, but to take pictures 
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you can see what my life is like.  Not all negative, but not all positive either.  
Yeah, it’s a good idea (Frank). 
4.4.2 A Shifting Identity 
Participants described that their DM1 diagnosis caused an identity shift; that is, 
participants’ symptoms altered their physical appearance and challenged their abilities to 
be employed, complete household chores or participate in recreational activities.   
Consequently, progressive disability impacted their self-esteem and caused participants to 
lose their sense of self and grieve their pre-symptomatic identities. 
4.4.2.1 A Changing Body 
Participants’ evolving physical appearance triggered their perception of a shifting 
identity; in particular, participants stated that their altered appearance and progressive 
functional decline challenged their self-confidence and their social participation.  
Participants commented that their changing bodies,—including low muscle tone, 
drooping eyelids, premature balding and facial atrophy—coupled with their need for 
assistive devices, significantly impacted their self-esteem.  Consequently, participants 
worried that they were unattractive, and that their functional decline made them feel older 
than their chronological age:   
I can’t wear high heels ‘cause I fall off them!  I gotta buy shoes with a low heel 
and that makes me feel so stupid because I feel like an old lady. You know, with a 
walker I feel like an old lady.  I’m not—I’m 51—but that’s not old to me you 
know? (Laura) 
Even participants in stable and loving relationships experienced poor self-esteem; some 
participants were not only embarrassed by their physical appearance, but also by 
impaired mobility and their propensity for falls:  “It’s not so much the scrapes on your 
hands and knees, it’s the scrapes on your dignity...” (Meg).  Further, participants felt 
judged and believed that members of the general public lacked empathy and treated 
disabled people unfairly.  When asked to comment about her shifting identity, Jenny 
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stated: “Thank God I knew people when I was still okay—walking around and stuff—
because otherwise I think I'd probably be treated differently, being in a wheelchair, 
people not knowing. Personality doesn't change because you're in a wheelchair.”   
Similarly, other participants believed that members of the general public perceived them 
as slovenly or cognitively impaired, particularly if they had a speech impairment or fell in 
public: “I fall, they judge me as clumsy, and when I appear with mud on me because I've 
fallen, they assume I don't bother bathing regularly.  So …that bothers me, the people 
that assume” (Meg). 
4.4.2.2 The Challenges of Everyday Activities 
  
Figure 4-1: :  Improvising to Manage the Challenges of Everyday Activities: Using a 
Rubber Grip to Open a Door 
I find sometimes, especially if it’s cold, if I’m cold, they (hands) don’t always work, like 
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when they seize up.  And some door handles, the outside doors are easy, it’s just a push 
latch, it’s fine, which I like better… But sometimes it’s just too damn hard. (Joe) 
Symptoms including weakness, gastrointestinal problems and chronic respiratory failure 
impeded participants’ from fully participating in activities they once enjoyed.  In 
particular, participants with diarrhea were concerned about incontinence, and individuals 
with breathing difficulties found it cumbersome to travel with their bipap machines.  
Participants described that DM1 symptoms also impacted their ability to do activities 
usually taken for granted like bathing, walking a short distance or climbing stairs: “I 
don’t like stairs…Walking down stairs is fine, but going up stairs... It’s hard on my legs, 
eh? I go up two flights and I breathe hard…Yeah, and I have to sit there and wait for a 
while. I sit there for a while, and then we’ll go up two stories. I’ve got five flights of 
stairs to go up” (Peter).  Additionally, participants described having difficulty exercising 
or opening doors (Figure 4-2) and bottles or jars.  Moreover, the local environment was 
described as inaccessible to those with disabilities; narrow aisles, sidewalks in poor 
condition, and a lack of handicapped accessible entrances made it difficult to navigate 
these spaces: 
I was going to take a picture of the mall because it’s the only one that on the  
centre doors it has no buttons. It doesn’t make sense because the bus, the  
Paratransit van, goes to a different door. That doesn’t make sense to me because  
it should be on these two doors (Frank). 
While myotonia, swallowing dysfunction (Figure 4-1), cardiac abnormalities and 
cataracts minimally impacted participants lives, fatigue was described as “a vicious 
enemy” (Marjorie) that exacerbated other symptoms. For example, Frank stated that his 
speech impairment worsened when he was tired, and excessive daytime somnolence 
caused participants to fall asleep at inappropriate times, making it difficult to work, 
complete chores or socialize: 
Falling asleep in the middle of conversations, it's embarrassing because I'll fall 
asleep in the middle of sentences, and it's not for lack of attention or lack of 
interest, it's just the myotonic dystrophy makes me tired (Meg).   
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Figure 4-2: Making Swallowing Safer 
Well, that’s (swallowing) not good now…  But my jaw is not working well.  I can’t 
chew.  …I can’t eat beef, steak or, yeah, the chewing is a problem and I just get tired of 
chewing at the table and I stop…You know, I manage to have ground meats, but even 
so, I don’t chew them.  I just mush them around and swallow and I know that’s not 
good but that’s all I can do. (Marjorie) 
4.4.2.3 Loss and Grief 
Participants’ functional decline and physical appearance left them “constantly grieving” 
(Marjorie) their pre-symptomatic identity.  Others described grieving for lost dreams, 
opportunities, and their previous physical abilities.  DM1 was isolating; some participants 
had few social connections because their symptoms precluded full-time employment or 
participation in recreational or leisure activities.  Consequently, participants’ 
relationships were impacted by limited finances, fatigue or a lack of motivation to be 
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social.  Tim and Frank perceived that their disabilities were off-putting to potential 
romantic partners, and some participants mourned their childless state due to infertility or 
because they feared transmitting the gene.  Ultimately, participants grieved who they had 
been prior to their diagnosis, and who they might have become had they not inherited 
DM1: 
All through high school, I wanted to be a dancer.  I used to take dance class and 
vocal class because I thought I was going to make it big and be discovered one 
day.  There were times when I couldn’t do stuff and they didn’t understand why I 
couldn’t do it.  My flexibility was going and that was probably early signs of MD.  
Now, there’s no way I could do that now, no way at all.  I couldn’t stand on a 
stage for long periods of time, dance or anything like that.  There’s no way (Tim). 
4.4.3 Managing Limitations 
Despite mourning their lost opportunities and progressive functional decline, participants 
were resilient and proactive about finding solutions to manage their limitations.  
Participants tempered their concerns about the future by adjusting their self-perceptions; 
that is, participants strategized solutions for mitigating their physical challenges and for 
finding purpose within their current abilities. 
4.4.3.1 Desiring a Sense of Purpose 
Participants expressed the need to feel valued and to be seen as contributing members of 
society: “Sometimes I’ll sort it (laundry) upstairs and that way at least they know I’m 
doing something … (Laura).”  Many described desiring a sense of purpose and sought to 
maintain their independence and sense of control.  Individuals took pride in their abilities 
and sought validation in volunteering or engaging in part-time work, being proactive 
about their health, driving, and completing household chores.  There was a clear sense 
that they tried to reframe their lost identity by focusing on their achievements and current 
abilities.  Like Joe and Frank, Max described that he had once been an award-winning 
athlete; however, when asked about his current accomplishments, he quietly stated that he 
took pride in:   
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Staying alive, basically.  Being able to live on my own and function as a human 
being to do what I do.  I’m able to watch TV, listen to the radio, talk on the phone 
and try to keep my place presentable to anybody who’s going to come over. 
4.4.3.2 Finding solutions 
Participants described changing their expectations, creating new goals, and finding 
solutions for everyday challenges.  In particular, individuals discovered tools or strategies 
to help them maintain their independence and functional ability while bolstering their 
self-esteem.  These strategies included engaging in volunteer or paid employment, using 
mobility aids (Figure 4-3), taking medication for excessive fatigue, and facilitating  
 
Figure 4-3: Mobility Aids Mitigate Functional Decline 
That’s my cane, my best friend.  You know, it’s like my third leg.  I go everywhere with 
that cane.  And I think it’s great.  (Tim) 
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household chores by using devices like rubber grips for opening jars or doors (Figure 4-
2).   Participants also adjusted their expectations about social and recreational outlets: 
It’s there, it’s going to just get worse, but it hasn’t really changed my lifestyle.  
Other than, yeah, less exercise, less sports …  But I mean participating, even 
kicking a ball around with the kids.  I can’t do it.  Which is pissing me off, but 
you get over it, you know, and do something else.  I can still play cards. (Joe)   
Participants also coped by moving to accessible or community oriented housing, 
appreciating humor, and having pets.   To preserve a “non-disabled” sense of self, some 
participants were selective about disclosing their diagnosis.  For example, Tim’s friends 
and family were aware of his condition, but he stated that he did not take his cane to work 
because he worried that his co-workers would treat him differently. 
4.4.3.3 Family Dynamics 
However, participants relied on family members or friends to assist them with completing 
tasks and maneuvering the local environment.  Strong family, friend (Figure 4-4), and  
marital relationships seemed key to living successfully with DM1.  Individuals with a 
strong support system described having more coping strategies (particularly if there was 
financial stability or someone to help with chores) and feeling less isolated (particularly if 
they lived with their spouse or children).  Overall, there was a sense that supportive 
family and community members eased the burden of disease and made individuals feel 
safe.   When asked what information would be important for researchers and health care 
providers to know, Marjorie replied:    
To fight depression.  Because she’s (neurologist) asked me about that.  My doctor 
too.  But I am not depressed because I have that man (husband) in my life.  I 
couldn’t be depressed. 
Conversely, patients who lived alone, were unemployed or lacked family support 
described feeling bored and isolated.  Limited finances made it difficult to participate in 
recreational activities; therefore, watching television was the primary leisure activity for  
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Figure 4-4: Supportive Relationships are Key to Living Well with DM1 
That’s in front of our building.  We have a little pavilion.  We sit on the benches and 
chat, and socialize, there.  That’s just off to the side, it’s just another table where we 
socialize a lot.  It was cold that day, so no one was there.  But usually there’s seven or 
eight people outside, chatting. (Frank) 
several participants.  Moreover, family or friends could exacerbate participants’ feelings 
of isolation, disability and dependence.  Tim’s gene negative sister would not 
acknowledge his DM1, and some non-affected family and friends did not understand the 
limitations imposed by fatigue and weakness. For example, Peter felt pressured to 
participate at a level that was discordant with his symptoms:   
That’s part of the myotonic dystrophy, it makes you tired, eh?  Mom tells me I 
should be out longer.  I say, Mom, you haven’t got it.  I’m tired.  She says, ‘well, 
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you shouldn’t be tired.’  ‘Well, I am, Mom.’  You know, I’m almost 50 years old, 
I get tired. 
4.4.3.4 What will the future hold? 
Participants were resilient despite worries about what the future might hold as their 
condition progressed.  Many of these fears stemmed from having watched a family 
member decline; some participants had a ‘crystal ball’ mentality and envisioned that total 
disability was imminent and inevitable:  “Probably as my disease starts deteriorating.  My 
hands – you know, pretty soon I won’t be able to do anything and I’ll go to a nursing 
home (Peter).”  Meg worried about what would happen to her son with congenital DM1 
should she become incapacitated, and others were concerned about burdening family 
members with their care.  In general, participants seemed more concerned about the 
effects of their decline on others, than for themselves.   
Participants described problem-solving strategies to assuage their fears.  In particular, 
participants described using bath seats and grab bars in the shower, and putting spikes on 
their shoes during the winter to prevent falls.  Moreover, some made plans for the 
future—albeit reluctantly—including financial plans and medical directives.  For 
example, Marjorie stated that she did not want a feeding tube should her dysphagia 
worsen.  However, there was a variable amount of financial and supportive resources 
available to participants, and those with supportive care partners or paid employment 
seemed more secure about their future. 
Others, however, coped by not dwelling on DM1, and described that there were others 
living with far worse conditions or limitations:  “So you do what you can, you do what 
you have to deal with, there's a lot of people who have a lot of bigger deals than this” 
(Meg).  The primary coping strategy for most participants was to “just deal with it” and 
to take each day as it comes:  
 When it changes, you’ve got to make the change.  That’s all there is to it.  You 
can’t get it back.  When it’s gone, it’s gone.  That’s the way this disease works.  
You have to learn to function with it.  You’ve got do what you can do with what 
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you’ve got left.  You do need assistance.  You do need people around you who 
can help you when you need help.  Don’t be afraid to ask for help, that’s what 
they’re there for, utilize that.  It may not be what you’re used to but you have to 
make the change if you’re going to get along with the disease. (Max) 
4.5 Discussion 
Shared decision making is the ‘pinnacle’ of patient-centered care (Barry & Edgman-
Levitan, 2012) and patients are increasingly collaborating with researchers to set clinical 
goals and research agendas (Schipper, Dauwerse, Hendrikx, Leedekerken, & Abma, 
2014; Teunissen, Visse, de Boer & Abma, 2013).   Recently, a mixed methods study 
assessing the research goals of patients with neuromuscular disease found that patients 
prioritize research that explores symptomatic management and medical care, their quality 
of life, and educational initiatives to raise awareness about neuromuscular disease 
(Nierse, Abma, Horemans, van Engelen, 2013).  There remains, however, a relative lack 
of patient-centered, qualitative research that explores the experiences of individuals 
living with myotonic dystrophy; consequently, there is little evidence that patients’ voices 
are being heard, or that their clinical and psychosocial needs are being met.   
To address this, we successfully used a novel and innovative qualitative research 
approach that explores all of the patient-identified psychosocial research goals reported 
by Nierse, Abma, Horemans & van Engelen (2013).  While photovoice has been used 
with patients with a variety of chronic neurological conditions (Genoe & Dupuis, 2013; 
Levin et al., 2007; Lorenz & Kolb, 2009 & Wiersma, 2011)  it has not been used in DM1.  
We found that photovoice is a useful research method for exploring the experiences of 
individuals living with DM1; our research participants captured a range of experiences 
including symptom impact on their quality of life, their concerns about the future, and 
their coping strategies.  While the qualitative approaches used in previous muscular 
dystrophy research provide rich data, we believe that photovoice is particularly beneficial 
for providing a unique perspective of patients’ lives while giving them the opportunity to  
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collaborate in research.  Participants’ photographs literally provide clinicians and 
researchers with a ‘picture’ of patients’ lives that would not be elucidated during a 
clinical encounter. 
There were, however, limitations and challenges to using this innovative method with this 
population.  Some participants had difficulty using the digital camera, and two 
participants did not complete the study.  We speculate that Max and Peter’s hand 
weakness or myotonia made it difficult for them to hold the camera and depress the 
shutter; in turn, they were unable to problem solve a solution for taking pictures.  
Moreover, DM1 symptoms including fatigue, speech impairments, mobility problems and 
apathy may have further impacted participants’ ability to comply with study procedures.  
However, while DM1-related symptoms complicated participation, the benefits of 
photovoice far outweighed the challenges.  We suggest that modifications or adaptations 
may be necessary to facilitate participation for some individuals.  For example, while we 
gave participants the opportunity to practice taking pictures, we suggest that more time 
should be spent during the camera orientation session to clarify instructions and verify 
that participants are comfortable using the camera.  It may also be advantageous to 
present participants with scenarios and then discuss potential problem-solving strategies 
should the camera fail to work, or fatigue or mobility impairments hinder their ability to 
take pictures.  Finally, we did not set out to include caregivers as research collaborators, 
but our research participants identified them as a valuable strategy that facilitated their 
study participation.  Therefore, it may be helpful to include caregivers at the outset of 
photovoice projects exploring patients with complex needs.  Despite challenges, 
participants were enthusiastic research collaborators who were candid about the impact of 
their progressive symptoms on their self-esteem, their social participation and their 
relationships.   
Therefore, this study provides a rich exploration of the impact of symptoms on DM1 
patients’ lives, and illustrates patients’ shifting identities, a concept that has not yet been 
fully articulated in the DM1 literature.  In particular, our study participants emphasized 
the impact of their changing bodies and their functional decline on their self-esteem and 
their sense of self.  Our findings suggest that symptoms like dysphagia or cardiac 
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abnormalities are not overly troubling for participants despite their propensity to cause 
sudden death (de Die-Smulders et al., 1998; Garrett, DuBose, Jackson, & Norman, 1969).  
Instead, participants were troubled by symptoms that directly impacted their quality of 
life like weakness, fatigue and their altered physical appearance.  These findings resonate 
with other muscular dystrophy patients (Boström & Ahlström, 2004; Cup et al, 2011; 
Gagnon, Mathieu & Noreau, 2007; Heatwole et al, 2012;  Nätterlund et al., 2001), and 
clinicians’ and patients’ divergent goals are well-described in the neurological disease 
literature (Bonelli & Hofmann, 2004; Heesen, Kopke, Richter, & Kaspar, 2007; 
Martinez-Martin, Rodriguez-Blazquez, Kurtis, Chaudhuri, & Group, 2011).   In 
particular, a study of caregivers for individuals with DM1 and dysphagia found that 
weakness and fatigue are more concerning to caregivers than swallowing dysfunction 
despite the potential for choking to lead to aspiration pneumonia or sudden death.  It is 
likely that the caregivers’ concerns mirror those of their affected family members 
(Authors, in press).  
Study participants also described the impact of DM1 on their relationships and discussed 
their feelings of isolation and boredom.  Participants articulated that the genetic and 
progressive nature of DM1 caused them to mourn for lost abilities and opportunities.  
This sense of grief and loss permeated the photographs and interview transcripts, whether 
it was the death of a child with DM1 or the progressive loss of function and social outlets.  
Grief resulting from being childless—due to infertility or fear of transmitting the gene—
was echoed by participants in a qualitative study examining the experiences of 46 
individuals living with a hereditary muscle disease (Boström & Ahlström, 2005).  In 
addition, some of our study participants also expressed a sense of failure or self-blame for 
their infertility or for giving birth to a child affected by congenital DM1.  Finally, while 
mourning the loss of the pre-diagnosis self is a common theme for individuals with 
muscular dystrophy--particularly in regard to embarrassment or self-consciousness about 
one’s appearance (Boström & Ahlström, 2005)— the extent and complex nature of DM1 
patients’ grief over their progressive functional decline has not yet been described.  We 
posit that our participants experienced a cyclical pattern of loss: disability caused the loss 
of independence through reduced recreational opportunities and employment.  In turn, 
these losses caused financial and social restrictions that resulted in greater social isolation 
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and loss of independence.  Ultimately, these losses contributed to a decreased sense of 
self that was attributed to disability, thus perpetuating the cycle.   
However, participants were resilient; their strategies for coping and maintaining 
independence were similar to those reported by other research participants, and included 
doing chores or other activities at their own pace, or re-framing their expectations for 
personal, social or recreational goals (Boström & Ahlström, 2004).  In the present study, 
while participants reflected on their past accomplishments and their present limitations 
with some degree of sadness and frustration, they demonstrated resilience by focusing on 
their current achievements.  Moreover, contrary to the established literature regarding the 
DM1 personality profile (Delaporte, 1998; Meola et al., 2003), several of our participants 
demonstrated initiative and showed resilience by putting their condition into perspective 
and taking it “day-by-day”, having a good knowledge base about their condition and an 
appreciation about prognosis, finding solutions to challenges, and being attentive and 
engaged study participants.  Three participants were employed (paid or volunteer) and 
two were advocates for DM1; one is a leader in the DM1 community, and another chose 
to attend a first-year Masters of Occupational Therapy course to discuss five of his 
pictures and answer questions about living with DM1.  The latter was in keeping with the 
tenets of photovoice to disseminate information to ‘stakeholders’.  Our results 
demonstrating participants’ advocacy, perseverance and insight into their condition are 
significant in light of the current literature that focuses on the apathy and limited 
cognitive capacity affecting those with DM1. 
4.6 Recommendations/Future Directions 
Results from this study suggest that our study participants with mild to moderate DM1 
are proactive about finding solutions for challenges.  Moreover, their photographs offer a 
window into participants’ lives that might not be accessible during a clinic 
visit.  Therefore, the participants’ photographs of barriers and facilitators to living 
successfully with DM1 might inform clinical recommendations, particularly suggestions 
for mobility aids or devices for assisting with daily tasks.  It may also be helpful to use 
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the photographs to create handouts or a poster of assistive devices or mobility aids for 
patients to use as a reference guide.   
This study identified a need for an in-depth, examination of facets of living with DM1 
including isolation, grief, and opportunities for social and recreational pursuits; 
qualitative research is well-suited to these inquiries.  Finally, since participants in the 
present study considered symptoms that clinicians provide rigorous surveillance for (e.g., 
dysphagia or cardiac abnormalities) to be minimally impactful, it would be valuable to 
interview health care providers and patients to ascertain which symptoms are of personal 
and clinical significance.   
This finding also underscores the importance of, and need for, a multi-disciplinary team 
that is situated in either a neuromuscular, rehabilitation or a family practice clinic.  In 
order to holistically address patients’ complex needs, it is imperative that the team 
includes physicians, nurses, occupational and physical therapists, speech pathologists, 
and social workers.  Nurses are educated specifically to collaborate with patients and 
their family members to address physical and emotional issues; in turn, nurses can help 
patients and caregivers navigate the healthcare system and obtain appropriate care in the 
hospital or in the community (personal communication, Wilma J. Koopman).   Nurses, 
therefore, are well-suited to providing holistic, patient-centered care for DM1 patients’ 
complex needs.  In particular, nurses have the skill set to address patients’ and caregivers’ 
educational and psychosocial concerns while monitoring their symptoms and treating 
complications.  Research suggests that patients who attend nurse-led chronic disease 
clinics have better self-care behaviors, improved outcomes, and greater satisfaction with 
their care (Hill, 1997; Strömberg et al, 2003).  There may be a unique opportunity for 
nurse practitioners to care for patients with a chronic and progressive disease that may 
not be of interest to some medical practitioners, particularly when their clinic time is 
limited and compensation is fee-for-service (personal communication, Wilma J. 
Koopman).  While researchers have proposed a DM1 management model and a nurse-led 
integrated clinical care pathway (Chouinard et al, 2009; Gagnon et al, 2007), these have 
not yet been systematically studied or implemented across clinical sites.  More research is 
108 
 
therefore needed to explore HCPs and patients’ perspectives of—and expectations for—a 
patient-centered approach to clinical care. 
4.7 Limitations 
This research study explored the experiences of nine individuals living with DM1 and is 
therefore not generalizable to a wider population of patients.  However, the results may 
resonate with DM1 patients in other clinical settings, and findings from this article may 
be useful for generating new research questions. 
4.8 Conclusion 
Photovoice offers an in-depth exploration of patients’ experiences that may impact 
clinical care.   While it is important to consider the unique challenges presented by those 
living with DMI, photovoice is an informative and appropriate research method for 
exploring their lived experience. In particular, the participants’ photographs and stories 
offer insight into patients’ lives that would not typically be ascertained during a clinical 
encounter.  Further, incorporating patients’ knowledge about DM1 and their strategies for 
disease management may be useful for guiding educational initiatives and clinical 
recommendations.  Finally, we argue that an awareness of—and appreciation for—
patients’ lived experience contributes to better patient-centered care, and that photovoice 
is useful for uncovering patients’ illness experiences and generating research questions.  
Nurses may be particularly well-suited to addressing DM1 patients’ complex 
biopsychosoical needs, and we propose that current physician-led DM1 clinical care 
models warrant further investigation. 
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Chapter 5 
5 Truths and Misinformation: A Qualitative Exploration of 
Myotonic Dystrophy Type 1 
5.1 Abstract 
Background: Myotonic dystrophy (DM1) is an autosomal dominant, progressive, and 
multi- system condition that impacts affected individuals physically, socially, and 
emotionally. Understanding individuals’ perceptions of their disease is critical to 
ensuring appropriate information, education and counseling.  
Methods: We conducted a content analysis of findings from a larger study that used a 
novel, qualitative research approach called photovoice to explore nine patients’ 
experiences of living with DM1. Participants took pictures that illustrated barriers or 
facilitators to living with DM1; their photographs then formed the basis of semi-
structured interviews. Transcripts were analyzed and among themes, we identified one 
titled DM1 Truths and Misinformation that described participants’ disease knowledge. 
Analysis revealed four categories within this broader theme: The Physical and Emotional 
Cost of DM1, Managing My DM1, Genetics and Me and Patients as Advocates and 
Educators.  
Results: Findings showed that DM1 participants had good core knowledge with respect 
to their disease and its implications. However, each participant held as fact, fragments of 
misinformation that shaped decision-making and pointed to a clear need for strategies to 
mitigate variable interpretation of health information.  
Conclusion: We conclude that there is a need for increased education and awareness 
about symptoms, genetic information and treatment strategies for patients, their family 
members, and health care providers. 
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5.2 Introduction 
Myotonic dystrophy type 1 (DM1)—the most common adult muscular dystrophy—is a 
chronic, progressive and life-limiting condition for which there are few treatments and no 
cure.  DM1 is autosomal dominantly inherited and caused by a CTG repeat expansion in 
the 3′ region of DMPK on chromosome 19q13 (Udd & Krahe, 2012). DM1 is 
characterized by anticipation; consequently, subsequent generations experience earlier 
disease onset and greater symptom severity (Arsenault et al., 2006). In addition to distal 
extremity weakness, there is a variable occurrence of cardiac arrhythmias, respiratory 
impairment, dysphagia, apathy, cognitive deficits, endocrine abnormalities, cataracts, 
pain, and sleep disturbances (Udd & Krahe, 2012).  The multi-system clinical 
manifestations may impact the physical, emotional and social function of affected 
individuals; in particular, DM1 affects family planning as well as other aspects of social 
and psychological health (Boström, Nätterlund, & Ahlström, 2005).  A DM1 personality 
profile is emerging from the literature suggesting that those affected may have avoidant 
personality traits and cognitive impairment.  Therefore, it may be difficult for those living 
with DM1 to participate in new activities or form relationships (Delaporte, 1998; Meola 
et al., 2003; Sistiaga et al., 2010).  Moreover, a study of 200 DM1 patients living in 
Quebec found that affected individuals had lower educational attainment, lower 
employment rates and were more reliant on social assistance than the general population 
(Laberge, Veillette, Mathieu, Auclair, & Perron, 2007).  As a result, individuals with 
DM1 may experience disrupted social participation and dissatisfaction with their 
employment status, recreational pursuits and mobility (Gagnon, Mathieu, & Noreau, 
2007).  Disease severity, fatigue, cognition and mood may impact DM1-affected 
individuals health related quality of life (Antonini et al., 2006; Laberge et al., 2013; Peric' 
et al., 2010). 
The literature suggests that DM1 patients’ variable symptom presentations may challenge 
care provision (Gagnon, Noreau, et al., 2007; Heatwole et al., 2012).  Furthermore, we 
speculate that health literacy—or “the degree to which individuals have the ability to 
obtain, process, and understand basic health information and services needed to make 
appropriate decisions” (Medicine, 2004) –may be impacted for affected individuals’ 
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presenting with cognitive impairment, apathy and low educational attainment (Censori, 
Danni, Del Pesce, & Provinciali, 1990).  Previous research suggests that affected 
individuals have misunderstanding or misperceptions about DM1 (Faulkner & Kingston, 
1998; Laberge et al., 2010); in particular, an interview study with 25 DM1-affected 
women found that while most participants had a good understanding of their DM1 
symptoms, half of the sample misunderstood genetic information regarding anticipation 
and the potential risks associated with maternal transmission (Faulkner & Kingston, 
1998).  A questionnaire study of 200 DM1-affected individuals’ assessing their 
knowledge and attitudes about DM1 found that participants were less likely than non-
affected participants to understand information about—and the consequences of—
inheritance patterns and clinical manifestations (Laberge et al., 2010).   
Individuals with low health literacy may be unable to understand information provided by 
their health care providers, including treatment advice and information about 
appointments (Schloman, 2004).   Therefore, the doctor-patient relationship may be 
impacted because individuals may not understand information and may therefore be 
unwilling or unable to ask for clarification (Peterson et al., 2011).  In turn, a survey study 
of approximately 1,500 patients with heart failure suggests that health literacy may 
impact an individual’s ability and willingness to comply with treatment recommendations 
(Peterson et al., 2011); low health literacy may be associated with poorer health status, 
outcomes, increased hospitalization rates (Williams, Davis, Parker, & Weiss, 2002), and 
an increased risk for mortality(Peterson et al., 2011).  Given that DM1-affected 
individuals may miss clinic appointments or seem uninterested in their health (Meola & 
Sansone, 2007), it is essential that researchers and clinicians assess patients’ 
understanding of health information.  To our knowledge, health literacy has not been 
evaluated in DM1.   
We speculate that patients’ misperceptions and misinformation about their health may 
impede their ability to participate in shared decision-making (SDM) (Charles, Gafni, & 
Whelan, 1997).  This is problematic because SDM is widely considered to be the 
‘pinnacle’ of a patient-centered care approach (Barry & Edgman-Levitan, 2012) that 
strives to use patients’ needs, values and goals to guide health management (Medicine, 
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2014).  We contend that an understanding of DM1-affected individuals’ knowledge and 
beliefs about their condition may directly impact patient-centered care approaches; that 
is, this information may be crucial for informing clinical care guidelines and for 
developing strategies for patient self-management. Therefore, exploring the health care 
perceptions of individuals living with DM1 is important for uncovering their 
understanding of DM1 to ensure that patients have the tools to proactively seek health 
information and manage their care.  
Few studies have used qualitative research methods to explore symptom impact on 
affected individuals and their family members (Bostrom & Ahlstrom, 2005; Bostrom, 
Ahlstrom, & Sunvisson, 2006; Boström & Ahlström, 2004; Cup et al., 2011; Geirdal, 
Lund-Petersen, & Heiberg, 2014; Heatwole et al., 2012).  We expect that an 
understanding of patients’ experiences with—and knowledge about—DM1 will lead to 
better patient-centered care.  We explored the experiences of individuals living with DM1 
using photovoice—an innovative research methodology that uses participants’ 
photographs to augment qualitative interviews (LaDonna & Venance, 2014; C. Wang & 
Burris, 1994, 1997).  One theme identified from this study related to participants’ 
knowledge about DM1. There was a mixture of fact and misperception that had the 
potential to impact their health and ability to make informed decisions that has the 
potential to influence shared-decision making.  Furthermore, this information may begin 
to inform health care providers about the level of health literacy in DM1.  The purpose of 
this analysis was to conduct an in-depth exploration of participants’ understanding about 
DM1, and to identify knowledge gaps that may challenge patient-centered care. 
5.3 Methods 
Twenty-two individuals with mild to moderate adult onset DM1 attending an academic 
neuromuscular clinic were invited to participate in a study using photovoice to explore 
their experiences living with DM1; nine individuals (n = 4 females) consented (Table 1) 
(LaDonna & Venance, 2014).  Reasons for declining participation included lack of time 
or interest and distance to travel. In addition, 7 individuals expressing interest in 
participation were lost to follow-up contact.   
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5.3.1 Data collection: Photovoice 
Photovoice uses the visual image to document individual experience, and it is 
useful for conducting research with participants with low literacy or poor cognition (C. 
Wang & Burris, 1994, 1997). Photovoice has also been used to explore a variety of 
chronic neurologic conditions (Aubeeluck & Buchanan, 2006; Guerra, Rodrigues, & 
Demain, 2013; Levin et al., 2007; Lorenz & Kolb, 2009; Wiersma, 2011).  Our 
photovoice study design incorporated three data collection components: a camera 
orientation session, an individual interview, and a focus group session (C. Wang & 
Burris, 1994, 1997).  KAL—a graduate student who does not participate in the clinical 
care of DM1 individuals—conducted all information sessions and interviews with the 
participants.   
After consenting, all nine participants attended an individual camera orientation session 
in which the purpose of the study was described, the ethics of picture taking was 
discussed (C. C. Wang & Redwood-Jones, 2001) and participants were provided with a 
digital camera and instructed about its use. Participants were asked to “take pictures of 
what it is like to live with DM1”, and to photograph barriers and facilitators to their 
health. Participants had 2-3 weeks to take pictures and then returned for an individual 
interview. Each individual interview was open-ended and participant directed; that is, all 
9 participants began the interview by discussing his or her photographs.  KAL would then 
use probes such as: “Can you tell me about DM1?” that were followed by questions 
pertaining to participants’ disease history, symptoms and daily activities.  At the end of 
the individual interview, participants were asked to select 2-3 pictures to discuss during a 
focus group session. Five participants participated in one of two focus group sessions of 2 
and 3 participants.  Participant 2 withdrew from the study citing fatigue, and Participant 3 
did not attend her scheduled focus group session; their data was retained and analyzed.  
Participants 8 and 9 only participated in individual interviews; their data was intended as 
a ‘member check’ (Lincoln & Guba, 1985) to ensure that the themes identified  resonated 
with their experiences.  We ceased recruitment when we determined that no new codes or 
themes were emerging, and that our data was therefore sufficient for providing a robust 
exploration of participants’ experiences living with DM1.  
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5.3.2 Data Analysis 
Participants were active collaborators in the data collection and analysis process; in 
particular, participants chose—and gave meaning to—the subject matter captured in their 
photographs (C. Wang & Burris, 1994, 1997).  In turn, an inductive content analysis 
(Miles, Huberman, & Saldana, 2014) was used in which the authors coded the interview 
transcripts using words or phrases that described participants’ actions or experiences.  
The most frequently occurring codes were collapsed into themes and categories.  Of the 
nine themes identified, one related to participant knowledge of their disease coded as 
DM1: Truths and Misinformation, captured passages describing patients’ knowledge or 
misconceptions about the etiology, inheritance patterns or symptoms of DM1. To provide 
a deeper exploration of this theme, two neuromuscular clinicians (SLV and AG) 
reviewed and coded these passages using words or phrases that described the topic being 
discussed (e.g., “genetics” or “symptom impact”), then labeled them as a “truth” (i.e., 
‘good’ understanding) or as “misinformation”.  KAL then reviewed and consolidated the 
codes into categories.   All researchers met regularly to discuss the codes and categories 
and to resolve areas of discrepancy; in particular, discrepant issues were resolved with 
discussion and/or by reviewing the patients’ transcript in tandem with his/her chart.   The 
final list of categories was developed by consensus.  NVivo©, a qualitative research 
software program, was used to organize and manage the data. To enhance the study’s 
relevance and resonance for clinicians, we conducted a retrospective chart review to 
collect demographic and clinical information (Table 2).  
The study was approved by the Western University Research Ethics Board, London, 
Ontario, Canada. 
5.4 Results 
All patients had been symptomatic for many years (range 8 to 34 years, mean ± SEM 
19.2 ± 3 years) prior to participating (Table 2).  Seven of the nine participants had a 
family history of DM1, and all but one were ambulatory. In general, all participants 
discussed DM1 symptoms and their impact on daily life with varying degrees of 
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certainty. Yet, all participants stated as fact, opinions that reflected misperceptions on the 
part of self, friends, family, family physicians, specialists and others.  Four categories 
were identified: The Physical and Emotional Cost of DM1, Managing My DM1, Genetics 
and Me and Patients as Advocates and Educators. 
Table 5-1: Participant snapshots 
Participant 1 Mid 50s and has mild DM1.  Participant 1 asked her husband to assist 
with data collection; together, they took 4 pictures.  She completed her 
individual interview, but did not attend her scheduled focus group 
session.   
 
Participant 2 Early 70s and has mild-moderate DM1.  Participant 2’s husband 
helped her take pictures and he attended her individual interview.  
They discussed 13 photographs.  Although Participant 2 was an 
enthusiastic research participant, she withdrew from the study because 
of fatigue.    
 
Participant 3 Early 40s and has moderate DM1.  He took 15 pictures and 
participated in Focus Group 1.   
 
Participant 4 Mid 40s and is moderately affected.  He took 40 pictures and 
participated in Focus Group 1.   
 
Participant 5 Early 40s and is mild-moderately affected.  Participant 5 took 11 
pictures and participated in Focus Group 2.   
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Participant 6 Mid 40s and has moderate DM1.  He was unable to take pictures 
because he had difficulty using the camera.  Instead, his interview was 
structured around the images he would taken.  Participant 6 
participated in Focus Group 2.   
 
Participant 7 Early 40s and has mild DM1.  Participant 7 chose the subject matter of 
her 28 images, but her partner took the pictures on her behalf.  Both 
participated in the individual interview session, and Participant 7 was 
a member of Focus Group 2.    
 
Participant 8 Late 50s and has moderate DM1.  Participant 8 stated that he had 
difficulty using the camera; consequently he was only able to capture 
one image.  Participant 8’s individual interview was used as a member 
check of the preliminary findings.   
 
Participant 9 Early 40s and is mildly affected.  Participant 9 took 5 photographs, 
and her individual interview was used as a member check of the 
preliminary findings.   
 
 
 
 
123 
 
 
Table 5-2: Clinical and demographic background of the participants continued 
Duration of Disease at Time of Study 19.2 ± 3 Years 
Age of Symptom Onset 27.6 ± 4.5 Years 
Time to Diagnosis 5.4  ± 2.9 Years 
Post-Secondary Education 2/9 (22%) 
Employed 2/9 (22%) 
Family Member with DM1 7/9 (78%) 
Number of Trinucleotide Repeats 793  ± 38 
Ptosis 7/9 (78%) 
Dysphagia/Dysarthria 7/9 (78%) 
Respiratory Involvement 5/9 (55%) 
Weakness 9/9 (100%) 
Ambulatory 8/9 (89%) 
Diabetes 2/9 (22%) 
Cataracts 6/9 (67%) 
Cardiac Involvement 4/9 (44%) 
Depression 3/9 (33%) 
Excessive Daytime Sleepiness  6/9 (67%) 
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5.4.1 Physical and Emotional Costs of DM1 
All participants were aware of the variable presentation and progressive nature of DM1 
and were able to accurately describe neuromuscular and systemic manifestations. 
Participants were often knowledgeable about symptoms and disease complications 
regardless of whether they had experienced them personally. In particular, patients 
correctly identified weakness, droopy eyelids, fatigue, myotonia, sleep abnormalities, 
pneumonia, diabetes, cataracts, and cardiac abnormalities as complications of the 
disorder.  
“You got muscles. Like my heart’s a muscle and since I have heart disease, I 
said where’d that come from? Myotonic dystrophy they told me. And that 
affected my muscle and my heart so they had to put in a pacemaker to pace it. 
But like I said, what’s going to happen eventually? They just keep putting in a 
new thing every ten years or whatever and after that they just said, it just stays in 
until you die I guess” (Participant 1).  
Occasionally, participants did not relate symptoms or consequences (e.g. excessive 
daytime sleepiness or ptosis) to their DM1, or they stated that potentially unrelated 
symptoms were caused by DM1. For example, Participant 2 identified a “cough” that was 
chronic—and clearly unrelated to her DM1—as the symptom that led her to believe she 
had inherited the disease from her father: “On my mother’s side there is no one. No one. 
It was dad and I know that because I nursed dad and I was the oldest girl and I was a 
nurse. So anyway, we spent a lot of time at their house. Dad got this cough and he would 
almost whoop. Well I have that...” (Participant 2). 
The emotional burden of DM1 on participants was significant (Figure 1), and participants 
articulated their grief for lost function, limited social and employment opportunities, and 
the ability – largely attributed to inheritance and the understanding of genetics - to have 
children. Moreover, participants had insight that DM1 affected their physical appearance, 
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resulting in body image concerns. These concerns were magnified by perceptions that the 
general public’s lack of awareness about DM1 contributed to judgmental behavior.  
“The main problem I have with this is not something you can see because a lot of 
people don't understand. Like, if you don't have an arm, okay, they figure that out. 
You know, if you don't have a foot or you have to wear shades, fine, but you can't 
see the myotonic dystrophy, and people judge. But it bothers me the most with (son 
with DM1) because they judge a person's intelligence by their speech. Son’s speech 
is not the clearest so they assume he's not the brightest, and he knows they assume 
he's not the brightest because of his speech, so that bothers me” (Participant 9).  
Participants correctly perceived the likelihood of progressive disability over time, but 
there was a ‘crystal ball’ mentality in which participants envisioned that worst case 
scenarios were inevitable. Participant 8 described his concerns about needing assistance 
in the near future: “Probably as my disease starts deteriorating. My hands – you know, 
pretty soon I won’t be able to do anything and I’ll go to a nursing home.”  Finally, some 
participants were aware of the early mortality that is associated with DM1 when 
symptoms present in adolescence or early adulthood: “Because, like people with 
myotonic dystrophy do have a shorter lifespan. Usually late 50’s, 56 and up usually is 
when... Not necessarily that you hit 56 and you die. But you’re still going to get worse 
and probably be in bed more and stuff like that” (Participant 3).  
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Figure 5-1: Physical and Emotional Costs of DM1:  The Challenges of Everyday 
Activities: When asked what household chores she had difficulty with, Participant 7 
responded: Everything.  Actually, vacuuming…Getting places to do the dusting and 
whatnot, depending on how much room there is.  I can't stand for long periods. I had 
to get a new fridge where the freezer was on the bottom so I could reach down into it, 
it's a drawer type.  It makes it much easier to get things. 
5.4.2 Managing My DM1 
Participants understood that while DM1 is currently without treatments that slow disease 
or provide a cure, there are a variety of strategies available for symptomatic management. 
The need for multi-disciplinary care was acknowledged, and participants were able to 
identify dietary management, feeding tubes, BiPAP, mobility devices, and regular 
monitoring for cataracts and cardiac care as important strategies for managing DM1. 
However, some participants engaged in a variety of self-care strategies of variable 
efficacy:   
“I am on a BiPAP machine but only during the night...I feel I need it because it is 
easier to breathe with it on...Because I have an air purifier, it takes all the toxins 
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out of the air and you get pure air and that takes away, that I don’t have to wear 
that because the pure air is there. I still wear the thing at night but the pure air is in 
the rooms all where I live so it’s just pure air and it’s clean, it’s fresh and it’s 
good, good for the body” (Participant 6).  
Furthermore, Participant 7 stated that her cough assist device improved her swallowing 
difficulties, and others believed that strenuous exercise was detrimental and should be 
avoided. Several participants, however, described that staying active could be beneficial; 
for instance, Participant 9 encouraged her affected children to be physically active 
because she erroneously believed that exercise would make them stronger, reverse their 
muscle weakness and atrophy, and improve function:  
“You know... there's no reason why my kids can't be great at karate even though 
they have muscle weakness. That's part of why they're in karate is to strengthen 
their muscles so when their muscles do let them down, they have more muscle 
memory than the average so they'll buck up to normal.”  
Finally, some participants articulated the rationale for being unable to drive due to 
excessive daytime sleepiness or muscle weakness, and compensated by arranging 
transportation through friends and family or by using mobility devices such as scooters 
(Figure 2) wheelchairs, or canes.  
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Figure 5-2: Managing My DM1:  Using A Mobility Device to Navigate Public 
Spaces: That’s my scooter, that’s very helpful.  My hot rod…. So, yeah, I just use it to 
go the library or just to go to downtown or whatever, the mall, around the building…it 
helps me a lot.  (Participant 4) 
5.4.3 Genetics and Me 
All participants described that DM1 was an inherited disease, but participants’ knowledge 
about genetics was unpredictable. Therefore, while some participants were well- 
informed about genetics, most described some incorrect information. In particular, 
participants did not accurately describe genes, inheritance patterns and the relationship of 
gender to the disease. While these beliefs were accepted as fact, it was also clearly 
apparent that participants had grappled with, and tried to make sense of, this very 
complex topic. In an effort to describe genetics to her child, one participant likened DM1 
to a ‘broken stair’ in the DNA structure.  
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“On one of the floors on (science museum) they have the double helix, so I was 
demonstrating to (daughter), this is what the helix looks like, and this, and I broke 
apart the stairs, is what ours looks like because that's where the myotonic dystrophy 
is, so she understands that. So that's what the myotonic dystrophy is, a broken stair 
in our spiral staircase.” (Participant 9) 
Participants were able to describe anticipation and the severity of a childhood 
presentation of DM1, yet misconstructions about inheritance were common. One 
participant stated that the likelihood of an affected sibling having an unaffected child was 
“slim”, another described that there was only a 25% chance of passing the gene on, and 
several incorrectly described the effect of gender on inheritance: “… they say mother to 
son, and son to daughter.  It seems to go that way.  My sister thought it goes from mother 
to daughter.  I said not.  Most of the kids seem it comes from the father to the daughter 
and vice versa for the father.” (Participant 1) 
Moreover, Participant 2 expressed surprise (perhaps understandably) that all of her 
children were affected because she believed that autosomal dominant inheritance meant 
that only half of her children would inherit the gene: “I am sorry all of my children have 
it.  This was supposed to be 50%”.   DM1 “skipping generations” was also reported; 
Participant 3 stated that his sister had undergone genetic testing and tested negative, yet 
he was concerned that his sister’s children might still inherit DM1: “Um, like they tested 
my sister and she’s fine... So, my sister’s fine. Don’t know if her children are going to 
have it but they’re too young to test right now. They gotta be at least in their teens and 
they’re not there yet. But they can have it”. 
Participants also stated that gender influenced disease severity and progression; they 
believed that men were more likely to inherit and that DM1 progressed faster in males. 
However, one participant believed that the disease was more severe in females, yet did 
not attribute this to the risk of having a severely affect child with congenital onset.   
Knowledge of genetics and inheritance influenced decisions around family planning. In 
some cases, reproductive decisions were made prior to diagnosis.  However, two 
participants decided not to have children after confirmation of their diagnosis to prevent 
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passing the gene to their children. Participant 6 had considered anticipation, and 
understood that he could have a severely affected child:  “Because I was told that if had a 
child with my wife, it could be delivered with it  (DM1) and so I said, ‘I can’t do that, I 
can’t do it, I wouldn’t do it.’  It’s unfortunate I can’t have a child but it’s just not a good 
idea.”  
However, while others understood the concept of inheritance, they did not fully 
comprehend the risk:   
“Like I mean apparently they’ve found the gene that does it.  That’s the normal 
gene or whatever, ours is this.  That’s as far as I know about it, that it’s mutated.  
If you have two of the little ones, you’re good.  But I’ve got one of each, so it’s 
only 25% my kids will get it.  It’s not like my partner has it.  She has two normal 
ones, so it’s 75% chance he’s going to be normal”  (Participant 5). 
5.4.4 Patients as Advocates and Educators 
Participants identified that the relative rarity of DM1 meant that neither the general 
public, nor most health care providers, were particularly knowledgeable about the 
condition. Participants took it upon themselves to take leadership roles in the DM1 
community (Participant 4) or to educate themselves, their health care providers or other 
stakeholders about DM1. For example, Participant 3 visited a Masters of Occupational 
Therapy class to educate students about his experiences, and Participant 5 was aware that 
patient education resources were available. However, he stated that the medical language 
was daunting: “I mean I can read Harper’s book, but there’s stuff there that is beyond me. 
My doctor understood it, but then that’s his language. I don’t speak that language.”  
However, participants also recognized that these resources were beneficial for their non-
neuromuscular health care providers, and participants depended on specialists to distil 
complex information:  
“As I said, I gave him [family physician] that Harper book and he went to town 
with that, and then he found as much as he could on his Blackberry. But he had 
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never come across it, at least not myotonic. I’m sure he’s seen or heard about MD, 
but not the myotonic. But, yeah, he found as much as he could” (Participant 5).  
Participants also discussed that there was limited clinical or pharmacological research 
available for DM1, particularly in comparison to other neurological illnesses. Participants 
were however engaged in, and advocates for, more basic science or patient-centered 
research:  
“Well I like to see things get better in the healthcare field for people with what I 
have and other people have what they have. Because like you said, there is no 
medication for us with this disease, they’re working on that, I hope they find 
something. ... So I’m here to try to help them the best I can, that’s why I’m here 
(participating in research)...it’s my health. I want to do what I can” (Participant 6).  
5.5 Discussion 
We examined the DM1-specific knowledge of individuals who were part of a larger 
qualitative research study that explored the experience of living with DM1. Findings 
revealed that DM1 participants had an overall solid foundation of core knowledge with 
respect to their disease and its implications. However, each participant held as fact, 
fragments of misinformation that often shaped decision-making.  We suggest that care 
cannot be ‘patient-centered’ if patients do not have the correct information to make 
informed health care decisions.  Therefore, we identified a clear need for strategies to 
mitigate variable interpretation of health information. Our findings have implications for 
the health literacy of—and patient-centered care provision for— DM1; in particular, we 
identified a clear need to address DM1-affected individuals’; knowledge gaps to optimize 
their ability to participate in shared decision-making.  
Study participants were able to knowledgably describe many of the multisystem 
complications of DM1. It is possible that patients learn the clinical manifestations of the 
disease through their lived experience. Twenty-five participants with affected children 
had more knowledge of the disease than subjects without affected children suggesting 
that experience rather than counseling may drive patient knowledge (Faulkner & 
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Kingston, 1998). However, participants sometimes misattributed the causality of 
symptoms such as excessive daytime sleepiness, and used their own strategies such as 
increasing caffeine intake to try and ameliorate fatigue. These findings resonate with 
studies that have examined the knowledge and perceptions of individuals with DM1 
(Faulkner & Kingston, 1998; Laberge et al., 2010).  Of the 200 individuals who 
completed a DM1-knowledge assessment questionnaire, 30.5% believed that they had a 
poor grasp of disease-specific information (Laberge et al., 2010). In particular, affected 
individuals were less likely than non-carriers to recognize that physical limitations, 
apathy, learning difficulties and decreased social and employment opportunities were 
potential implications of DM1 (Laberge et al., 2010). Importantly, patients with a number 
of neuromuscular diseases considered a lack of information about their condition more 
concerning than their degree of disability (Abresch, Seyden, & Wineinger, 1998).  
Genetics was the theme most frequently identified with inaccuracies in interpretation for 
participants in the present study; although we recognize that this study was distant from 
any genetic counselling participants might have received. Nevertheless, this finding is 
consistent with the literature. Faulkner et al. interviewed 25 reproductive-age women 
with DM1 and found that participants had sound knowledge of DM1 symptoms, yet only 
56% of the subjects were able to describe the risk of transmission correctly (Faulkner & 
Kingston, 1998). Similarly, Laberge et al. (Laberge et al., 2010) found that half of the 
200 DM1 patients surveyed did not have a thorough understanding of the mode of 
inheritance. In the present study, in addition to difficulties describing the inheritance 
pattern, there were expressed beliefs that gender influenced both inheritance and disease 
progression. While participants accurately described anticipation, the increased risk of a 
severely affected infant was not ascribed to maternal inheritance. This finding has 
implications for clinical care as all participants had received information from patient 
education resources, either in the neuromuscular clinic or from genetic counsellors after a 
genetics referral. However, this is perhaps not surprising given that findings from other 
qualitative research studies suggest that variable knowledge about genetics is common in 
other chronic disease populations (McKibbin et al., 2014; Saukko, Ellard, Richards, 
Shepherd, & Campbell, 2007).  
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We speculate that the intra- and inter-individual variability of disease expression within 
families over time with mildly symptomatic or asymptomatic relatives in previous 
generations contributes to the confusion regarding inheritance. Another potential 
explanation is an interaction between mild cognitive impairments in DM1 affected 
individuals and the complexity of genetic concepts, which are often not revisited in a 
systematic way in the clinic after initial discussions around diagnosis and inheritance.  
Cognitive deficits associated with DM1 have been described (Meola & Sansone, 2007; 
Sistiaga et al., 2010) and we speculate this may explain some of the knowledge gaps in a 
general population of DM1 patients. In patients with DM1, each additional 100 CTG 
repeats reduced the odds of answering questions on the mode of inheritance correctly by 
18% (Laberge et al., 2010).  Subtle cognitive impairment, however, may remain 
undetected on routine clinical assessment in the absence of the application of specific 
assessment tools such as the Montreal Cognitive Assessment.  
Regardless, the participants in the present study were active and engaged research 
participants who perceived themselves as educators and advocates.  Participants were 
able to articulate a number of common disease features with good insight into how 
symptoms impacted their daily lives.   However, it may be inappropriate to attribute 
misperceptions solely to cognition; instead, other factors including (1) the variable 
presentation of symptoms in other family members  (2) a large amount of complex 
information being given to patients during time-limited clinic appointments, and (3) a 
lack of ‘checking’ on the part of health care providers to ensure that participants are 
retaining appropriate information may contribute to patients’ variable understanding of 
complex health information.  
To address these factors, we suggest that patients would benefit from follow-up 
appointments at regular intervals with review and assessment of relevant knowledge and 
given the opportunity to ask and answer questions that facilitate engagement with shared 
decision-making.  We recognize, however, that traditional, physician-led clinical care 
models may be impeded by system capabilities— including time-limited appointments—
from fulfilling this need. Others have suggested that a more holistic or multi-disciplinary 
clinical approach may be useful for addressing DM1-affected individuals’ complex needs 
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(Gagnon, Chouinard, Laberge, et al., 2010; Gagnon, Chouinard, Lavoie, & Champagne, 
2010; Gagnon, Noreau, et al., 2007).  We therefore, suggest that patients would benefit 
from referral to nurses and other allied health professionals familiar with myotonic 
dystrophy, including social workers and occupational therapists, for further clarification 
about symptoms or general disease-specific information, to assist patients in decision-
making, and to provide reassurance, particularly in regard to disease progression and 
genetic information. Counseling and educational interventions may improve patient 
knowledge in this category (Furr & Kelly, 1999). It is likely that this information sharing 
will be an ongoing process to ensure adequate comprehension, retention of information 
and application to relevant decision making over the disease course. Anecdotally, we 
hosted a DM1 patient education day in which patients not only had the opportunity to 
learn about the latest DM1-related information and research from various health care 
providers, but they were also able to share common experiences with others with DM1. 
Given that one participant in the present study found the language of patient education 
resources to be difficult to understand, patient education days provides good opportunity 
for health care providers to simplify and clarify a wide range of health information. 
5.2 Limitations and Future Directions 
This is a small study that reported on the experiences of nine patients living with DM1; 
Findings, therefore, are not generalizable, however may resonate with DM1-affected 
individuals and clinicians in other settings.   Similarly, we did not set out to evaluate the 
health literacy of DM1-affected individuals; instead, findings pertaining to disease 
knowledge were identified during data analysis of participants’ photographs and 
narratives regarding their experiences living with DM1. Therefore, future research 
questions could be directed at the health literacy assessment of individuals with DM1 that 
can then be used to develop interventions and patient education materials. In turn, 
qualitative interviews with patients would be useful for assessing the content, readability 
and applicability of any education or research materials.  It may also be advantageous to 
examine current DM1 clinical care models to determine if they are meeting patients’ 
complex physical, psychosocial, and educational needs.    
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Importantly, we identified that some participants felt responsible for educating non-
neurology specialists about DM1.  It may, therefore, be important not only to assess and 
clarify patients’ knowledge, but also to provide in-services, one page “DM1 fact sheets” 
for family and generalist physicians, or to give presentations to other specialties to ensure 
that accurate information is disseminated to health professionals caring for individuals 
with DM1.  Patients may be a powerful and under-utilized resource for raising awareness 
in the clinical setting. 
5.3 Conclusion 
While patients are knowledgeable about DM1, they have misinformation and 
misperceptions that may affect their ability to make important decisions about their 
health.  Findings suggest that information about genetics is particularly problematic for 
patients, and that misinformation may influence decision-making.  Therefore, future 
research should address the educational needs of patients; in turn, educational 
interventions are required to bridge these health literacy gaps and optimize the health and 
decision-making capabilities of patients with DM1. 
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Chapter 6 
6 “[The neurologist] is throwing you a raft”:  Exploring 
motivations for on-going clinic attendance for 
individuals living with chronic, progressive and life-
limiting neurological conditions 
6.1 Abstract 
Background: Patient-centered care may be challenged for patients with complex chronic 
conditions, particularly those presenting with cognitive or behavioral impairments.  It is 
therefore essential to explore patients’ and caregivers’ perceptions about their health 
expectations and their clinical care.  Myotonic dystrophy (DM1) and Huntington’s 
disease (HD)—chronic, life-limiting neurological conditions with few treatments—are 
suitable for this inquiry.   
Methods: Constructivist grounded theory—a qualitative research methodology that 
explores basic social processes—informed data collection and analysis.  Fourteen 
patients, 10 caregivers and 11 health care providers (HCPs) were purposively sampled 
from one academic medical centre in Ontario, Canada to participate in semi-structured 
interviews.  Three levels of coding were done to generate themes; in turn, themes were 
condensed into categories. 
Results: Patient and caregiver participants described continuing clinic attendance to seek 
expert information and social support.  Medical management, altruism and reassurance 
provided the motivation.  However, patients’ and caregivers’ motivations change over 
time, with clinic becoming more important for caregivers as their loved one’s condition 
deteriorates.  Regardless, participants describe clinic as a ‘safe place’ that decreases their 
isolation and empowers them to actively participate in health care and research.   
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Conclusion: In the absence of disease-halting or curative treatments, patient and 
caregiver participants perceived that they derived a therapeutic benefit from the attentive 
care provided by expert HCPs. However, traditional physician-led medical models may 
be less focused on patients’ and caregivers’ supportive goals, and we suggest that nurse-
led—or other clinical care models—warrant further investigation. 
6.2 Introduction 
The current health care system more readily accommodates patients with acute, treatable 
problems, not those with complex, chronic, and progressive conditions (Nolte & McKee, 
2008).   Wagner and colleagues (2000) proposed a Chronic Care Disease Model that 
makes chronic disease management proactive, not reactive; ideally, key elements 
including team-based care, patient self-management strategies, information technologies, 
and integrated decision making should coalesce to enhance the patient-provider 
relationship and improve health outcomes (Coleman, Austin, Brach & Wagner, 2009).   
Wagner et al. (2005) argue that a chronic disease management approach must be patient-
centered; that is, care must incorporate the experiences, values, needs, and goals of the 
patient and his or her loved ones.  Moreover, patients should be encouraged and 
empowered to manage their own care; to do this, health care professionals (HCPs) need 
to provide patients with adequate information and evidenced-based treatment approaches 
(Wagner, 2005).  However, we speculate that patients with progressive, chronic diseases 
presenting with cognitive and behavioral impairments challenge models of patient-
centered, chronic care.  Care is further complicated by conditions that are hereditary and 
have few treatments available.  Myotonic dystrophy (DM1) and Huntington’s disease 
(HD)--chronic, progressive, hereditary and life-limiting neurological conditions for which 
there are no treatments to slow or reverse neurodegeneration--are well-suited to studying 
patient-centered health care delivery and expectations for individuals with complex, 
chronic disease.   
DM1 and HD are genetic disorders characterized by progressive physical, cognitive and 
behavioral symptoms that may impact individuals’ personal relationships and their ability 
to fully participate in work or leisure activities (Gagnon, Mathieu & Noreau, 2007; 
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Nance, 2006).  As a result, individuals may have a lower socioeconomic status and a 
reduced quality of life.  DM1, the most common adult-form of muscular dystrophy, is a 
multi-system condition causing muscle weakness, excessive fatigue, swallowing 
dysfunction, heart and breathing problems and endocrine abnormalities including 
infertility and diabetes (Harper, 2001). There is also a well-recognized DM1 personality 
profile described in the literature suggesting that patients may have cognitive and 
behavioral impairments including low IQ and apathy (Sistiaga et al, 2010; Delaporte, 
1998; Meola et al, 2003).  HD is a progressive neurodegenerative disease with similar 
features including involuntary movements, cognitive impairment and psychiatric 
manifestations.  In particular, apathy and other psychiatric features including depression, 
anxiety and psychosis can significantly impact individuals living with HD.   However, 
both conditions are highly variable, and symptoms can differ substantially, even for 
individuals within the same family.  Regardless, affected individuals have a reduced life 
expectancy; sudden cardiac events and pneumonia are the leading causes of death for 
individuals with DM1 (de Die-Smulders et al., 1998; Mathieu et al., 1999), while 
pneumonia and suicide are the most common causes of death for HD-affected individuals 
(Roos, 2010).  While there is no cure for DM1 or HD, there are limited therapies 
available to mitigate symptoms.    
DM1 and HD are relatively uncommon conditions affecting 1:8000 and 1:10,000 
worldwide.  Therefore, few family physicians follow DM1 or HD-affected individuals, 
and patients typically attend specialty neurology clinics that provide diagnostic 
evaluations, follow-up, and referrals to tertiary health care providers (Chouinard et al., 
2009).  Treatment plans may include medications to treat symptoms, surveillance for 
progressive symptoms, and referrals to specialists to monitor complications and quality of 
life, or to physical therapists for mobility occupational therapy to address activities of 
daily living or social work to consider disability applications (Gagnon et al, 2007; 
Gagnon et al, 2010; Nance, 2012; Roos, 2010; Sturrock & Leavitt, 2010; Turner & 
Hilton-Jones, 2008).  However, patients’ cognitive and behavioral impairments, coupled 
with a lack of treatment options, may complicate clinical care; in particular, the literature 
suggests that individuals with DM1 may miss clinic appointments and be disinterested in 
their health (Meola & Sansone, 2007) or demonstrate poor adherence to clinical 
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recommendations (Chouinard et al, 2009).  Moreover, HD patients may be unaware of 
their involuntary movements or the extent of their cognitive and behavioral impairments 
(Kremer, 2002).  Given few treatment strategies, and the lack of awareness that patients 
may have about their condition, it is unknown why many DM1 or HD patients maintain 
regular follow-up at a specialty neurology clinic. 
To our knowledge, motivations for clinic attendance for individuals with DM1 or HD 
have not been explored.  However, reasons for clinic attendance have been studied in 
other chronic conditions including cancer (Brain et al., 2000; Thomas, Glynne-Jones, & 
Chait, 1997), HIV/AIDS (Bodenlos, 2007), and asthma (Van Baar et al, 2006).   For 
example, 833 individuals with a family history of genetic cancers attended clinic to find 
out information about their individual and family members’ risk of inheriting cancer, to 
participate in research, and to learn about genetic testing, screening and prevention (Brain 
et al.,2000).  Patients with asthma attended to manage their symptoms, seek further 
medical investigations, and to hear information about new treatment options (Van Baar et 
al, 2006).  However, patients also felt compelled to attend appointments that were 
scheduled in advance to avoid adversely affecting their relationship with their health care 
provider (Van Baar et al, 2006).  It is important to note, however, that unlike DM1 and 
HD, these conditions have evidenced based treatments that may slow progression or 
improve the outcomes of the underlying disease process. We, therefore, sought to explore 
patients’, caregivers and health care providers (HCPs) perspectives about why patients 
with life-limiting neurological conditions with few treatment options choose to maintain 
regular, on-going follow-up at an outpatient neurology clinic.  In particular, what do they 
perceive are patients’ health care expectations, and does the current clinical model meet 
their needs?   
6.3 Methodology 
6.3.1 Constructivist Grounded Theory 
Constructivist grounded theory (CGT) (Charmaz, 2006; 2014) informed the iterative data 
collection and analysis process.  Grounded theory is rooted in symbolic interactionism, 
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and it uses inductive methods to develop theory about basic social processes that are 
grounded in empiric data (Glaser & Strauss, 1967; Strauss & Corbin, 1990; Charmaz 
2006; 2014).  
6.4 Methods 
Individuals with mild to moderate DM1 or HD (by physician report) who maintain 
regular clinic attendance were recruited from outpatient neuromuscular and movement 
disorder clinics at one academic center in Ontario, Canada.  Follow-ups for HD and DM1 
patients are typically scheduled every 6 months to two years; therefore, we defined that a 
patient maintained ‘regular clinic attendance’ if they had attended at least two 
consecutive appointments.  Individuals were recruited using purposeful and convenience 
sampling; that is, since both DM1 and HD can cause cognitive problems, health care 
professionals at each clinic were asked to identify and approach patients who they 
perceived were able to provide informed consent and comply with study procedures.  To 
facilitate participation for individuals with limited mobility, lack of transportation, or for 
those who travel long distances to clinic (up to 200km), KAL consented and interviewed 
participants directly following their clinic appointments.  Health care professionals caring 
for patients with DM1 and HD were also invited to participate. 
Fourteen patients (n=5 DM1), 10 caregivers (n=2 DM1) and 11 HCPs participated in 
semi-structured interviews.  The HCPs included neurologists specializing in 
neuromuscular conditions or movement disorders, a psychiatrist and a respirologist; a 
nurse practitioner; two social workers; and a physical therapist.  KAL interviewed most 
participants; however, since KAL had working relationships with several of the HCP 
participants, a research assistant (CP) conducted the HCP interviews.  As the iterative 
data collection and analysis progressed, the interview probes evolved to explore themes.  
Charmaz (2006; 2014) suggests that grounded theory researchers engage in initial, 
focused and theoretical coding.  KAL first read the first two DM1, HD and HCP 
transcripts as a whole, then coded each line or sentence using gerunds or in vivo codes 
that captured the meanings or actions described by the participants.  Next, KAL 
consolidated the most frequently occurring codes into preliminary categories, then coded 
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the next six transcripts using these categories to determine their fit and relevance.  KAL 
met frequently with SLR and SLV to discuss preliminary findings. The research team 
finalized a list of categories by consensus that KAL used to re-code the entire dataset.  
Throughout the research process, data within and between transcripts were constantly 
compared, and KAL wrote memos and drew diagrams to capture and explicate 
increasingly abstract ideas about the data.   Memos were invaluable not only for making 
the emerging analysis more theoretical, but also for determining avenues for theoretical 
sampling to elaborate on the categories.  For example, while the focus of this study was 
on individuals living with chronic neurological disease, it became apparent very early in 
the research process that caregivers were integral to clinic attendance for several 
individuals.  Therefore, we amended our ethics application to include caregivers.  While 
they were given the option of participating in separate interviews, all patient-caregiver 
dyads chose to be interviewed together.     
Recruitment and data collection ceased when the researchers determined that theoretical 
sufficiency had been reached; that is, while gathering additional data might have 
provided new insights, we determined that the collected data was sufficient for obtaining 
a robust exploration of the participants’ perceptions of—and motivations for—clinic 
attendance.  NVivo©, a qualitative research software program, was used to organize and 
manage the data.   This study was approved by the Western University Research Ethics 
Board; all participants were assigned a pseudonym to ensure confidentiality.  
6.5 Results 
The process for choosing to attend an outpatient neurology clinic follows a trajectory 
from seeking a diagnosis, to monitoring symptoms, to seeking guidance as the condition 
manifests and progresses.  Participants described that living with an uncommon condition 
was isolating, and they framed their reasons for maintaining clinical follow-up at a 
specialty neurology clinic by describing negative experiences with former health care 
providers and members of the public. In essence, the clinic was a “safe place” where they 
felt understood and where they could seek information and actively participate in their 
care.  Importantly, the DM1 and HD clinics were not just resources for patients living 
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with manifest disease; instead family members, especially partners and children who 
were at risk, also came to clinic for counseling and support.  Sometimes this care was 
informal, but in some situations family members were able to access clinic staff (for 
example the social worker or the nurse practitioner) without the patient present.   
However, the motivation, emotional experience and the importance of attending clinic 
seemed to change over time for both patients and their family members along various 
points of the disease trajectory.   
6.5.1 First Contact: Seeking a Diagnosis 
Patients typically present to a specialist clinic for an initial consultation to seek a 
diagnosis (1) when there is a family history of DM1 or HD, but the individual does not 
know his/her gene status; (2) when individuals are gene positive but pre-symptomatic; (3) 
or when individuals are experiencing neurological symptoms and may or may not have a 
positive family history for DM1 or HD.    Findings suggest that individuals often 
experience anxiety prior to visits because they are apprehensive about their “genetic fate” 
(Dr. Green, neurologist).   
6.5.2 Recalling Negative Experiences 
Apprehension is also heightened by the genetic nature and variable and unpredictable 
disease course of these conditions.  Patient and caregiver participants framed their 
reasons for seeking regular, on-going follow-up at a specialty clinic by reflecting on 
negative experiences in their daily lives or during encounters with HCPs.  Often, patients 
had been caregivers for affected family members; consequently, they had seen first-hand 
the “devastating” progression of DM1 and HD and the judgment and negative attention 
focused on their loved one.  Participants described that their loved one had been mocked 
in public, misdiagnosed and/or prescribed inappropriate treatments.   These experiences 
seemed to cause great anxiety for patients as they contemplated what their future might 
hold:    
But she (mother) just had a lot of movements and stuff.  So a lot of people made 
fun of her all the time.  But coming to the neurologist back then, it was horrific to 
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just see what my mom was going through.  And the two of us would just bawl all 
the way home… just because they couldn’t do nothing.  And oh my God, I was 
freaking out for myself too (Patricia, HD patient).   
Participants understood that DM1 and HD are uncommon conditions; few participants 
had heard about DM1 or HD prior to a family member’s diagnosis, and they perceived 
that the conditions were poorly understood by the general public and most HCPs: “I talk 
to some people that they probably heard about it but I don’t think they know much about 
it.  I know me, the first time I find out about it, I didn’t know what the hell it was, I didn’t 
have the slightest idea.  Hell, my doctor didn’t know what it was” (Lucy, HD Caregiver).   
Participants also described that they or their loved one were sometimes dismissed by 
HCPs who were perplexed about their symptoms: “His mother really wandered for, I'm 
going to say a good 10 years.  Everybody just thought she was crazy… nobody would 
pay attention to her…” (Michelle, HD Caregiver).   
Some participants described having to undergo numerous medical tests that sometimes 
resulted in a misdiagnosis or inappropriate pharmacological management.  Negative 
experiences further impacted patients following their diagnosis.  While not unique to 
DM1 or HD, some participants had a poor relationship with their treating neurologist 
which impacted their willingness to attend clinic; consequently, they either temporarily 
stopped attending or they asked to be referred to another specialist such as the participant 
below: 
I wasn’t followed for anything for the myotonic dystrophy because I never really 
had any problems, right?  I mean other than little stuff and then when I started 
falling, my gait had changed and I started falling a lot.  Then they sent me to 
(doctor) and (we) had a bit of a misunderstanding shall we say.  I just don’t like 
the (doctor’s) bedside manner (Maxine, DM1). 
Given the uncommon occurrence of these conditions, they were usually the only patient 
with DM1 or HD in their family physician’s practice.  Therefore, they stated that their 
family physician had little knowledge about--or experience managing—their complex 
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symptoms.  When asked if her husband’s family physician managed his HD symptoms, 
Michelle (HD caregiver) responded: 
Our family doctor knows nothing, actually.  It's a bit disturbing…. his doctor told 
us, ‘I've been a doctor for 25 years and I've never had a patient with it and I'm not 
prescribing for you.  Go to the other doctor’….I don't think you should be 
shutting a door on someone who gets something that you didn't learn about.  I 
mean, there's so much on the internet, that he could at least give him a little bit of 
sympathy… 
6.5.3 Clinic is Experienced as a ‘Safe’ Place 
Once patients adjusted to the initial shock of their diagnosis and had developed rapport 
with a specialist neurologist, most participants perceived that the clinic was a comfortable 
place where patients and families could seek the therapeutic benefit of expert 
information, reassurance and support.  As Jeff (HD) and his father described, it was 
sometimes difficult for participants to articulate what made the clinic seem comforting:  
“It’s just whenever I come here, it’s hard to put into words…”(Jeff, HD patient).   “It’s 
like a shrine, it’s like you’re going to go to, it’s like going to church on Sunday, it’s like 
going to a shrine, like when he comes here he feels, I don’t know, it gives you a different 
feeling of something I guess (Frank, Jeff’s caregiver).”   
Patients and caregivers seemed to experience the specialty neurology clinic as a ‘safe’ 
place staffed by experts who were aware of their limitations and treated patients as 
individuals, not as a disease.   They seemed comforted knowing that someone was 
“…looking after me that way, rather than being out there on your own and all this stuff 
starts happening and you have nobody to turn to” (Tim, DM1).  In contrast to their 
experiences in non-neurological practice settings or in the community, patients felt 
understood at clinic; that is, they did not have to explain their condition, their physical 
and behavioral impairments or their appearance.  Participants like Doug (HD) felt 
comfortable talking about HD with the clinic social worker, but not with others because 
“they don’t understand it.”  Moreover, some HCPs perceived that being understood at 
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clinic seemed to reduce some of the anxiety of living with—and the fatigue of having to 
continuously explain—an uncommon condition.   
 I think them just knowing that people understand and that they care… I think 
when you make that connection, even how insignificant it might seem to us 
because we don’t think we’re doing a lot… it’s someone that’s trying or does 
understand that they have challenges and that they’re dealing with that, and 
someone that will just listen to their frustrations (Mae, allied health professional). 
Seeing others with their condition was another aspect of feeling understood.  While it was 
troubling for some participants to see patients with more severe disease in the waiting 
room, for others, it provided a degree of comfort and eased their sense of isolation:  “I’m 
comfortable coming here because other people if they come here have the same thing…It 
just makes me feel better knowing other people have it….(Jeff, HD).”  Jeff’s caregiver 
added,   “Yeah, you just feel that you’re not alone” (Frank). 
 
Figure 6-1: Maintaining Clinic Attendance in a ‘Safe Place’ 
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6.5.4 Motivations for attending clinic: Seeking Expert Information 
At each stage of the disease trajectory, seeking expert information was described as the 
main motivating factor for clinic attendance.  “Just having a doctor or social worker or 
nurse who is an expert in that field, really helps them.  More often than not, they have 
lots of questions to ask as well, which could be on a social front, medical front, nursing 
front, whatever.  But they really have got quite a lot of questions to clarify each time that 
they are with us” (Dr. Night, specialist physician).   Information however, meant different 
things at different time points, including seeking a diagnosis, education about DM1 or 
HD, monitoring symptoms and seeking a prognosis.  Participants were particularly 
motivated to obtain information from experts about how their condition would impact 
their daily lives.  Some contrasted the knowledge they received from their specialist with 
the care provided by their family physician: 
  I think since she’s a specialist per se and my family doctor is more general, like 
he knows maybe the idea of muscular dystrophy and what it kind of pertains to, I 
think Dr. Thompson would know more detail, like digs deeper into it.  He might 
say, people with muscular dystrophy, yeah, they have trouble with their hands, but 
Dr. Thompson knows they have trouble with their hands but she knows why they 
have trouble with their hands (Tim, DM1 patient). 
The clinic is also a resource for patients to seek pragmatic help completing paperwork for 
disability or insurance claims, and for inquiring about—or receiving assistance 
obtaining—medical or community resources including medical alert bracelets, support 
groups or funding opportunities.  Clinic staff sometimes served as a liaison between 
patients and employers to facilitate appropriate work conditions for patients’ changing 
needs.   Expert assistance seemed to ease these daunting tasks for patients:  
 Yeah, he (Ray, allied health professional) just happened to come out because my 
insurance company sent me out to apply for CPP and he offered to come out and 
go through it with me.  So that was a big help because that was overwhelming.  I 
just looked at it and I just put it away.  …He come right out to the house…  He 
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wrote everything out and worded things the right way and he was awesome.  I 
don’t think I would have got it done.  (Patricia, HD patient) 
Patients and caregivers described that attending a specialty clinic staffed by experts was 
also important and necessary for obtaining the latest information about research 
opportunities and therapeutic advances and for having their questions answered:  
 I have questions that cannot be answered by anybody else, they don’t know the 
answers.  My family doctor doesn’t really know the disease, I come here because 
I know it’s helpful and sometimes you have questions that only Dr. Thompson 
can answer because that’s what she specializes in.  And sometimes, it’s not only 
me, sometimes my caregiver will have a question for Dr. Thompson that I don’t 
think of, for their personal knowledge or for me.  It just helps me see where I’m at 
and if I’m having problems with something what can be done to help me, what 
different things, depending on what it is (Jackie, DM1 patient). 
Another key reason that individuals maintained regular follow up was to have their 
symptoms monitored and to measure their disease progression.   Often, seeking 
information about disease progression provided patients with reassurance that they had 
not declined substantially or that their current symptoms may be improved with medical 
management.   For patients and caregivers, this was described as ‘hearing good news’ 
that relieved some of the tension of living with a progressive and unpredictable illness:   
 …one day Martha was testing my strength and she was doing my shoulders and 
she told me, she goes, for somebody with MD, you have very strong shoulders.  
That makes me feel good because I know, okay, I have strong shoulders at least.  
Something is strong on me, right? ….  So, I think having them as kind of a safety 
net or knowledge of information or just something to fall back on is a good 
feeling I think.  Everybody needs something. (Tim, DM1 patient) 
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6.5.5 Seeking Connection 
Given the inherited and unrelenting physical and cognitive decline of DM1 and HD, 
participants described experiencing shame or stigma, and in turn, several felt compelled 
to ‘hide’ or keep their diagnosis a secret.  Participants described that they did not tell 
employers about their condition and avoided friends and family; others had family 
members who refused to acknowledge or speak about the disease publicly.  Participants 
feared that their genetic status could impact them financially (job or insurance loss) or 
socially (avoidance; fear of being mocked).  Isolation and a sense that patients were 
‘fighting the battle alone’ permeated the interviews.  Therefore, the lack of community 
awareness was exacerbated—and patients’ sense of isolation increased— by an 
unwillingness for some individuals with DM1 or HD to share their stories:  “I would 
never go over to your house and just sit down and start chatting about what I have, it just 
wouldn’t happen, so it (clinic) kind of makes you kind of talk about it, even though you 
may not want to, but it needs to be addressed” (Beth, HD patient).   
 Clinic, therefore, gave patients and caregivers the opportunity to form relationships and 
share their stories with HCPs and other families living with these conditions.  For some, 
clinic was viewed as a social outing where they could meet—perhaps for the first time—
others with their condition, or form relationships with HCPs who were understanding and 
who specialized in their uncommon condition:   
Each day goes by and you’re wondering, where is this disease going to end up?  
And then, seeing the specialists that know what they’re doing helps to give you 
some hope.  You see somebody that understands, that can understand the 
Huntington’s, or whatever, somebody that wants to take interest in it…(Rob, HD 
patient). 
Participants described that their HCPs were ”easy to talk to”, and some described their 
HCP as a friend.  Participants appreciated ‘small talk’ during clinic visits about personal 
hobbies or interests, important life events like weddings, and the sense that they were 
known and treated as an individual, not as a disease:  “I don’t know how they all know 
every little detail about me …” (Patricia, HD patient). A sense of connection seemed 
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equally important for the HCPs:  “I do love it and I don’t need to be doing this job any 
longer… but I’ve connected so well with the Society and with the families that I work 
with that I feel part of their family now” (Ray, HD social worker).   HCPs also described 
that it was a “privilege” to care for multiple generations of a family (Dr. Green, 
neurologist), and they enjoyed forming warm, long-term relationships with patients and 
their family members and helping them navigate complicated decisions (Dr. Matthews, 
neurologist). 
6.5.6 Drivers of On-Going Clinic Attendance 
Seeking expert information and connection are driven by three factors:  symptom 
management, altruism and hope.  While there are no treatments to slow or reverse 
neurodegeneration, there are management options available to address problematic 
symptoms including medications, assistive devices (e.g., mobility aids; BiPap), referral to 
specialists, and counseling.  For some patients, however, seeking a tangible 
pharmaceutical treatment was not their main goal for attendance.  Patients and caregivers 
either perceived that there were few treatments available, or they were not aware that 
medications or interventions that their clinician had prescribed (e.g., psychiatric 
medications for behavioral complications) were treatments for their HD or DM1.  HCPs 
also indicated that pharmacological treatment was not always the patients’ and 
caregivers’ motivation for attending clinic: 
 From our point of view, we want to make sure that they are getting the right 
treatment.  But, for them, treatment is just a part of the management.  The 
physician is very interested to improve the affective symptoms, for example, from 
a psychiatry point of view, then you are just very interested in controlling the 
motor symptoms.  But the patients, all they want is to make sure they get the best 
treatment and that’s why they come back.  And things change as well, they’re 
always evolving (Dr. Night, specialist physician) 
Instead, altruism seemed to be the main driver for maintaining regular follow-up.  
Patients and caregivers described that they wanted to be advocates for individuals living 
with their condition.   Some participants described that they believed that little could be 
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done to help them, but that their regular attendance at clinic might help future 
generations, primarily their children or other at-risk family members.  In particular, 
participants came to clinic to hear about—and perhaps participate in—therapeutic 
advances and research opportunities; for instance, one participant with an unusual disease 
presentation consented to having her blood sent for analysis, and several other 
participants had enrolled in clinical trials.  
Patients viewed themselves as educators; that is, they provided information to their non-
specialist HCPs, and they perceived that by attending clinic and participating in research, 
that they were teaching consultants and trainees more about the condition.   In turn, their 
participation would raise greater awareness for the medical community that could lead to 
therapeutic breakthroughs.  “I like to participate with (researchers) so people learn about 
it, so maybe somewhere down the road there’s a cure or some time down the road there’s 
something that people will learn and then, like after I’m gone, people that have it may 
have it easier than I do basically” (Tim, DM1 patient).   
Most HCPs indicated that their main role was to give patients and their families hope by 
providing management strategies and information about research and therapeutic 
advances.  For some, attending clinic gave patients and their families something to ‘cling’ 
to, namely reassurance that the patient’s symptoms were being managed and that the 
medical and research communities were working toward a therapeutic treatment or a 
cure:   
 It’s kind of like you’re in a lake, drowning.  And he’s throwing you a raft, while 
other doctors are just standing around doing nothing.  At least Dr. Green is 
throwing us a raft, some kind of a dingy.  Some hope that, if you work hard 
enough, you might be able to get on the raft and float away (Thora, HD 
caregiver).   
However, while symptomatic management and altruism provided hope for some 
participants, this experience was mixed.  Others sensed that they faced progressive 
decline with few treatment options to reverse or mitigate deteriorating symptoms, 
therefore they believed that “hope is what you make.  I don’t depend on anybody else for 
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it…”(Maxine, DM1 patient).   Instead, some individuals described that they attended 
clinic to seek social support and information, not hope:        
 Hope, well, I think I’m going to die with Huntington’s and not of 
Huntington’s...I’m not in a rush to cure me.  So, if people are sort of younger, got 
children, then the hope is somewhere there’s a tablet that’s going to cure this.  I 
can see why people would go for hope.  I never even ask it of the doctor.  I just 
figure Dr. Green will tell me when there’s a tablet he wants to put me on.  But 
right now, there isn’t one available that will slow it down because it’s (disease 
progression) slow enough as it is.  I don’t know.  I could see the hope.  I don’t go 
for hope, no, I go for information, definitely not hope.  Maybe in 10 years I might 
say, oh well, maybe they’re going to do something (Margaret, HD patient).  
6.5.7 Evolving Motivations 
However, patients’ and caregivers’ motivations for attending and their degree of 
participation in their health care changed over time; immediately following diagnosis, 
some caregivers had to prod their loved one to attend.  However, once patients had 
adjusted to their diagnosis, attending clinic generally became less anxiety provoking, and 
patients typically became active and enthusiastic care participants: 
 He didn’t want to go…it was a fight, his girlfriend at the time and myself had 
been trying to get him to go because we knew he needed to.  And finally, I was so 
worried he would cancel the day we finally were to go …Once he met Dr. Green 
and Ray, everything was great…. he just felt very comfortable with both of them 
(Sue, HD caregiver). 
Some participants indicated that, over time, the need to measure progression became 
more important for caregivers than for patients because this information helped 
caregivers manage uncertainty and provided guidance about seeking different care or 
resources for their loved one.   For instance, several patients were not interested in 
knowing how their condition was progressing, while caregivers acknowledged that 
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having this information was important for considering future care responsibilities as one 
caregiver discusses her: 
 And we want to be prepared …we had a lot of stuff for my mom with, like, a 
walker and … we have lots of bars for him.  And Dr. Thompson mentioned the 
community help at …  So I think it’s us that are more seeking the information 
than Nick because he just takes every day at a time (Vanessa, DM1 caregiver). 
Moreover, as the patients’ cognitive and behavioral function progressively declined, 
caregivers once again took an increasingly active role getting patients to clinic and 
directing the clinical encounter.  Caregivers were a source of information for clinicians, 
particularly if the patient was unaware of—or downplayed—his or her symptoms: 
 So I think from a patient’s perspective, they walk in there presenting the best that 
they possibly can and as much as they’re coming for a reason, they don’t want to 
talk about those reasons.  And the caregiver comes with, ‘and here’s what’s really 
happening’ and ‘this is why I’m here today’.  So I think that there are two 
different agendas that are always happening when two people come into that room 
together.  (Ray, HD social worker) 
In the end stages of disease, while visits still addressed symptom management for the 
patient, the focus of the visit often shifted to supporting family members as they coped 
with their loved one’s complex and progressively worsening condition.  In a sense, as the 
patient’s condition deteriorated, ‘caring for the caregiver’ often became the goal of clinic 
visits.   
6.5.8 Taking Charge—Encouraging a Patient and Family Centered 
Approach 
Despite their motivations for attending, participants acknowledged—and HCPs 
encouraged— that patients and caregivers were responsible for taking charge of health 
care decisions and directing care.  Sometimes caregivers would speak for the patient—
particularly as the patient’s cognition or speech became increasingly impaired— but 
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HCPs would continue to encourage the patient to speak for him or herself:  “It was funny 
because we were answering questions for Nick and she (Dr. Thompson) goes, I know you 
love him and you’re his care-keeper but I would like Nick to talk” (Vanessa, DM1 
caregiver).  Moreover, when asked about her goals for clinical follow-up, the nurse 
practitioner stated that the focus of the clinic visit was to address patient-identified needs: 
“I don’t have any goals, it’s whatever the patient determines is their goal.  So, I ask the 
patient, what do they think the visit is for, do they have any questions, concerns, things 
that they specifically want to address, they want me to address, and then I’ll address 
those.”   HCPs typically used the clinical encounter to identify worsening symptoms in 
order to manage and prevent complications, but a psychosocial approach sometimes 
usurped the traditional medical model if patients identified concerns they wanted to 
address:   
(Describing a typical dictation): ‘You’ll see that today I didn’t examine him or 
her because we spent all the time…talking about their difficulty with weight loss, 
eating properly and making sure that blah, blah, blah.’  So, not necessarily did I 
have to examine their reflexes every time, because we spent 15 minutes…talking 
about personal issues…” (Dr. Bennett, neurologist). 
Patients and caregivers also decided if, when and how much information they wanted to 
obtain about their condition.  For some, reading about their condition or attending a 
support group was beneficial.   Others, however, were determined to take it ‘day by day’ 
and not research what their future might hold, or they did not feel emotionally prepared to 
read about the potentially devastating complications of HD or DM1: 
 Well I know what it is and I know what it does and stuff like that but for me to 
learn more about it I have to be in a certain state.  I don’t like to read about it too 
much, I have to be in a certain frame of mind to read about it, because it’s not 
exactly the most enjoyable reading material, I have to be in a certain state to read 
about it and learn more about it (Jackie, DM1 patient). 
For most patients, the clinic was enough of a supportive resource that they did not feel 
inclined to seek further support elsewhere.  Some patients and caregivers were opposed to 
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the idea of attending a support group; participants were either uninterested in the topics 
presented at group, or they were not ready to see individuals with more severe disease.  
Reasons for choosing to obtain information or support varied for patients and caregivers: 
I think it probably would be a great idea if Rose went and talked to people about 
that kind of stuff because it’s just going to get worse.  It’s not getting better 
obviously.  And me telling her or saying it upsets me, it doesn’t do anything.  But 
maybe if she heard from other people, maybe how they deal with somebody like 
me.  That’s how I dealt with my mom, but that’s just me.  You have to do your 
own thing, right?  But maybe the support groups, not with me.  I’m not ready to 
go to it.  But I know one day I want to, but not right now.  But maybe it would 
make you feel better (Patricia, HD patient).   
6.6 Discussion 
We identified that patient and caregiver participants attend clinic to be proactive seekers 
of expert medical management, community support, and information about DM1 or HD; 
these factors are driven by their motivation to manage symptoms, decrease their isolation, 
and learn about their uncommon condition.  Researchers who used an exploratory 
qualitative approach to explore the experiences of 9 individuals (n=1 DM1) attending a 
neuromuscular rehabilitation centre in the United Kingdom also found that information 
seeking and a sense of community were important factors for clinic attendance (Hartley, 
Goodwin & Goldbart, 2011).  However, our study advances the work of Hartley, 
Goodwin and Goldbart (2011); that is, the authors’ study explored the experiences of 
attending clinic for patients with various nerve and muscle conditions, but our study adds 
descriptions about what motivates individuals with DM1 and HD to present to clinic, and 
the factors that facilitate their desire to maintain follow-up.  We also captured the 
perspectives of caregivers and health care providers regarding on-going clinical follow-
up for DM1 and HD.  Patient and caregiver participants’ describe that attending clinic 
was beneficial because of the attentive care delivered by DM1 or HD experts.  We 
suggest, however, that a different clinical model might more efficiently address 
participants’ educational and psychosocial support needs.  
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Participants framed their reasons for maintaining on-going follow-up by describing prior 
negative experiences that they— or other affected family members—had with health care 
providers or members of the general public.   In particular, participants perceived that the 
general public and most HCPs lacked knowledge about DM1 and HD; consequently, 
participants described feeling judged, shamed and isolated.  At clinic, however, 
participants described that they felt understood and validated by experts who were 
interested in their condition.  This is similar to findings from Hartley, Goodwin & 
Goldbart (2011) who suggest that the clinic becomes a place of “empathy” (p. 1022 & 
1029). Ultimately, the actions, motivations and drivers of clinic attendance seem to 
indicate that—in the absence of pharmaceutical treatment to change the underlying 
disease process—patients, caregivers and HCPs perceived that attending clinic was, in 
and of itself, a form of ‘treatment’.  Patients and caregivers indicated that the act of being 
monitored by an expert HCP meant that they were being proactive about their health, and 
actively participating in the “fight’ to find a cure.  Attending clinic gave patients and 
caregivers the opportunity to be advocates and educators by participating in research and 
educating clinicians about their condition.  Additionally, patients and caregivers 
discussed that seeking connections with other patients in the waiting room or with HCPs 
with a specific interest in their condition was therapeutic because they felt understood 
and cared about.  In particular, the belief they were seen as an individual, and not a 
disease, was key to experiencing this benefit.   
Hartley, Goodwin and Goldbart (2011) posit that the specialist care provided at a multi-
disciplinary neuromuscular centre in the UK might be a source of hope and optimism for 
patients. For some participants, the therapeutic benefit of seeking information and 
connection was experienced as hope, but this was not universal.  Furthermore,  treatment 
and research did not appear to be participants’ primary motivations for attending clinic. 
Instead, the rapport that patients had with HCPs fostered their ability to talk about their 
condition and to seek social support. Clinic attendance seemed to ease participants’ 
isolation and reassure them that the medical community had not forgotten them.   
Attending clinic provided patients with the opportunity to be proactive in managing their 
unpredictable health. Patients with chronic and progressive conditions may feel 
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disempowered by their progressive functional decline, which contributes to a sense of 
insecurity or to a ‘disrupted’ or shifting identity (LaDonna & Venance, in press; 
Aujoulet, Luminet & Deccache, 2007).  Moreover, patients living with hereditary illness 
may feel powerless based on the fear they may have passed the gene to their children 
(Aujoulet, Luminet & Deccache, 2007).  Our participants’ narratives were threaded with 
suggestions that they had experienced some degree of disempowerment, but coming to 
clinic appeared to be a way for them to exert some control.  Participants indicated 
participating in disease surveillance by attending clinic with expert HCPs meant that they 
were being proactive about their health. That is, clinic attendance was perceived as a 
tangible way to ‘do something’ to address their complex and evolving needs. We suggest 
that patient and caregiver participants perceived that they were collaborators with HCPs 
in trying to find answers for their uncommon disorders, and were therefore active, not 
passive recipients of care.  We propose that patients and caregivers attend clinic—not 
necessarily for hope—but to be reassured that they are actively ensuring that the medical 
community has not forgotten—nor will forget-- their rare condition.   
That patients with DM1 and HD are interested and engaged in their health is a novel 
finding considering that the literature—particularly with respect to the DM1 population—
suggests that patients are disinterested in their health (Meola & Sansone, 2007) or adhere 
poorly to treatment recommendations (Chouinard et al, 2009).  This has significant 
implications for patient-centered care provision in these populations; in particular, our 
analysis suggests that patient and caregiver participants are proactive about seeking and 
providing information and support throughout the disease trajectory.   While HCP 
participants wished to be patient-centered, they indicated that this approach was 
complicated by patients’ progressive cognitive and behavioral decline; in particular, they 
described that patients become less aware of their symptoms and the importance of 
managing potential complications.  Moreover, previous research suggests that issues of 
clinical concern to HCPs may not be what patients or caregivers prioritize (Authors, 
2014, Heatwole, 2012; Kremer, 2002).   We speculate that time-limited appointments or 
other system impacts may preclude traditional physician-led clincs from providing 
opportunities for in-depth discussions about patients’ and caregivers’ understanding of 
disease implications or their psychosocial concerns.  Since our patient and caregiver 
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participants seem proactive and engaged, we speculate whether another—perhaps nurse-
led model— might be advantageous for collaborating with patients to develop strategies 
for self-management. 
6.6.1 Limitations 
This is a small, highly contextualized study and may not reflect other clinical settings.   
For instance, many DM1 and HD clinics in the United States are multi-disciplinary 
‘centers of excellence’ funded by the Muscular Dystrophy Association (MDA, 2014) or 
the Huntington’s Disease Society of America (HDSA, 2014).   
We recruited patients followed in clinics at one academic health science center , therefore 
we do not represent the voices of patients who chose not to seek follow-up  or are 
followed in other clinical settings.  Since we speculate that motivations for attendance 
change over time and that caregivers take a more active role as the patient deteriorates, it 
is a challenge to recruit individuals in the later stages of disease.  These patients may be 
institutionalized, lost to follow-up, or difficult to interview because of profound speech or 
cognitive impairments.  We did, however, ask participants to speculate about a time when 
they might choose not to follow-up. Most participants envisioned that they would 
continue to attend clinic until they were physically unable to come, or if they believed 
that nothing more could be done to help them.  And finally, while the interviews were 
conducted by a researcher not involved in patient care, participants may still have 
provided information that they believed the researcher, or their HCP, wanted to hear.  
Attempts were made to reassure participants that their responses would not affect their 
care, but we cannot ensure that participants were not impacted by this concern. 
We acknowledge that patients’ have variable disease presentations, and that some 
patients with significant central nervous system involvement— including memory 
impairments or problems with executive function—may not have the same degree of 
interest or ability to participate in their health care.  However, we speculate that patients 
may be judged as a homogenous group rather than as individuals with separate concerns, 
interests and abilities; consequently, their knowledge and contributions to self-
management may be overlooked.   
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6.6.2 Future Directions 
Our findings have raised additional questions that are well-suited to qualitative inquiry.  
For example, while the purpose of this study was to focus on individuals and their family 
members who are living with manifest disease; the data suggests that clinic attendance 
prior to diagnosis is often anxiety-provoking and problematic for patients and their 
families.  Additionally, partners and children of affected parents also access clinic staff to 
seek information and counseling.  This leads to questions about who is considered a 
‘patient’ and how resources are allocated.  Research exploring clinic access by non-
affected individuals has implications for health care delivery and potentially could lead to 
recommendations for better supportive care for caregivers and those at-risk.  Exploring 
the experiences of patients who attend well-funded and resourced, multi-disciplinary 
clinics might inform both funding agencies and individual practitioners about clinical 
care models and guidelines for best practice. 
6.7 Conclusion 
Our findings suggest that patients and their loved ones living with chronic, progressive 
and life-limiting neurological illness maintain regular attendance at an outpatient 
neurology clinic because they perceive that the clinic is a ‘safe’ place where they can 
seek information, personal connection and explore avenues to advocate for their 
condition and contribute to scientific advancements.  Clinic visits are, therefore, a form of 
being proactive; that is, patients and caregivers experience a benefit from learning about 
their condition, educating the medical and general communities about DM1 or HD, 
helping future generations and seeking social support.  While motivations for clinic 
attendance change over time for patients and caregivers, these factors seem to reduce 
some of the anxiety of living with a life-limiting condition.  However, these findings lead 
us to question whether the current clinical models in this academic center should shift 
from a physician-led model to one that supports an increased role for allied health 
professionals. The study shows that people come to clinic primarily for the safe place it 
provides, and to escape judgment and isolation.  Traditional medical models and 
traditional physician training are less focused on these supportive goals, suggesting that 
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perhaps nurses, whose training emphasizes more holistic models of care, could provide 
productive and cost effective leadership of such clinics.   Regardless, despite the lack of 
treatment options to halt or reverse the disease process, on-going clinic attendance 
appears to be therapeutic in and of itself, and seems to provide a tangible benefit for 
patients and loved ones living with DM1 or HD.   We anticipate that findings from this 
research will inform health care professionals about DM1 and HD patients’ perspectives 
about being proactive about their clinical care; in turn, this knowledge may contribute to 
scholarly conversations that may enhance or change current care practices for these and 
other chronic disease populations with progressive cognitive and behavioral decline. 
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Chapter 7 
7 “We Like to Think We’re Making a Difference”: Health 
Care Providers’ Perspectives About Caring for 
Individuals with Myotonic Dystrophy and Huntington’s 
Disease 
7.1 Abstract 
Background: Patient-centered care for individuals with Myotonic dystrophy (DM1) and 
Huntington’s disease (HD)--chronic, progressive and life-limiting neurological 
conditions—may be challenged by patients’ cognitive and behavioral impairments.  
However, no research has explored health care providers’ (HCPs’) perspectives about 
patient-centered care provision for these patients along their disease trajectory.   
Methods: Constructivist grounded theory informed the iterative data collection and 
analysis process. HCPs at one academic centre in Ontario, Canada were invited to 
participate in semi-structured interviews; 5 neurologists, 2 specialist physicians, a nurse, 
two social workers and a physiotherapist consented.  Three stages of coding (initial, 
focused and theoretical) were used to analyze participants’ transcripts, and codes were 
collapsed into themes and categories.   
Results:  Three categories including An Evolving Care Approach, Evolving Roles, and 
Making a Difference were identified.  Participants described that their clinical care 
approach evolved depending on the patient’s disease stage and caregivers’ degree of 
involvement.  Regardless, HCPs described that their main goal was to provide hope to 
patients and caregivers through medical management, crisis prevention, support and 
advocacy.  Despite the lack of curative treatments, HCPs described that patients benefited 
from on-going clinical care provided by proactive clinicians.       
Conclusion:  Providing care for individuals with DM1 and HD is a balancing act.  In 
particular, HCPs must strike a balance between (1) the frustrations and rewards of 
patient-centered care provision, (2) addressing symptoms and preventing and managing 
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crises while focusing on patients’ and caregivers’ quality of life concerns, and  (3) 
advocating for patients while addressing caregivers’ needs.  This raises important 
questions about physician-led, patient-centered clinical care models, and we propose that 
a nurse-led model may be more appropriate for addressing patients’ and caregivers’ 
complex biopscyhosocial needs. 
7.2 Introduction 
Patient-centered care for individuals with uncommon neurological disorders may be 
complicated by variable symptom presentations, limited treatment options, and a lack of 
evidence-based clinical management models (Jaglal et al, 2014).   Moreover, shared 
decision making is considered the ‘pinnacle’ of patient-centered care (Barry & Edgman-
Levitan, 2012), but researchers and clinicians struggle to define what this means in 
practice, and whether a patient-centered care approach is always feasible, achievable or 
desirable (Berwick, 2009).  Previous qualitative research found that clinicians caring for 
patients with progressive neurological disease face numerous challenges as patients 
approach end of life; in particular, patients’ complex and variable disease presentations 
complicate prognostication, and it is difficult for clinicians to communicate effectively 
with individuals who have cognitive or speech impairments (Wilson, Seymour & 
Aubeeluck, 2011).  However, end of life is only one phase of chronic neurological 
diseases; therefore, it is necessary to explore the complex and evolving needs of patients 
over a long disease trajectory that may span years or decades.  While there are numerous 
articles that suggest care guidelines for patients with DM1 or HD (Nance, 2007; Roos, 
2010; Sturrock & Leavitt, 2010; Turner & Hilton-Jones, 2008; Gagnon, Mathieu & 
Noreau 2007)—to our knowledge clinicians’ perspectives about providing care for these 
patients along their disease trajectory has not been explored.   This knowledge gap is 
significant because we speculate that a patient-centered care approach may be 
challenging to enact for individuals living with complex, chronic conditions, particularly 
those presenting with cognitive or behavioral dysfunction.  Myotonic dystrophy (DM1) 
and Huntington’s disease (HD)—genetic, chronic, progressive and life-limiting 
neurodegenerative conditions—are well-suited to exploring clinicians’ perspectives about 
caring for patients living with protracted physical, behavioral and cognitive impairments.           
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Exploring care approaches in DM1 and HD may illuminate care delivery for a range of 
chronic neurological conditions that also impact mobility, cognition and social function.  
DM1, the most common adult-form of muscular dystrophy, is a multi-system disorder 
affecting the muscular, ocular, cardiac, endocrine, gastrointestinal, and central nervous 
systems. The clinical manifestations of DM1 include muscle weakness, delayed muscle 
relaxation, arrhythmias, excessive sleepiness, and early-onset cataracts (Harper, 2001).  
There is a well-recognized DM1 personality pattern described in the literature suggesting 
that patients may have low IQ and apathy (Winblad, Lindberg & Hansen, 2005); in turn, 
patients may miss clinic appointments and seem indifferent about their health (Meola & 
Sansone, 2007). Similarly, while HD is characterized by impaired motor function, its 
psychiatric issues --including depression, apathy, anxiety, obsessions and compulsions, 
impulsivity, irritability and aggression, and psychosis—are often far more debilitating to 
patients and their families (Roos, 2010; Sturrock & Leavitt, 2010).  Moreover, cognitive 
impairment variably affects individuals with HD, but when present, results in difficulty 
with executive function, and problems acquiring, processing and remembering 
information (Bonelli & Hofmann, 2004).  Therefore, patients may be unaware of the 
extent of their symptoms and deficits.  Both conditions are life-limiting, and pneumonia 
is a common cause of death in DM1 and HD (de Die-Smulders et al., 1998; Mathieu, 
Allard, Potvin, Prevost, & Begin, 1999).    Additionally, DM1 patients may experience 
sudden death secondary to choking or a cardiac event (de Die-Smulders et al., 1998; 
Mathieu, Allard, Potvin, Prevost, & Begin, 1999), and the suicide rate in HD is higher 
than the general population (DiMaio et al, 1993).   
There are no treatments for DM1 or HD that slow or reverse neurodegeneration, and 
there is no cure for either condition. However, there are strategies to manage symptoms, 
and the goal for treating individuals with DM1 and HD is to increase quality of life to 
“reduce the burden of symptoms, maximize function, and to eliminate unnecessary 
‘surprises’ as affected individuals pass expected disease milestones” (Nance, 2007, p. 
176).  Due to the relative rarity of DM1 and HD, most family physicians, and many 
neurologists for that matter, have little experience managing these patients; thus, care is 
often provided by specialty neuromuscular or movement disorder clinics (Chouinard et 
al., 2009).  The literature suggests that a multidisciplinary approach that supports the 
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individual and his or her family along the disease trajectory is an ‘ideal’ care plan for 
individuals with DM1 (Chouinard et al, 2009; Gagnon et al,  2007) and HD (Nance, 
2007; Nance, 2012).  Chouinard et al (2009) proposed a DM1 Management Model that 
considers the multi-system nature of the disorder, the propensity for individuals to have 
limited educational, economic and social opportunities, and the lack of knowledge of 
non-specialist health care providers (Chouinard et al, 2009).  Similarly, Nance (2007) 
proposed the “HD Molecule” as a model for HD care:  the patient and his or her family 
members are at the center of complex care needs including symptomatic and crisis 
management, family issues, education and support that—ideally--should be addressed at 
each visit by a multi-disciplinary care team.  Treatment plans may include medications to 
alleviate symptoms, referrals to specialists to monitor complications, and assessments by 
physical therapy, occupational therapy or social work to address activities of daily living 
and quality of life (Nance, 2012; Roos, 2010; Sturrock & Leavitt, 2010; Turner & Hilton-
Jones, 2008).  However, treatment approaches may be complicated because symptom 
presentation, severity, and disease course vary by individual, even among individuals 
within the same family.  Patients’ progressive functional decline may further challenge 
clinical approaches, and therefore family members may become instrumental for 
monitoring an individual’s physical and behavioral changes, and ensuring that he or she 
is following treatment recommendations (Sturrock & Leavitt, 2010).         
There are no studies that explore clinicians’ approaches to patient-centered care for 
patients with DM1 or HD along their disease trajectory. Therefore it is unknown if 
current care approaches are optimizing patient-centeredness, and if patients’ and 
caregivers’ concerns are being heard and adequately addressed.  The challenges of caring 
for these complex patients warrant investigation because findings may have health care 
delivery implications—not only for patients with DM1 and HD--but for patients with 
other chronic diseases that present with cognitive or behavioral impairments.   Therefore, 
our purpose was to explore how health care professionals perceive of-- and provide care 
for—individuals with DM1 or HD throughout their disease course.   How do they 
approach the care of these individuals, how effectively do they feel they are meeting 
patients’ needs, and how does their approach to care evolve over the course of the illness?  
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7.3 Methods 
This analysis is part of a larger study that explored perceptions about clinic attendance for 
individuals living with DM1 and HD (Authors, in preparation).  Briefly, the iterative data 
collection and analysis process was informed by constructivist grounded theory, a 
qualitative research methodology that studies basic social processes to develop an 
explanatory theory (Charmaz, 2006; 2014).  Patients with mild to moderate DM1 or HD 
(by physician report), their caregivers, and health care professionals were purposively 
sampled from the neuromuscular and movement disorders outpatient clinics at an 
academic medical center in Ontario, Canada.  Table 1 provides a snapshot of the clinical 
contexts.  Participants were invited to participate in semi-structured interviews; 14 
patients (n= 5 DM1), 10 caregivers (n= 2 DM1), and 11 HCPs including five 
neurologists, a psychiatrist, a respirologist, a nurse, two social workers, and a 
physiotherapist consented.  We ceased recruitment when we determined that the collected 
data was sufficient to provide a robust exploration of participants’ experiences of caring 
for individuals with HD and DM1.  This study reports on the data collected from health 
care providers; patient and caregiver data will be reported elsewhere (LaDonna, Watling, 
Ray & Venance, In Preparation) 
Table 7-1: Clinical Care for DM1 and HD Patients at One Academic Center in Ontario, Canada 
 Myotonic Dystrophy (DM1) Huntington’s Disease (HD) 
Clinical Cohort  Approximately 150 patients 
are followed every 6 months 
to 2 years.   
 
 
 Approximately 125 patients are 
followed every 3-6 months. 
Clinical Context 
 
 DM1 patients are seen in a 
general adult muscle disease 
clinic.   
 
 HD patients may be seen in the 
monthly HD multi-disciplinary 
clinic. 
--Or-- 
 in a general movement 
disorders clinic.   
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Staff/Personnel 
 
 All DM1 patients are 
followed by one 
neuromuscular specialist. 
 One nurse practitioner 
follows most adult 
neuromuscular patients. 
 Medical students, residents 
or fellows may participate in 
care. 
 
 Four neurologists specialize in 
movement disorders; one staffs 
the multi-disciplinary clinic. 
 A psychiatrist and social 
worker staff the multi-
disciplinary clinic; their 
services are also available by 
referral.   
 There is not a nurse affiliated 
with the HD multi-disciplinary 
clinic.   
 Medical students, residents or 
fellows may participate in care. 
 
Management  Neurological examination, 
evaluation of cardiac, 
respiratory and swallowing 
symptoms, and assessment 
of psychosocial needs.   
 Medical treatment:  
stimulants for fatigue, bipap, 
cpap  
 Annual ECG 
 Referrals may be made to 
cardiology, respirology, 
speech language pathology, 
occupational or physical 
therapy, or other specialists 
or allied health professionals. 
 
 Neurological examination, 
evaluation of motor and 
psychiatric symptoms, and 
assessment of psychosocial 
needs.   
 Medical treatment: anti-
depressants or anti-psychotics 
to treat psychiatric symptoms; 
tetrabenazine to manage 
chorea. 
 Referrals may be made to 
speech language pathology, 
occupational or physical 
therapy, or for psychiatric or 
psychological care.  Patients 
may also see the HD social 
worker or psychiatrist 
independently from regular 
neurological follow-up.   
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CP conducted all of the HCP interviews, which were recorded and transcribed verbatim; 
in turn, KAL coded each line or sentence of the first two transcripts from each participant 
group using words or phrases that captured the experiences or actions described by the 
participants.  Next, KAL consolidated the most frequently occurring codes into 
preliminary categories, and used these to code the next six transcripts to determine their 
fit and relevance.  KAL met frequently with SLR and SLV to discuss preliminary 
findings. The research team finalized a list of categories by consensus; KAL then re-
coded the entire dataset.  Throughout the research process, data within and between 
transcripts were constantly compared, and KAL wrote memos and drew diagrams to 
capture and explicate increasingly abstract ideas about the data.    Nvivo, a qualitative 
research software program, was used to organize and manage the data.  This study was 
approved by the Western University Research Ethics Board; to protect confidentiality, all 
participants were given a pseudonym.  
7.4 Results 
Three categories including An Evolving Care Approach, Evolving Roles, and Making a 
Difference were identified.  The participants described that their approach to care evolved 
along the disease trajectory and was dependent on the patient’s disease stage, and the 
presence of caregivers and their degree of involvement.  HCPs also perceived that their 
role in care evolved over the disease trajectory, encompassing educating patients and 
families, preventing crises, and providing medical management, support, and advocacy.  
In the absence of disease-halting or curative treatment, these roles contributed in various 
ways to an overarching goal of providing hope.  Reflecting on their efforts to make a 
meaningful difference to patients and their families, HCPs described the rewards and 
challenges of their care approach; in particular, while participants expressed frustration 
and a sense of futility about their inability to provide a cure, they perceived that patients 
benefited from regular follow-up with proactive clinicians. 
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7.4.1 An Evolving Care Approach 
7.4.1.1 First contact 
Patients are typically referred to a specialty neurology clinic for three reasons: (1) they 
are at-risk for inheriting DM1 or HD; (2) they are gene positive but pre-symptomatic; or 
(3) they have neurological symptoms with or without a family history.  Initial visits 
typically include a review of symptoms and family history, and a comprehensive 
neurological exam.  Clinicians perceive that patients come to seek a diagnosis and 
information from a specialist regarding symptoms, genetic status or the impact that the 
disease will have on their families.  Family members often attend the initial visit not only 
to support their family member, but also because there is a—perhaps unspoken--
expectation that they will also receive information and counseling.   Patients who do not 
know their gene status or who are gene positive but pre-symptomatic may be 
apprehensive about their initial clinic visit: 
 I’m kind of the physician that people hate to meet…There was one lady who was 
a runner, and literally her husband came bolting upstairs…and said ‘have you 
seen my wife?’...He tried to drop her off…and she just bolted…because coming 
to see me is potentially coming face-to-face with your genetic fate (Dr. Green, 
neurologist). 
7.4.1.2 A flexible approach to follow-up 
The approach and content of the follow-up visit varies at each time point, and continues 
to evolve once HD and DM1 patients begin to manifest symptoms. A typical 60 minute 
visit for both DM1 and HD consists of a neurological exam including a review of 
symptoms and a functional assessment, followed by a discussion about treatment options 
and research opportunities.   Medications—including stimulants to treat excessive fatigue 
in DM1, or anti-depressants for the psychiatric manifestations of HD-- are available to 
mitigate symptoms, but are generally only prescribed if the patient is experiencing 
decreased quality of life.  Patients and caregivers are then given the opportunity to ask 
questions or to have their concerns addressed.      
182 
 
We would talk about any of the cognitive issues, memory problems, any 
behavioural change, any problems with interpersonal with their working, or at 
home with the family.  And, then we’d review generally how they’re doing, 
functioning, working, how work is going, how are things going with the family, 
plans and things long-term.  We might talk about driving issues, if that were a 
problem.  And, then any other, obviously starting out first with any concerns they 
have or any issues.  Usually a caregiver would come and I would also speak with 
the caregiver about how things are going (Dr. Roberts, neurologist). 
While the clinicians’ approaches were similar at both clinics, the structure of care and the 
role of allied health professional participants differed.    While the neuromuscular clinic 
team has access to allied health professionals including physical therapy and social work, 
these clinicians cover a large spectrum of neurological illness and do not specialize in 
DM1.  DM1 patients are therefore only referred to a physiotherapist on an as-needed 
basis: “So, I don’t follow them.  I don’t follow their progression.  I don’t know when 
they’re coming” (Diane, allied health professional).  Similarly, the social worker typically 
works with DM1 patients on a one-time referral basis to assist with disability paperwork.  
In contrast, the social worker is an integral member of the multi-disciplinary HD clinic.  
In addition to providing care outside of the clinical setting, the social worker evaluates 
patients concurrently with a neurologist and a psychiatrist during clinic visits: 
 … it’s an extremely thorough dialogue and what I really like about it is, it’s not 
your typical medical model.  It’s much more of a bio-psycho-social … not just 
the physical function of the person but how they’re interrelating with their work, 
peers, how they’re interrelating with their family members, how is it affecting 
their quality of life…(Ray, allied health professional).   
While HCPs seemed to have standard templates for how they conducted initial and 
follow-up visits, they described encouraging patients and their loved ones to direct the 
focus of the clinic visit, and to be actively engaged in making health care decisions.  
However, HCPs described that this had variable efficacy because patients were 
sometimes unaware or disinterested in addressing symptoms that could lead to morbidity 
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and mortality; in particular, patients’ progressive cognitive and behavioral functional 
decline directly impacted their ability to recognize and address problematic symptoms.  
Participants stated that family caregivers became increasingly important for addressing 
concerns and making decisions:   
 It’s often significant, again in the patients that have cognitive involvement 
because they may have lost the cognitive capacity to understand what’s going on, 
or they’ve become apathetic so they don’t really care.  They need somebody to 
motivate them to do all the right things like take the medications they’re 
prescribed for other conditions, to understand why they need investigation for 
certain things, and why they need to go to other appointments.  It’s very helpful to 
have a caregiver there to help them do all of those things (Dr. Matthews, 
neurologist).   
Sometimes, a conversation with patients about the purposes and goals of follow up visits 
was perceived as mutually beneficial: 
So, I ask the patient, what do they think the visit is for, do they have any 
questions, concerns, things that they specifically want to address, they want me to 
address, and then I’ll address those.  I generally will do a physical exam and 
surveillance for their breathing, cardiac, swallowing, speech and how they’re 
managing at home in terms of a functional perspective.  That’s within the realm of 
whether or not they’re interested in that and sometimes their goals will be, ‘I was 
just told to come here, and so I’m coming.’  And, so, then we have to discuss that 
as well (Martha, nurse). 
7.4.2 Evolving Roles 
One participant described that neurologists perceive that they are the “quarterback” (Dr. 
Matthews) who is responsible for directing all aspects of the patient’s care with support 
from nurses, specialists and allied health professionals.  Moreover, participants 
recognized the lack of curative treatments for DM1 and HD, and therefore defined their 
role as primarily one of providing hope by:  (a) providing expert evaluation and 
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education; (b) preventing and managing crises, (c) being an advocate, and (d) providing 
support.  These roles were not seen as mutually exclusive; rather, they were perceived as 
inter-related and evolving over time.  In particular, the HCPs perceived that discussing 
research opportunities, offering symptomatic management options and reassuring patients 
about their functionality provided patients with the sense that “… somehow in seeing us, 
we’re dealing with the active disease and, in seeing someone, something’s being done to 
help treat them” (Dr. Roberts, neurologist).  Clinicians also sought to ease patients’ 
isolation and to reassure them that they had not been forgotten by the wider medical and 
research communities:     
One of the things I see as my job is to let them know that no, actually there is a lot 
of stuff that’s happening.  I think they’re starting to see it now in the sense that 10 
years ago former doctor didn’t talk to them about clinical trials in Huntington’s 
disease because there weren’t any; whereas, now we’ve got a couple of research 
opportunities for you if you’re interested…. I think they do get some hope from 
that (Dr. Green, neurologist). 
7.4.2.1 Providing expert evaluation and education 
Prior to, and following diagnosis, participants stated that the primary role of the specialist 
clinician was to provide education and guidance to patients and family physicians, while 
providing surveillance for emerging or worsening symptoms.  Participants described the 
importance of specialists’ expertise in relation to family physicians’ lack of familiarity 
with these uncommon conditions, and perceived their role as one of educating family 
physicians and augmenting primary care:      
Some family docs are quite knowledgeable, or take it upon themselves to learn a 
little bit about the disorder.  But when you think that it’s really 1 in 8,000, not 
every family physician will have an individual or a family with myotonic 
dystrophy….it’s an uncommon disorder when you think about all the other things 
that family physicians have to deal with…So, my role… is that our clinic notes 
serve as a guide or a template for what needs to be watched for (Dr. Thompson, 
neurologist).      
185 
 
Patient education largely involved describing inheritance patterns, symptoms and the 
variability of disease progression.  Providers also supplied patients with pragmatic 
information regarding management strategies (e.g., breath stacking to improve respiratory 
function for DM1 patients), assistive devices, and information about funding or support 
resources.  Some HCPs prioritized keeping abreast of the latest research and 
pharmaceutical options then distilling information for patients.  While HCPs perceived 
most patients to be active participants in their care, they identified that information 
seeking was often a more important priority for caregivers, especially as the patient’s 
condition deteriorated.  Therefore, HCPs made judgment calls about the amount, content 
and timing of information that was given to patients at different points along the disease 
trajectory.      
I try to encourage them to ask questions because at the first visit after I say you’ve 
got Huntington’s disease, I could yammer on for another 20 minutes, but they 
hear nothing because they’re just stuck on I’ve got HD...that’s led me to not give 
them too much information the first time because it’s going to have to be 
reinforced on subsequent visits …(Dr. Green, neurologist). 
7.4.2.2 Preventing and managing crises 
In the absence of treatments to reverse or slow disease progression, HCPs stated that their 
treatment approaches centered around preventing complications and managing crises.  
Clinic visits were an opportunity to monitor symptom progression and order tests or refer 
to other specialists to evaluate potentially life-limiting complications.   
The reason that I’ve gotten into the care of that patient population (DM1) here is 
because … We want to identify patients that potentially need some type of 
breathing support for the rest of their life and can we identify that group that’s 
going to do well … and then try to look for those resources (Dr. Vincent, 
specialist physician). 
The HCPs described that an essential part of their role was to be flexible about care 
approaches and to put structures in place to enable a rapid response to serious and acute 
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issues.  Specialists and allied health professionals were aware that mobility and 
transportation difficulties complicated patients’ ability to come to clinic, and therefore 
made efforts to accommodate patients.  Strategies included evaluating the patient in 
tandem with other doctor’s appointments, making house calls (HD social worker), having 
nurses or social workers respond quickly by phone to emergencies or acute issues, and to 
‘squeeze’ patients into clinic for acute needs. 
…if they’re coming to, say, see the doctor, and we know they need this done, 
there might be transportation issues or distances, so then I’ll offer them up I can 
do it on a day they’re coming for other tests or other doctors visits if they could 
wait that long.  But, if it’s a whole year, I try and get them in just on my own day 
or see them when they’re coming to see Dr. Vincent or see them when they’re 
coming to see Dr. Thompson or Martha (Diane, allied health professional). 
7.4.2.3 Being an advocate 
Participants emphasized the importance of advocating for patients by raising community 
awareness about these uncommon conditions.  HCPs described ‘being a spokesperson’ 
for DM1 or HD by participating in charity events and giving talks at support groups or 
patient education conferences.  Clinicians—particularly nurses and social workers—were 
instrumental in helping patients obtain funding and community resources.   “Martha 
(nurse) is very good at connecting people…I think Martha is the lynch pin…for linking 
people to resources” (Dr. Thompson, neurologist).  Moreover, HCPs sometimes acted as 
a liaison between the patient and his or her employer, family physician or family 
member.   In particular, clinicians tried to balance caregivers’ concerns with being a 
‘voice’ for the patient and encouraging the patient to express his or her needs.  
7.4.2.4 Providing support 
Similarly, supportive care meant a number of things to participants including providing 
counseling to help patients and families adjust to the diagnosis and strategies for 
managing the disease as it progressed, seeking resources for patients and their families, or 
offering guidance for family physicians to provide primary care for HD or DM1 
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individuals.  Specialist physicians perceived an inverse relationship between their role 
and the patients’ disease progression; that is, as patients begin to deteriorate and options 
for symptomatic treatments diminished, allied health professionals become increasingly 
important for obtaining resources and helping patients and their families cope with 
behavioral and cognitive changes.   
Dr. Green will often say that…I’m more important to be at these clinics than he is 
because it’s (HD) much more of a psycho-social disease and there’s not a whole 
lot that can be done likely to stop the disease at this point.  He can manage some 
of the symptoms but it’s important for someone, like myself, to be around to help 
manage all the social challenges that come along with the disease (Ray, allied 
health professional). 
7.4.3 Making a Difference 
7.4.3.1 Frustrations 
The variable and unpredictable features of DM1 and HD--namely the behavioral and 
cognitive impairments—frustrated practitioners and challenged their ability to 
prognosticate and provide education and care.  These frustrations were exacerbated by a 
lack of resources including limited funding and community resources, few treatments and 
research advances, and lack of time to address patients’ complex care needs.   Clinic time 
was limited and some HCPs had a backlog of patients requiring initial consultations and 
follow-up; consequently, providers were not always able to address patients’ multiple 
physical and psychosocial needs.  Moreover, there was limited funding available for 
allied health professionals to provide supportive services:   
There’s probably a greater need for these services… particularly social work, 
speech and swallowing.  …  Certainly the social work position that we have 
funded…is only a part-time position.    I’m quite suspicious that he does more 
than 1½ days per week, but that’s all he gets paid for (Dr. Green, neurologist). 
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HCPs devoted a significant amount of their limited clinic time providing education about 
DM1 and HD, including management strategies to mitigate symptoms.  HCPs described 
that patients did not retain information, and some were either unaware--or apathetic 
about--the importance of following treatment recommendations: 
 They are draining in the sense that, you can see them year after year after year and 
nothing has changed, they’re still eating like they’re not supposed to, they’re still 
smoking and they’re not supposed to, they may or may not take care of 
themselves, and that’s just the way they are.  So, I find them a significant 
challenge to take care of (Martha, nurse). 
Moreover, HCPs expressed a sense of futility that despite their best efforts, patients’ 
function and quality of life would continue to deteriorate: 
We do contribute for sure because we manage fairly complicated aspects of the 
disease, including, for example, the behavioural aspects…  It is not satisfying in 
any way because this is a progressive, relentless degenerative disease and we 
can’t do anything.  Unlike, for example, dystonia torticollis,  blepharospasm, or 
even Parkinson’s disease, where we have excellent medications that can improve 
the quality of life for potentially 20 years. (Dr. Bennett, neurologist). 
7.4.3.2 Rewards 
These challenges were tempered by the perceived rewards of caring for individuals with 
DM1 or HD.  Most HCPs stated that they pursued a career in health care because of an 
intrinsic desire to make a difference in peoples’ lives.  Moreover, the specialist 
physicians were inspired—and rewarded--by the intellectual challenge of diagnosing and 
managing complex neurological disease.  Therefore, despite a sense of futility, HCPs 
received small and intangible benefits by being proactive about providing care for 
patients and families.  In essence, HCPs believed that providing support and advocacy 
was the ‘right thing to do’ in the absence of other therapeutic options: “neurology seems 
to be a specialty that you could make a difference in, despite not having curative 
treatments for a lot of the conditions that we have.  So, having a relationship with patients 
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and families was an important aspect of neurology as a career path” (Dr. Thompson, 
neurologist). 
One participant described that caring for these patients filled a void in care that had not 
previously been addressed by his departmental colleagues:  “I didn’t think that our 
(specialist) group was providing them with all the necessary service that was required to 
properly care for this population (DM1)” (Dr. Vincent, specialist physician).    Other 
participants enjoyed forming long-term relationships with patients; having the “privilege” 
to care for multiple generations of a family (Dr. Green, neurologist), and guiding patients 
through difficult and emotional situations: 
… you follow these people along for years you get to know them.  I’ve followed 
several mothers through pregnancies.  Another whole issue is the genetic 
counselling of a woman in childbearing years about the risks that she might have 
an affected child ….There is some reward in being able to take somebody through 
that, even though you can’t actually treat the disease (Dr. Matthews, neurologist). 
7.5 Discussion 
When asked whether patients benefit from regular on-going follow-up, Martha (nurse) 
responded:   
I’m biased, because I’m the one that’s giving them care.  It’s hard to know.  I 
think there, again, we do not know whether or not it makes any difference to their 
life, quality of life, or their health--if they come to the clinic or don’t come to the 
clinic--because I don’t think that study’s been done.  We like to think we’re 
making a difference, but I don’t think we know that. 
The lack of literature exploring clinicians’ perspectives about patient-centered care 
provision for patients with DM1 or HD left us with similar questions: how do health care 
professionals describe their management approach for these patients, and do they believe 
that the current patient-centered clinical care models meet patients’ needs? Participants 
described the necessity and importance of providing proactive, expert, evolving and on-
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going care in specialty neurology clinics because they recognized that the uncommon 
prevalence of DM1 and HD and limited system resources precluded primary care HCPs 
and generalists from addressing patients’ and caregivers’ complex needs.   However, 
similar issues—coupled with patients’ variable disease presentation—also challenged 
specialist HCPs abilities to provide patient-centered care.  Researchers seeking to develop 
a chronic care model for neurological conditions (CCM-NC) interviewed 180 HCPs, 
community members and policy makers identified similar challenges (Jaglal et al, 2014).  
While this study comments on general care for a number of neurological conditions, it 
does not specifically explore the perspectives of providing patient-centered care for DM1 
and HD affected individuals along their disease trajectory.  Our findings, however, 
suggest that patient-centered care provision for patients with DM1 and HD is a balancing 
act; in particular, HCPs must consider whether system capabilities—including time, 
funding, and their medical training-- afford them the opportunity to address concerns that 
are most important to patients and their families. 
Moreover, HCPs must constantly temper their frustrations and sense of futility with the 
perceived rewards of caring for individuals with DM1 and HD.  While our participants 
had expert knowledge about these conditions and were able to form long-term 
relationships with patients, they described that they were frustrated by the lack of 
pharmaceutical treatments, limited community resources and funding opportunities, 
overburdened clinics with long wait lists, and the emotional cost of caring for these 
patients.   Our findings that HCPs have limited time to address caregivers’ needs resonate 
with other providers caring for chronic neurological conditions (Jaglal, 2014; Nance, 
2009).  In particular, the current physician-led model at our academic centre is not 
designed to provide this degree of social support.   In the current fee-for-service model in 
Ontario, specialist physicians are paid for services provided only to the individual 
referred for consultation, therefore—while our participants described that they spent 
considerable time addressing caregivers’ needs--there are limited opportunities for 
remuneration for this important work.  Similar challenges—particularly time-limited 
appointments and a lack of adequate resources to support allied health professionals—
was echoed in a small qualitative study examining the perspectives of physicians caring 
for patients with Alzheimer’s disease (Hinton et al., 2007). In essence, there was a sense 
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amongst our participants that the current physician-led care model at our academic centre 
was not doing ‘enough’; that is, participants were unsure if their care approach was 
making a difference in patients’ and caregivers’ daily lives.  As Dr. Thompson 
(neurologist) stated:  “we can do a lot better.”    
HCPs also seemed to struggle striking a balance between their role as a patient advocate 
with their reliance on—and need to support—caregivers.  While participants stated that 
they encouraged patients to direct the clinical encounter, they raised concerns that 
patients’ progressive cognitive decline and behavioral impairments challenged education 
and symptomatic management, and they had to rely on caregivers’ to provide health 
information as patients’ health deteriorated.  Moreover, the hereditary nature of DM1 and 
HD—and the complex care needs patients require as they progressively decline—requires 
health care professionals to address the needs of caregivers and those at-risk (Sturrock & 
Leavitt, 2010).  In addition, our findings resonate with previous literature (Heatwole, 
2012; LaDonna, Koopman, Ray & Venance, In Press) that suggests that issues of clinical 
concern to HCPs may not be what patients and caregivers are aware of or want to 
address.  In particular, while HCPs focus on symptoms that may cause morbidity or 
mortality, patients and caregivers are generally concerned with issues that impact their 
relationships (Cup et al, 2011) and participation in education, employment, and leisure 
and recreational activities (Gagnon, Mathieu & Noreau, 2007).  We speculate that our 
physician participants perceived that they were qualified to treat symptoms, but were less 
comfortable addressing patients’ and caregivers’ social and quality of life issues.   This 
has important implications for treatment approaches and raises questions about patient-
centered clinical care models: Is care still ‘patient-centred’ if HCPs address issues they 
know to be important, even if they are not prioritized by patients and families? Are HCPs 
trained adequately to maintain patient-centred care as patients functionally 
decline?  Finally, are health care teams sufficiently nimble to engage allied health 
professions who may be better equipped to address patients' evolving needs?  
Reconciling these questions and complications to create a clinical model that is 
responsive to patients’ and caregivers’ needs is challenging.  The multi-disciplinary team 
at our institution’s HD clinic seemed to alleviate some of these challenges.  In contrast, 
192 
 
the neuromuscular specialists described that there was not a structure in place to support a 
multi-disciplinary DM1 clinic, and they differed in their beliefs about the feasibility and 
utility of creating one.  Further, our participants suggested that—in the absence of 
disease-halting or curative treatments—that their main role was to provide hope for 
patients at each stage of their disease process through education, advocacy, support, and 
medical management.    
We question, however, whether the traditional ‘neurologist-as-quarterback’ clinical 
model described by our participants is the most efficient and effective model for 
providing hope and addressing the evolving needs of patients and caregivers.  
Furthermore, participants suggested that the physician’s role may become less useful as 
patients deteriorate because the issues that physicians are best trained to address may not 
be the issues that concern patients and caregivers most.  Too often, HCPs efforts to make 
a difference in patients’ and caregivers’ lives may  focus on the ‘margins’ of the illness 
experience – those things that are readily addressed by traditional medical models of care, 
such as providing education about illness, prescribing medications to treat symptoms, and 
assessing and preventing complications.  We are not suggesting that these efforts are not 
important.  Rather, we are suggesting that these efforts may be insufficient, and may miss 
critical opportunities to make a difference in patients’ and caregivers’ daily lives. 
Participants in the present study recognized that nurses and allied health professionals 
become increasingly more important as patients’ symptoms progress, perhaps because 
their expertise is better aligned to the needs of patients and families with evolving chronic 
illnesses.  We therefore propose that alternate models of care and leadership, including 
family health care teams, or rehabilitation or nurse-led clinics, may have merit in these 
populations.  Research suggests that a chronic care model for neurological conditions 
should be an ‘intersectoral collaboration’ between policy makers, community members, 
and the health care system (Jaglal, 2014).  Moreover, multi-disciplinary, nurse-led clinics 
are the standard model for other chronic disease populations including heart failure 
(Strömberg et al, 2003) cancer (Moore et al, 2002), and diabetes (Denver, Barnard, 
Woolfson & Earle, 2003); this research suggests that patients attending nurse-led clinics 
have improved self-care behaviors and/or better outcomes.  Our findings support 
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Chouinard and colleagues (2009) who proposed a nurse-led model for the care of patients 
with DM1.  While physicians remain integral to diagnosis and treatment, we propose that 
nurses are ideally suited to providing holistic, patient-centered care for patients and their 
families along the disease trajectory; that is, nurses are able to monitor symptoms and 
treat complications while also providing education, advocacy and on-going support.  
Nurses are trained to see--and provide emotional support—to the patient and caregiver as 
a unit (personal communication, Wilma J. Koopman), and may therefore be best-suited to 
creating a comfortable clinic space where patients and caregivers can have their complex 
biopsychosocial needs addressed.   
Work is currently being done to create and assess a nurse-led, integrated clinical care 
pathway for DM1 at a neuromuscular clinic in Quebec (Chouinard et al 2009, Gagnon et 
al, 2010).  The DM1 clinic is led by a nurse care manager (NCM) who works with an 
interdisciplinary team to fulfill the essential care roles identified by our study 
participants; that is, the NCM monitors symptoms, treats complications, educates, and 
supports the psychosocial needs of the patient and his or her family (Gagnon et al 2008).  
Moreover, several clinics for DM1 and HD in the United States are funded by patient 
advocacy groups that support a multi-disciplinary group of clinicians to provide care and 
present research opportunities to patients and families (Muscular Dystrophy Association, 
2014; Huntington’s Disease Society of America, 2014).   However, to our knowledge, 
while multi-disciplinary, nurse-led or the CCM-NC clinical models show promise, they 
have not yet been systematically evaluated or implemented across North America (Jaglal, 
2014; Gagnon et al 2008).     
7.5.1 Limitations and Future Directions 
This is a small study describing the perceptions and experiences of health care providers 
caring for patients with DM1 and HD at one Canadian academic centre.  We recognize 
that clinics and treatment approaches may vary at different locations, and our highly 
contextualized study is therefore not generalizable to other settings.   
Study participants described the challenges of supporting family physicians to care for 
DM1 and HD in the community.  We did not, however, interview any family physicians 
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about their perceptions of, and approaches to, providing primary care for these 
individuals.  Similarly, we suggest that nurse-led clinics might be a useful model of care 
for DM1 and HD patients, yet recruitment challenges and the limited number of nurses 
specializing in DM1 and HD at our institution precluded greater nurse participation.   
However, since care for patients with DM1 and HD is complex, future research should 
explore the perspectives of nurses, family physicians and other care allied health 
professionals.  Finally, it is essential to understand the experiences and health care 
expectations of DM1 and HD individuals and their families prior to proposing a model of 
care. 
7.6 Conclusion 
Despite challenges providing patient-centered care, HCP participants perceive that DM1 
and HD patients benefit from clinical follow-up with expert clinicians who are proactive 
about managing complications, providing support, and conveying hope.  However, our 
findings suggest that patients’ and caregivers needs may not be sufficiently addressed by 
traditional physician-led clinical models.  Moreover, participants identified a need for 
greater involvement from allied health professionals, and we suggest that nurses are well-
suited for enacting a holistic care approach.  It may also be necessary to modify current 
medical education curricula and resident training programs to ensure that clinicians are 
better equipped to holistically integrate the complex needs of patients living with chronic 
disease into collaborative practices.  Regardless, we propose that research exploring 
clinical models for patients with complex physical, cognitive and behavioral needs is 
warranted.  We anticipate that our findings will add to scholarly conversations about 
patient-centered care for patients with complex chronic conditions, and that our findings 
may resonate with-- and inform-- care practices for various patient populations who 
experience unrelenting, chronic and progressive physical and cognitive decline. 
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Chapter 8 
8 Discussion 
Patient-centered care—“care that is respectful of and responsive to individual patient 
preferences, needs, and values” (Institute of Medicine, 2014)—may be challenged by 
DM1-affected individuals’ complex needs (Gagnon et al, 2010; Heatwole et al, 2012), 
and the lack of disease-halting or curative treatments.  Limited research has explored the 
perspectives of DM1-affected individuals and their caregivers, and researchers have not 
yet used qualitative methodologies to explore patient-centered care provision in DM1.  
Similarly, patients’ motivations for maintaining follow-up at a neurology outpatient clinic 
are unknown.  The relative absence of DM1 patients’ experiences in the literature 
questions whether their voices are being heard or if their psychosocial needs are being 
met.   
Thus, the purpose of this research was to add patients’ and caregivers’ perspectives to the 
literature and to explore how patient-centered care provision for DM1 is perceived—and 
if it is feasible—at one academic centre in Ontario, Canada.   Three qualitative 
methodologies were used to illuminate patients’ and caregivers’ experiences living with 
DM1 (Chapters III and IV), their health care expectations, and their motivations for clinic 
attendance (Chapter VI).  Individuals living with Huntington’s disease and their 
caregivers were purposively sampled to increase the breadth and depth of the experiences 
of clinical care for patients with inherited and life-limiting neurological conditions 
(Chapter VI).  I also explored health care providers’ perspectives about providing care for 
these patients and families (Chapters VI; Chapter VII).  Findings from this research 
suggest that there are numerous challenges—and rewards—to effective patient-centered 
care provision for DM1 and HD. However, most patient, caregiver and HCP participants 
perceived that affected individuals and their families receive tangible benefits from 
maintaining follow-up at a neurology outpatient clinic.  Patient and caregiver participants 
described being proactive seekers of information and care, and they conceptualized the 
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neuromuscular and movement disorders clinics at our institution as a ‘safe place’ (Figure 
8-1).    
 
Figure 8-1: Clinic is a “Safe Place” 
8.1 What is Already Known 
8.1.1 Myotonic Dystrophy (DM1) 
DM1 is a multi-system disorder that is characterized by an unrelentingly progressive and 
devastating disease course.  The muscular, cardiac, respiratory, endocrine, 
gastrointestinal and central nervous systems are affected, and primary clinical 
manifestations include progressive muscle weakness, muscle stiffness due to delayed 
relaxation (myotonia), arrhythmias, excessive sleepiness, early-onset cataracts, and 
cognitive and behavioral manifestations, namely low IQ and apathy (Harper, 2001).  In 
particular, “the general clinical impression in most cases is one of apathy, decreased 
emotional participation, and psychomotor delay” (Meola & Sansone, 2007, p. 296), and 
there is a well-recognized DM1 personality pattern described in the literature (Winblad, 
Lindberg & Hansen, 2005).  In particular, “a TCI (Temperment and Character Inventory) 
based portrait of the average DM1 patient, then, is that of a private, introverted individual 
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with little self-esteem, burdened by fatigue and low energy” (Winblad, Lindberg & 
Hansen, 2005, p. 290).  While it is unknown if the emotional symptoms are a reaction to 
the disease process or an organic part of the disorder caused by central nervous system 
lesions (or both), it is important for health care providers to assess cognitive and 
behavioral impairments because they may have a significant effect on an individual’s 
quality of life (Bungener, Jouvent & Delaporte, 1998).   
Qualitative and quantitative inquiries have described the impact of DM1-affected 
individuals’ physical, cognitive and emotional symptoms on social participation 
(Gagnon, Mathieu & Noreau, 2007; Gagnon et al, 2008), their relationships (Cup et al, 
2011), and their quality of life (Laberge et al, 2013)).   Care for DM1-affected individuals 
may be challenged by their variable symptom presentations (Heatwole, 2012; Gagnon et 
al, 2010) lifestyle risk factors and challenges engaging in health promotion behaviors 
(Gagnon et al, 2013). Apathy and disinterest in their health have been attributed causality 
for missed clinical appointments (Meola & Sansone, 2007) or failure to adhere to 
treatment recommendations (Chouinard et al, 2009). Guidelines for DM1 care have been 
proposed (Gagnon et al 2007, Chouinard et al, 2009), but these have not yet been 
systematically implemented or evaluated.   Potentially, one of the main challenges facing 
the implementation and evaluation of patient-centered care provision is the lack of a 
uniform conceptualization or definition of what ‘patient-centered’ care is and how it is 
applied in practice.  In particular, clinicians and researchers debate the feasibility, 
achievability and desirability of taking a patient-centered care approach (Berwick, 2009). 
8.2 What Participants Have Taught Us 
8.2.1 Challenges to providing patient-centered care for individuals 
with DM1 
While participants described that on-going clinic attendance is beneficial for DM1-
affected individuals and their caregivers, this research uncovered several challenges to 
patient-centered care.   
205 
 
8.2.1.1 Variable knowledge 
Studies describe that DM1 patients’ have variable understanding about their condition 
(Laberge et al, 2010; Faulkner, 1998) and I speculate that this impacts clinical practice.  
Our findings suggest that while some participants were well-informed about their 
condition and were able to articulate their symptoms, some individuals accepted 
misinformation about DM1 as fact—particularly in regard to genetic information—that 
they in turn used to make important decisions (Chapter V).  This occurred despite formal 
genetic counseling consultations and discussions during clinic visits.  Previous research 
suggests that individuals with DM1 either do not accept their diagnosis or do not 
understand the hereditary ramifications of their condition (Nätterlund, Sjöden & 
Ahlström, 2001).  These findings resonate with the present research, but we suggest that 
poor understanding of chronic health conditions is not specific to DM1; in particular, 
patients with other chronic health conditions may also have difficulty synthesizing and 
understanding complex genetic information (McKibbin et al, 2014).  It may therefore be 
necessary to assess patients’ knowledge at each clinic visit, or to provide patients with 
more frequent follow-up—perhaps with a nurse or social worker—to provide ample 
opportunity for patients to ask questions and to resolve knowledge gaps.    
8.2.1.2 Striking a Balance:  Providing Care for Patients with 
Chronic Neurological Conditions 
Findings from Hard to Swallow (Chapter III) and Picturing the Experience (Chapter IV) 
resonate with previous literature suggesting that patients and clinicians may have 
divergent clinical care goals (Heatwole et al, 2012).  While speculative, it appears that 
patients and caregivers focus primarily on symptoms that impact their daily activities and 
quality of life (Chapter III, Chapter IV), while clinicians focus on symptoms that either 
have the potential to cause serious complications or result in sudden death, and/or those 
that they are able to treat.  Some of the caregivers in the Hard to Swallow study were 
perplexed that I was interested in studying dysphagia since they perceived that their loved 
one had to face far more troubling symptoms like weakness and fatigue.  Similarly, none 
of the patient participants in the Picturing the Experience study volunteered swallowing 
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dysfunction as one of their troubling symptoms, and only reflected on it when asked 
direct questions about their diet.  It is possible that dysphagia develops slowly and 
individuals are therefore able to compensate for their swallowing problems by developing 
strategies like avoiding certain foods, regurgitating objects or having liquids with meals.  
We speculate that caregivers’ lack of concern mirrors their loved one’s attitudes about 
swallowing dysfunction; that is, swallowing is—in essence—not on patients’ or 
caregivers’ ‘radar’ because patients have found ways to cope with, or adapt to this slowly 
progressive symptom.  In contrast, weakness and fatigue significantly impacted 
participants’ ability to work or participate in recreational or leisure activities.  This 
finding resonates with previous research that describes symptom impact on DM1-affected 
individuals’ social participation (Gagnon, Mathieu & Noreau 2007; Gagnon et al, 2008) 
and health related quality of life (Antonini et al, 2006; Peric et al, 2010; Laberge et al 
2013).  Cup et al (2011) also described the impact of chronic neuromuscular conditions 
on the marital relationship and on caregivers’ quality of life (Geirdal, Lund-Petersen & 
Heiberg, 2014).  Our caregiver participants’ described having to prod loved ones to leave 
the house, exercise or participate in social activities.  Some caregivers also described that 
their loved ones’ fatigue impacted their relationship; that is, individuals with DM1 were 
either too tired to participate in activities, or they would fall asleep at inappropriate times 
– sometimes in the middle of a conversation.  
We speculate that physician-led clinical care models typically address diagnosis and 
treatment; consequently patients’ and caregivers’ educational and psychosocial needs 
may not be sufficiently managed.  HCP participants described that allied health 
professionals should become more involved in care as patients’ symptoms progress 
(Chapter VII); we therefore suggest that there is a need for a holistic clinical approach 
that addresses patients’ symptoms and emotional needs while supporting patients and 
families with their daily challenges.   
8.2.1.3 Adapting the care plan across the disease trajectory 
Findings suggest that clinical care evolves throughout the patients’ disease trajectory 
(Chapters VI and VII).  This may occur not only because of progressive functional 
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decline, but also because of the emotional difficulty patients may experience as they 
adjust to their diagnosis and their shifting identity (Chapter IV; Nätterlund, Sjöden & 
Ahlström, 2001).  Patients, caregivers and HCPs described that patients’ and caregivers’ 
motivations for clinic attendance changed over time.  Moreover, while HCPs described 
having a ‘template’ for clinic visits, it was evident that they adapted their approach based 
on a patient’s stage of disease and his or her cognitive or behavioral abilities.   
Despite the lack of disease-halting or curative treatments— and other HCP-identified 
challenges providing patient-centered care for individuals with DM1 (and HD)— all 
participants described that patients and caregivers experience tangible benefits from on-
going clinical care. Findings from an exploratory study in the United Kingdom that 
examined the experiences of patients attending a neuromuscular disease rehabilitation 
centre found that patients attend clinic to obtain knowledge and understanding about their 
condition from experts, and to receive community support from individuals with similar 
conditions (Hartley, Goodwin & Goldbart, 2011).  In turn, the rehabilitation centre may 
become a place of “empathy” that can provide hope for patients (Hartley, Goodwin & 
Goldbart, 2011).    
However, ‘hope’ was not universally experienced by patients; instead, patient and 
caregiver participants seemed to attend clinic to be understood, and to collaborate with 
experts to educate the general and medical communities.  Participants were aware that 
there was likely little that could be done to help them; consequently, participants wanted 
to help future generations by collaborating with experts to work toward therapeutic 
advancements and ‘fight’ for a cure.  This resonates with the experiences of patients with 
other chronic illness (Karlawish, Casarett & James, 2002; Tong et al, 2008 , Madsen, 
Holm & Riis, 1999)  but was perhaps an unexpected finding given the literature that DM1 
patients may lack awareness or motivation (Chouinard et al, 2009; Meola & Sansone, 
2007). 
The idea of clinic as a place of hope may therefore need to be re-considered; instead, we 
suggest that clinic be conceptualized as a place to empower patients through education 
and collaboration.   For example, patients and their families may not fully appreciate the 
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implications of their life-limiting symptoms, so clinic is an ideal—and perhaps safe—
place for experts to educate patients and their families, and engage them in conversations 
about self-management.   Clinic visits are an also an opportunity for HCPs to collaborate 
with patients to advocate for research or to educate medical and other health professional 
students and the general public about these uncommon illnesses.   
8.2.2 Being Proactive 
Despite challenges, the patients at the centre of the care at our institution demonstrated 
that they actively seek information about their condition and opportunities to make a 
difference for future generations.  This research found that, in general, the patient 
participants attended their clinic appointments and were interested in their health. 
Most participants in the studies described in Chapters III-VII were actively engaged and 
articulate about the impact of symptoms on their daily lives and their health care 
expectations. I recognize that individuals with DM1 have variable disease presentations, 
and that our research participants were purposively recruited.  However, we speculate 
that—in general—DM1-affected individuals’ physical appearance and speech 
impairments may cause them to be unfairly labeled by the general public or health care 
providers.   Participants in this research perceived that they were judged by members of 
their community.  This resonates with previous muscular dystrophy literature that 
suggests that individuals living with different forms of muscular dystrophy experience 
judgment, shame or stigma (Boström & Ahlström, 2004).  However, the photovoice 
participants described that they found solutions for coping with their shifting identity and 
for managing the challenges of everyday activities.  Participants were resilient, and 
problem-solved solutions for daily challenges like opening doors, jars or bottles, and 
participants were also able to mitigate difficulties with study procedures.  For instance, 
participants recruited friends or caregivers to assist them with picture taking, participate 
in their individual interview, or transport them to the clinic visit. 
Patients were not only active research participants, but also active in deciding if and 
when to seek health information and social support (Chapter VI).  Some chose not to 
attend support groups or to read about DM1, while others actively sought information 
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from medical journals and patient advocacy groups (Chapters III-VI).  Participants took 
their role as patient educators seriously; that is, participants stated that their clinic 
attendance taught HCPs about their uncommon, variable and unpredictable condition 
(Chapter VI).  A qualitative analysis of interviews and focus groups conducted with 30 
patient educators/mentors living with arthritis found that sharing their stories with health 
professional students helped them “reframe” their illness from a negative experience into 
something that makes a positive contribution to student learning.   In turn, the patient 
educators believed that their contributions may improve the wider health care system 
(Laukner, Doucet & Wells, 2012).   Similarly, our participants valued their own 
expertise, and took it upon themselves to educate non-specialist clinicians or members of 
the public by giving them information about DM1 or participating in patient advocacy 
groups (Chapters III-VI).  One of our study participants is a leader in the DM1 patient 
advocacy community, and another shared his pictures and experiences with a graduate 
class in occupational therapy to teach future clinicians about DM1. 
8.3 What This Research Adds 
This research is the first to explore caregivers for individuals with DM1 and dysphagia, 
collaborate with participants using photovoice, and include the perspectives of patients, 
caregivers, and HCPs about the expectations and motivations for ongoing clinic 
attendance. While the experiences of caregivers for individuals with muscular dystrophy 
have been explored, these studies did not specifically address the experience of providing 
care for an individual with dysphagia.  Moreover, caregiving for DM1-affected 
individuals has not previously been explored in the context of caregivers’ lived time, 
space, bodies and relationships.  This work contributes to a deeper understanding of the 
perspectives of providing care for individuals with DM1, and supports previous research 
suggesting that symptoms that clinicians prioritize are not necessarily those that are most 
concerning for individuals with DM1 and their caregivers (Heatwole et al, 2012).      
This research used photovoice—a novel and innovative qualitative methodology— to 
engage DM1-affected individuals as research collaborators.   The visual representation of 
patients’ perspectives of their illness experience—including their knowledge and 
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misperceptions about DM1 (Chapter IV)—is a novel contribution to the literature. This 
research also contributes photographic representations of DM1 patients’ problem-solving 
techniques and provides insight into how they cope with the challenges of daily activities.   
Previous research has explored European neuromuscular disease patients’ experiences of 
attending a rehabilitation centre (Hartley, Goodwin & Goldbart, 2011); however, our 
research advances this work by  contributing an exploration of patients’, caregivers’ and 
health care providers’ perceptions of health expectations and motivations for on-going 
clinic attendance across the disease trajectory.  To our knowledge, DM1 and HD have not 
previously been explored together to provide a greater sense of the experiences of 
patients living with genetic, life-limiting neurological conditions.  The idea that patients’ 
and caregivers’ motivations for clinic attendance change over time has also not been 
reported.  From this research, we learned that DM1 and HD individuals and their 
caregivers are proactive about managing patients’ health, and are driven by symptomatic 
management, altruism, and reassurance.   In particular, they look for information and 
social support in a clinical context that they experience as ‘safe’.   Previous work has 
described a neuromuscular clinic as a place of “empathy” (Hartley, Goodwin & Goldbart, 
2011) that provides supportive care (Gagnon et al, 2010).  However, DM1 and HD 
patients’ and caregivers’ conceptualization of clinic as a ‘safe place’ is a novel finding.  
This research contributes that—in the absence of disease-halting or curative 
pharmaceutical therapies—clinic attendance for these individuals is considered treatment.       
To our knowledge, neither HCPs descriptions of their roles caring for patients with DM1 
and HD, nor the challenges and rewards of patient-centered care for this population, have 
previously been reported.   HCPs describe patient-centered care for DM1 and HD as a 
‘balancing act’ in which HCPs have to balance (1) patients’ medical and psychosocial 
needs, (2) their sense of futility that their best efforts will not prevent patients from 
deteriorating, (3) their rewards for caring for these individuals (4) and the need to be a 
patient advocate while addressing caregivers’ concerns.  Hope might be expected as a 
dominant theme and has been suggested as a reason for creating neuromuscular disease 
clinics (Hartley, Goodwin & Goldbart, 2011), and here, HCPs identified providing hope 
as one of their main roles in the care of these individuals.  However, hope was not 
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universally experienced—or sought—by patients and their caregivers.  Instead, 
participants appeared more interested in proactively seeking reassurance that they were 
being cared for, and that they were collaborating with HCPs to find answers to their 
uncommon conditions.  Our novel research findings suggest that maintaining clinical 
follow-up empowered participants to exert control over their unpredictable illness.  
Clinicians and researchers may therefore need to rethink assumptions about what patients 
may want from their care, and perhaps offer patients opportunities—including research, 
education or advocacy roles—that will enable them to make tangible contributions to 
their health.  Finally, perhaps the most novel and significant contribution of this work is 
that it has identified that individuals with DM1 are proactive research participants and 
collaborators, advocates and educators. 
8.3.1 Implications  
Findings from this research have started to change practice.  One clinician noted that 
seeing the photographs and reading participants’ experiences from the Picturing the 
Experience (Chapter IV) study was the first time that she felt that she understood and 
‘knew’ her DM1 patients.   Prior to reading the manuscript, this clinician had difficulty 
identifying whether patients were interested in participating in clinic or whether they 
fully grasped the implications of DM1.  However, the photovoice study gave this 
clinician a tangible ‘picture’ of patients’ lives, and she was therefore better able to 
understand how patients cope with their condition.   
Another clinician stated that she altered her approach to clinic visits after reading the 
Hard to Swallow manuscript.  Previously, this clinician had devoted a significant amount 
of clinic time to addressing dysphagia at each visit and discussed the importance of diet 
and swallowing studies. After reading the paper and discovering that swallowing function 
may not be what patients and clinicians want to spend clinic time addressing, this HCP 
altered the approach and switched the focus from discussing potential complications to 
ensuring that patients knew how to safely manage a choking episode (i.e. “what is the 
universal sign for choking?”  “do you  know the Heimlich maneuver?”). 
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8.3.1.1 Considerations Using Qualitative Research for  
Exploring DM1  
Relatively few studies have qualitatively explored individuals living with myotonic 
dystrophy, and it is unknown if patients’ cognitive and behavioral impairments have 
impacted the lack of patient-centered research in this population.   However, interviews 
with DM1 individuals were excluded from previous research because patients’ speech 
impairments complicated interviews, and the researchers’ perceived that were not able to 
reflect on their condition (Nätterlund, Sjöden & Ahlström, 2001).  There were challenges 
using these methodologies in DM1 including (1) difficulty conducting and transcribing 
interviews with patients’ with speech impairments, (2) fatigue precluding participation, 
and (3) participants’ challenges with problem-solving.  For example, it was difficult to 
conduct and transcribe an interview for a participant with dysarthria, one participant 
withdrew from photovoice because of fatigue, and two participants were unable to use the 
digital cameras.  However, the benefits of using qualitative methodologies and methods 
with DM1-affected individuals were considerable.  All participants—regardless of their 
symptom presentation and challenges complying with study procedures—had keen 
insights into their condition and the impact of symptoms on their daily lives.  They also 
were able to articulate their strategies for proactively managing their condition and 
discussing their health care expectations. I am confident that qualitative research methods 
and methodologies are appropriate and useful for adding DM1 patients’ voices to the 
literature. All participants were enthusiastically engaged in the research process, and 
some appreciated having the opportunity to share their stories and educate researchers 
and clinicians about DM1:   
It (research study) gives them an idea of what it’s like and learn that it’s not all 
negative and that … like I say, you don’t know what it’s like unless you live it, 
but to take pictures you can see what my life is like.  Not all negative, but not all 
positive either.  Yeah, it’s a good idea (Photovoice Participant 4). 
The greatest challenge of using qualitative research came not from patient participants, 
but from trying to have their voices included alongside those of basic scientists and 
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clinicians in academic medical journals.  Previous research has explored the limited 
proliferation of qualitative research in these journals (Gagliardi & Dobrow, 2011; Shuval 
et al, 2011).  Two medical journals declined to send our photovoice article for peer 
review; one editor stated that their journal “did not publish this kind of work” and another 
sent a thoughtful email in which he expressed his personal interest in our manuscript but 
stated that financial limitations and page restrictions prevented him from publishing 
“sociological” work.  Given that ‘patient-centered’ care is a ‘hot topic’ in medical 
education and care provision, it is puzzling that medical journals are reluctant to publish 
qualitative work that directly reflects patients’ and caregivers’ experiences.  However, we 
suspect that this is not an uncommon experience despite calls for greater inclusion of 
qualitative work in medical journals (Malterud, 2001), and discussions about the 
importance and usefulness of qualitative methodologies for exploring neurological 
conditions (Macdonald & Chalk, 2011).  I have argued throughout this research that 
patient-centered care cannot be examined without exploring patients’ experiences and 
needs.  Qualitative research is well-suited to this, and steps—including educating the 
wider medical community about the value and rigor of qualitative inquiry, finding 
reviewers skilled in qualitative research for scientific journals, and creating better funding 
opportunities for qualitative research—need to be implemented in order for qualitative 
research to become more widely-distributed (Krumholz, Bradley & Curry, 2013).     
8.3.1.2 Future Directions 
The theme of ‘patients (and caregivers) as educators’ was identified across my research 
studies, and this is an important area for future exploration, particularly since anecdotal 
evidence suggests that two clinicians changed aspects of their practice based on patients’ 
and caregivers’ perspectives.  A modified grounded theory analysis of 356 second year 
medical students’ written reflections about the role of patient educators in their 
undergraduate medical education found that patient educators enabled students to see 
chronic disease in context with patients’ lives.  In turn, they were better able to 
understand the complexities of patient-centered care.  Students viewed patient educators 
as experts and collaborators who enhanced their medical education (Oswald, Czupryn, 
Wiseman & Snell, 2014).  Therefore, I suggest that patients should be encouraged to 
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speak to medical and other health professional students, and participate in medical rounds 
presentations with consultant specialists.  In particular, future studies might pair medical 
students with patients to conduct or evaluate research. 
However, while some DM1 participants described themselves as educators who were 
responsible for teaching the general public or non-specialist HCPs about their uncommon 
condition (Chapter IV; Chapter VI), they had variable understanding about their DM1 
(Chapter V).  We identified knowledge gaps—particularly in regard to genetic 
information—but we did not formally assess participants’ health literacy.  Since poor 
health literacy can negatively affect patients’ health outcomes (DeWalt et al, 2004), a 
formal assessment of health literacy in DM1 is warranted. 
Similarly, patients and caregivers may lack awareness about the implications of their 
symptoms; consequently, patients’, caregivers’ and HCPs’ goals may not align.  This 
raises important questions about how clinicians can address issues that may contribute to 
morbidity and mortality while addressing concerns that are important to patients and their 
caregivers.  I suggest that the first step is to continue to ask patients what is important to 
them and to disseminate this information to clinicians and researchers; in turn, additional 
research and better education for patients, caregivers and clinicians is necessary to 
highlight the issues of concern and develop innovative ways to create patient education 
materials or other educational initiatives.  For example, including participants’ 
photographs in educational materials may be a novel way to share coping strategies with 
the DM1-patient community.  Further, nurses and allied health professionals may close 
some of the gaps by addressing psychosocial concerns while physicians provide medical 
surveillance.  
This research suggests that patient-centered care in DM1 warrants further investigation 
and focus the role of caregivers in clinical care.  It may therefore be important to re-frame 
the conceptualization of ‘patient-centered’ care to one that is ‘patient and family 
centered’.  In particular, I question whether the physician-led clinical care model at our 
academic centre is the most efficient approach for meeting patient and caregiver 
participants’ complex needs.  Findings suggest that physicians may provide care on the 
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‘margins’ of the illness experience; that is, they are able to provide education and 
symptomatic management, but HCP participants identified that they have limited time—
and perhaps training—to address psychosocial needs.  While physicians are integral to 
DM1 patient care, I speculate that consolidated clinic models—such as family health care 
teams, rehabilitation centres or nurse-led clinics—may be important to explore.  An 
integrated care pathway led by a nurse care manager (NCM) in Quebec has been 
evaluated, and findings suggest that the NCM provides systematic, comprehensive and 
evidenced based follow-up to DM1-affected individuals.  This evaluation of the NCM is 
a first step to developing the role of nursing at other neuromuscular clinics, but has not 
yet been formally implemented or evaluated at other centres (Gagnon et al, 2010). 
8.3.2 Trustworthiness 
A number of strategies can be used by qualitative researchers to establish the 
trustworthiness of their findings.  Guba & Lincoln (1985) suggest that trustworthy 
qualitative research demonstrates credibility, transferability, dependability and 
confirmability.  We used several of the approaches described by Shenton (2004) to ensure 
that these criteria were met.  Member checking, an iterative data collection and analysis 
process, and peer debriefing and review were used to ensure that we represented a “true 
picture” (Shenton, 2004, p. 63) of participants’ experiences (credibility).  Member 
checking was part of the iterative data collection and analysis process; that is, questions 
were added to the semi-structured interview guides to probe themes identified in early 
interviews (Chapter III, IV and VI).  We were therefore able to determine whether 
experiences resonated with multiple participants; in addition, we purposively recruited 
two participants for the photovoice study (Chapter IV) to add their perspectives and to 
review preliminary study findings with them.  Additionally, the research team met 
frequently to discuss the analysis; any discrepancies were resolved by consensus.  Finally 
three of the studies have been peer reviewed (Chapter III; Chapter VI; and Chapter V); 
one has been accepted (Chapter III), one accepted with revisions (Chapter IV), and one 
invited for further consideration (Chapter V).  Transferability—rather than 
generalizability—is the goal of qualitative inquiry.  We ensured that readers have enough 
information to evaluate resonance and whether findings can be applied to another setting 
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by providing a detailed description of the research context and participants.  In addition, 
there is an extensive audit trail of each study that details the data collection and analysis 
procedures; other researchers can therefore recreate our studies (dependability), although 
we anticipate that the co-construction of findings from different researchers and 
participants might produce different interpretations.  Finally, a combination of previously 
mentioned strategies—including a detailed audit trail, member checking and iterative 
data collection and analysis—ensures that our findings were identified through rigorous 
and emergent research (confirmability).   
8.4 Conclusion 
This research sought to explore the experience of living with—and providing care for—
DM1; three qualitative research methodologies were used to examine questions 
pertaining to lived experience and patient-centered care provision.  The objectives of this 
research (1) to add patients and caregivers voices to the literature and (2) explore health 
care expectations and motivations for on-going clinic attendance to add to scholarly 
conversations about patient-centered care provision in DM1 have been met. Patients and 
caregiver participants were proactive about seeking health information, managing their 
care, and were engaged research collaborators.  While care for DM1 patients is 
complicated by their variable symptom presentations, the lack of disease-halting or 
curative treatments, and limited time to address patients’ and caregivers’ psychosocial 
needs, findings suggest that patients and caregivers benefit from regular clinical care.  
Findings have important implications for patient-centered care provision in DM1; that is, 
we have identified that current physician-led clinical models at our academic centre may 
not be meeting the complex biopsychosocial needs of individuals with DM1, and we 
suggest future avenues for research. Moreover, the variable definitions and 
conceptualizations of patient-centered care make it difficult—if not impossible—to 
evaluate current models.  Therefore, a unified patient-centered care definition—based on 
the experiences of patients, caregivers, and clinicians—needs to be devised, implemented 
and evaluated; qualitative research is well-suited to this inquiry.     
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